Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2017 | Jan. 26, 2018 | Jun. 30, 2017 | |
Document and Entity Information [Abstract] | |||
Entity Registrant Name | HEALTHCARE REALTY TRUST INC | ||
Entity Central Index Key | 899,749 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2017 | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2,017 | ||
Document Fiscal Period Focus | FY | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Common Stock, Shares Outstanding | 125,144,327 | ||
Entity Public Float | $ 3,878,376,057 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Real estate properties: | ||
Land | $ 201,283 | $ 199,672 |
Buildings, improvements and lease intangibles | 3,601,460 | 3,386,480 |
Personal property | 10,314 | 10,291 |
Construction in progress | 5,458 | 11,655 |
Land held for development | 20,123 | 20,123 |
Total real estate properties | 3,838,638 | 3,628,221 |
Less accumulated depreciation | (897,430) | (840,839) |
Total real estate properties, net | 2,941,208 | 2,787,382 |
Cash and cash equivalents | 6,215 | 5,409 |
Restricted cash | 0 | 49,098 |
Assets held for sale and discontinued operations, net | 33,147 | 3,092 |
Other assets, net | 213,015 | 195,666 |
Total assets | 3,193,585 | 3,040,647 |
Liabilities: | ||
Notes and bonds payable | 1,283,880 | 1,264,370 |
Accounts payable and accrued liabilities | 70,995 | 78,266 |
Liabilities of assets held for sale and discontinued operations | 93 | 614 |
Other liabilities | 48,734 | 43,983 |
Total liabilities | 1,403,702 | 1,387,233 |
Commitments and contingencies | ||
Stockholders' Equity: | ||
Preferred stock, $.01 par value; 50,000 shares authorized; none issued and outstanding | 0 | 0 |
Common stock, $.01 par value; 300,000 and 150,000 shares authorized; 125,132 and 116,417 shares issued and outstanding at December 31, 2017 and 2016, respectively. | 1,251 | 1,164 |
Additional paid-in capital | 3,173,429 | 2,917,914 |
Accumulated other comprehensive loss | (1,299) | (1,401) |
Cumulative net income attributable to common stockholders | 1,018,348 | 995,256 |
Cumulative dividends | (2,401,846) | (2,259,519) |
Total stockholders’ equity | 1,789,883 | 1,653,414 |
Total liabilities and stockholders' equity | $ 3,193,585 | $ 3,040,647 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2017 | Dec. 31, 2016 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, authorized shares | 50,000,000 | 50,000,000 |
Preferred stock, issued shares | 0 | 0 |
Preferred stock, outstanding shares | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, authorized shares | 300,000,000 | 150,000,000 |
Common stock, issued shares | 125,132,000 | 116,417,000 |
Common stock, outstanding shares (shares) | 125,132,000 | 116,417,000 |
Consolidated Statements of Inco
Consolidated Statements of Income - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
REVENUES | |||
Rental income | $ 422,852 | $ 407,481 | $ 383,333 |
Mortgage interest | 91 | ||
Other operating | 1,647 | 4,149 | 5,047 |
Total Revenue | 424,499 | 411,630 | 388,471 |
EXPENSES | |||
Property operating | 157,233 | 146,458 | 140,195 |
General and administrative | 32,992 | 31,309 | 24,716 |
Acquisition and pursuit costs | 2,180 | 4,496 | 2,209 |
Depreciation and amortization | 142,472 | 127,690 | 116,614 |
Bad debt, net of recoveries | 169 | (21) | (193) |
Total Expenses | 335,046 | 309,932 | 283,541 |
OTHER INCOME (EXPENSE) | |||
Gain on sales of real estate assets | 39,519 | 41,038 | 56,602 |
Interest Expense | (56,402) | (57,351) | (65,534) |
Loss on extinguishment of debt | (44,985) | (27,998) | |
Pension termination | (4) | (5,260) | |
Impairment of real estate assets | (5,385) | (3,639) | |
Impairment of internally-developed software | (654) | ||
Interest and other income, net | 896 | 375 | 389 |
Total other income (expense) | (66,357) | (15,942) | (46,094) |
INCOME FROM CONTINUING OPERATIONS | 23,096 | 85,756 | 58,836 |
DISCONTINUED OPERATIONS | |||
Income (loss) from discontinued operations | (9) | (71) | 715 |
Impairments of real estate assets | (121) | (686) | |
Gain on sales of real estate properties | 5 | 7 | 10,571 |
INCOME (LOSS) FROM DISCONTINUED OPERATIONS | (4) | (185) | 10,600 |
NET INCOME | $ 23,092 | $ 85,571 | $ 69,436 |
BASIC EARNINGS PER COMMON SHARE: | |||
Income from continuing operations (in dollars per share) | $ 0.18 | $ 0.79 | $ 0.59 |
Discontinued operations (in dollars per share) | 0 | 0 | 0.11 |
Net income (in dollars per share) | 0.18 | 0.79 | 0.70 |
DILUTED EARNINGS PER COMMON SHARE: | |||
Income from continuing operations (in dollars per share) | 0.18 | 0.78 | 0.59 |
Discontinued operations (in dollars per share) | 0 | 0 | 0.11 |
Net income (in dollars per share) | $ 0.18 | $ 0.78 | $ 0.70 |
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC (in shares) | 117,926,158 | 108,572,102 | 99,171,352 |
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - DILUTED (in shares) | 118,017,165 | 109,386,997 | 99,880,302 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Statement of Comprehensive Income [Abstract] | |||
NET INCOME | $ 23,092 | $ 85,571 | $ 69,436 |
Other comprehensive income: | |||
Reclassification adjustment for losses included in net income (Pension termination) | 2,519 | ||
Reclassification adjustment for losses included in net income (Interest expense) | 176 | 168 | 115 |
Losses on settlement of swaps arising during the period | (74) | (1,684) | |
Other comprehensive income | 102 | 168 | 950 |
COMPREHENSIVE INCOME | $ 23,194 | $ 85,739 | $ 70,386 |
Consolidated Statements of Equi
Consolidated Statements of Equity - USD ($) $ in Thousands | Preferred Stock | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Cumulative Net Income | Cumulative Dividends | Total Stockholders' Equity |
Beginning Balance at Dec. 31, 2014 | $ 0 | $ 988 | $ 2,389,830 | $ (2,519) | $ 840,249 | $ (2,007,494) | $ 1,221,054 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of stock, net of costs | 25 | 66,886 | 66,911 | ||||
Common stock redemption | (1,367) | (1,367) | |||||
Stock-based compensation | 2 | 6,027 | 6,029 | ||||
Net income | 69,436 | 69,436 | |||||
Amounts reclassified from accumulated other comprehensive loss arising from loss on defined benefit pension plan | 2,519 | 2,519 | |||||
Loss on interest rate swaps | 0 | (1,569) | (1,569) | ||||
Dividends to common stockholders ($1.20 per share) | (120,266) | (120,266) | |||||
Ending Balance at Dec. 31, 2015 | 0 | 1,015 | 2,461,376 | (1,569) | 909,685 | (2,127,760) | 1,242,747 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of stock, net of costs | 140 | 450,409 | 450,549 | ||||
Common stock redemption | (1,460) | (1,460) | |||||
Stock-based compensation | 9 | 7,589 | 7,598 | ||||
Net income | 85,571 | 85,571 | |||||
Loss on interest rate swaps | 0 | 168 | 168 | ||||
Dividends to common stockholders ($1.20 per share) | 0 | (131,759) | (131,759) | ||||
Ending Balance at Dec. 31, 2016 | 0 | 1,164 | 2,917,914 | (1,401) | 995,256 | (2,259,519) | 1,653,414 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of stock, net of costs | 84 | 248,508 | 248,592 | ||||
Common stock redemption | (1) | (3,017) | (3,018) | ||||
Stock-based compensation | 4 | 10,024 | 10,028 | ||||
Net income | 23,092 | 23,092 | |||||
Loss on interest rate swaps | 102 | 102 | |||||
Dividends to common stockholders ($1.20 per share) | (142,327) | (142,327) | |||||
Ending Balance at Dec. 31, 2017 | $ 0 | $ 1,251 | $ 3,173,429 | $ (1,299) | $ 1,018,348 | $ (2,401,846) | $ 1,789,883 |
Consolidated Statements of Equ7
Consolidated Statements of Equity (Parenthetical) - $ / shares | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Dividend per share to common stockholders (in dollars per share) | $ 1.20 | $ 1.20 | $ 1.20 |
Cumulative Dividends | |||
Dividend per share to common stockholders (in dollars per share) | 1.20 | 1.20 | 1.20 |
Total Stockholders' Equity | |||
Dividend per share to common stockholders (in dollars per share) | $ 1.20 | $ 1.20 | $ 1.20 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Statement of Cash Flows [Abstract] | |||
Net income | $ 23,092 | $ 85,571 | $ 69,436 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 142,472 | 127,690 | 116,614 |
Other amortization | 3,879 | 3,351 | 3,749 |
Stock-based compensation | 10,028 | 7,598 | 6,029 |
Amortization of straight-line rent receivable | (6,072) | (7,201) | (9,600) |
Amortization of straight-line rent liability | 1,497 | 67 | 771 |
Gain on sales of real estate assets | (39,524) | (41,044) | (67,229) |
Loss on extinguishment of debt | 44,985 | 27,998 | |
Impairment of real estate assets | 5,385 | 121 | 4,325 |
Pension termination | 5,260 | ||
Impairment of internally-developed software | 654 | ||
Equity income from unconsolidated joint ventures | (7) | ||
Provision for bad debts, net | 159 | (21) | (194) |
Changes in operating assets and liabilities: | |||
Other assets | (2,156) | (1,332) | (2,932) |
Accounts payable and accrued liabilities | (7,307) | 449 | (2,202) |
Other liabilities | 3,335 | (23,977) | 1,304 |
Net cash provided by operating activities | 179,766 | 151,272 | 153,983 |
INVESTING ACTIVITIES | |||
Acquisitions of real estate | (274,668) | (224,944) | (154,858) |
Development of real estate | (14,911) | (34,719) | (17,354) |
Additional long-lived assets | (80,613) | (71,433) | (48,769) |
Investment in unconsolidated joint ventures | (8,701) | ||
Proceeds from sales of real estate | 119,426 | 93,253 | 153,281 |
Proceeds from mortgages and notes receivable repayments | 19 | 19 | 1,918 |
Net cash used in investing activities | (259,448) | (237,824) | (65,782) |
FINANCING ACTIVITIES | |||
Net borrowings (repayments) on unsecured credit facility | 82,000 | (99,000) | 121,000 |
Repayment on term loan | (50,000) | ||
Borrowings of notes and bonds payable | 297,459 | 11,500 | 249,793 |
Repayments on notes and bonds payable | (5,829) | (37,910) | (72,724) |
Redemption of notes and bonds payable | (442,774) | (326,830) | |
Dividends paid | (142,327) | (131,759) | (120,266) |
Net proceeds from issuance of common stock | 248,554 | 450,503 | 66,942 |
Common stock redemptions | (1,686) | (1,756) | (1,367) |
Settlement of swaps | (1,684) | ||
Debt issuance and assumption costs | (4,007) | (4,621) | (2,482) |
Net cash provided by (used in) financing activities | 31,390 | 136,957 | (87,618) |
Increase (decrease) in cash, cash equivalents and restricted cash | (48,292) | 50,405 | 583 |
Cash, cash equivalents and restricted cash at beginning of period | 54,507 | 4,102 | 3,519 |
Cash, cash equivalents and restricted cash at end of period | 6,215 | 54,507 | 4,102 |
Supplemental Cash Flow Information: | |||
Interest paid | 64,395 | 55,878 | 69,773 |
Mortgage notes payable assumed upon acquisition (adjusted to fair value) | 46,374 | 13,951 | 28,783 |
Invoices accrued for construction, tenant improvements and other capitalized costs | 8,303 | 11,734 | 10,431 |
Capitalized interest | $ 871 | $ 1,258 | $ 239 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2017 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Business Overview Healthcare Realty Trust Incorporated (the “Company”) is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The Company had gross investments of approximately $3.8 billion in 201 real estate properties, construction in progress, land held for development and corporate property as of December 31, 2017 . The Company’s 201 owned real estate properties are located in 27 states and total approximately 14.6 million square feet. The Company provided property management services to approximately 11.5 million square feet nationwide. Square footage and property count disclosures in this Annual Report on Form 10-K are unaudited. Principles of Consolidation The Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, joint ventures, partnerships and consolidated variable interest entities (“VIE”) where the Company controls the operating activities of the VIE. In accordance with the consolidation accounting standards, the Company must evaluate each contractual relationship it has with its lessees, borrowers, or others to determine whether or not the contractual arrangement creates a variable interest in those entities. If the Company determines that it has a variable interest and the entity is a VIE, then management must determine whether or not the Company is the primary beneficiary of the VIE, resulting in consolidation of the VIE if the Company is the primary beneficiary. A primary beneficiary has the power to direct those activities of the VIE that most significantly impact its economic performance and has the obligation to absorb the losses of, or receive the benefits from, the VIE. The Company had no VIEs as of December 31, 2017 and 2016 . The Company's investments in its unconsolidated joint ventures are included in other assets and the related equity income is recognized in other income (expense) on the Company's Consolidated Financial Statements. See Note 7 for additional information. All significant intercompany accounts, transactions and balances have been eliminated upon consolidation in the Consolidated Financial Statements. Use of Estimates in the Consolidated Financial Statements Preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates. Segment Reporting The Company owns, leases, acquires, manages, finances, develops and redevelops outpatient and other healthcare-related properties. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single reportable segment. Real Estate Properties Real estate properties are recorded at cost or at fair value if acquired in a transaction that is a business combination under Accounting Standards Codification Topic 805, Business Combinations . Cost or fair value at the time of acquisition is allocated among land, buildings, tenant improvements, lease and other intangibles, and personal property as applicable. The Company’s gross real estate assets, on a financial reporting basis, totaled approximately $3.8 billion as of December 31, 2017 and $3.6 billion as of December 31, 2016 . During 2017 and 2016 , the Company eliminated against accumulated depreciation approximately $10.2 million and $6.7 million , respectively, of fully amortized real estate intangibles that were initially recorded as a component of certain real estate acquisitions. Also during 2017 and 2016 , approximately $2.6 million and $0.1 million of fully depreciated tenant and capital improvements that were no longer in service were eliminated against accumulated depreciation. Depreciation expense for the three years ended December 31, 2017, 2016 and 2015 was $129.4 million , $116.5 million and $106.5 million , respectively. Depreciation and amortization of real estate assets and liabilities in place as of December 31, 2017 , is provided for on a straight-line basis over the asset’s estimated useful life: Land improvements 5.0 to 39.0 years Buildings and improvements 3.3 to 39.0 years Lease intangibles (including ground lease intangibles) 2.1 to 99.0 years Personal property 2.8 to 20.0 years The Company capitalizes direct costs, including costs such as construction costs and professional services, and indirect costs, including capitalized interest and overhead costs, associated with the development and construction of real estate assets while substantive activities are ongoing to prepare the assets for their intended use. Capitalized interest cost is calculated using the weighted average interest rate of the Company's unsecured debt or the interest rate on project specific debt, if applicable. The Company continues to capitalize interest on the unoccupied portion of the properties in stabilization for up to one year after the buildings have been placed into service, at which time the capitalization of interest must cease. Land Held for Development Land held for development includes parcels of land owned by the Company, upon which the Company intends to develop and own outpatient healthcare facilities. The Company’s investment in six parcels of land held for development located adjacent to certain of the Company's existing medical office buildings in Texas, Iowa and Tennessee totaled approximately $20.1 million as of December 31, 2017 and 2016 . Asset Impairment The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its operators. In addition, the Company reviews for possible impairment, those assets subject to purchase options and those impacted by casualties, such as tornadoes and hurricanes. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property or the estimated fair value less costs to sell the property. Acquisitions of Real Estate Properties with In-Place Leases Acquisitions of real estate properties with in-place leases are accounted for at relative fair value. When a building with in-place leases is acquired, the cost of the acquisition must be allocated between the tangible real estate assets "as-if-vacant" and the intangible real estate assets related to in-place leases based on their estimated fair values. Where appropriate, the intangible assets recorded could include goodwill or customer relationship assets. The values related to above- or below-market in-place lease intangibles are amortized over the remaining term of the leases upon acquisition to rental income where the Company is the lessor and to property operating expense where the Company is the lessee, and are amortized over the remaining term of the leases upon acquisition. The Company considers whether any of the in-place lease rental rates are above- or below-market. An asset (if the actual rental rate is above-market) or a liability (if the actual rental rate is below-market) is calculated and recorded in an amount equal to the present value of the future cash flows that represent the difference between the actual lease rate and the average market rate. If an in-place lease is identified as a below-market rental rate, the Company would also evaluate any renewal options associated with that lease to determine if the intangible should include those periods. The Company also estimates an absorption period, which can vary by property, assuming the building is vacant and must be leased up to the actual level of occupancy when acquired. During that absorption period, the owner would incur direct costs, such as tenant improvements, and would suffer lost rental income. Likewise, the owner would have acquired a measurable asset in that, assuming the building was vacant, certain fixed costs would be avoided because the actual in-place lessees would reimburse a certain portion of fixed costs through expense reimbursements during the absorption period. All of these intangible assets (above- or below-market lease, tenant improvement costs avoided, leasing costs avoided, rental income lost, and expenses recovered through in-place lessee reimbursements) are estimated and recorded in amounts equal to the present value of estimated future cash flows. The actual purchase price is allocated based on the various asset fair values described above. The building and tenant improvement components of the purchase price are depreciated over the estimated useful life of the building or the weighted average remaining term of the in-places leases. The at-market, in-place lease intangibles are amortized to amortization expense over the weighted average remaining term of the leases, customer relationship assets are amortized to amortization expense over terms applicable to each acquisition, and any goodwill recorded would be reviewed for impairment at least annually. The fair values of at-market in-place lease and other intangible assets are amortized and reflected in amortization expense in the Company’s Consolidated Statements of Income. See Note 8 for more details on the Company’s intangible assets. Fair Value Measurements Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements. A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: • Level 1 – quoted prices for identical instruments in active markets; • Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Executed purchase and sale agreements, that are binding agreements, are categorized as level one inputs. Brokerage estimates, letters of intent, or unexecuted purchase and sale agreements are considered to be level three as they are nonbinding in nature. During 2017 , in connection with the sale of a medical office building, the Company recorded an impairment charge in continuing operations of approximately $5.1 million based on the contractual sales price, a level one input. The Company used level one inputs to record an impairment charge in continuing operations of approximately $0.3 million related to another property sold during 2017, reducing the Company's carrying value to the estimated fair value of the property less costs to sell prior to sale. Fair Value of Derivative Financial Instruments Derivative financial instruments are recorded at fair value on the Company's Consolidated Balance Sheets as other assets or other liabilities. The valuation of derivative instruments requires the Company to make estimates and judgments that affect the fair value of the instruments. Fair values of derivatives are estimated by pricing models that consider the forward yield curves and discount rates. The fair value of the Company's forward starting interest rate swap contracts are estimated by pricing models that consider foreign trade rates and discount rates. Such amounts and the recognition of such amounts are subject to significant estimates that may change in the future. For derivatives designated in qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive income (loss). Gains and losses are reclassified from accumulated other comprehensive income (loss) into earnings once the underlying hedged transaction is recognized in earnings. As of December 31, 2017 and 2016, the Company had $1.3 million and $1.4 million , respectively recorded in accumulated other comprehensive loss related to forward starting interest rate swaps entered into and settled during 2015 and a hedge of the Company's variable rate debt. See Note 10 for additional information. Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. Restricted cash includes cash held in escrow in connection with proceeds from the sales of certain real estate properties. The carrying amount approximates fair value due to the short term maturity of these investments. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Company's Consolidated Balance Sheets with the same amounts shown on the Company's Consolidated Statements of Cash Flows: December 31, (Dollars in thousands) 2017 2016 Cash and cash equivalents $ 6,215 $ 5,409 Restricted cash — 49,098 Total cash, cash equivalents and restricted cash $ 6,215 $ 54,507 Allowance for Doubtful Accounts and Credit Losses Accounts Receivable Management monitors the aging and collectibility of its accounts receivable balances on an ongoing basis. Whenever deterioration in the timeliness of payment from a tenant or sponsoring health system is noted, management investigates and determines the reason or reasons for the delay. Considering all information gathered, management’s judgment is exercised in determining whether a receivable is potentially uncollectible and, if so, how much or what percentage may be uncollectible. Among the factors management considers in determining collectibility are: the type of contractual arrangement under which the receivable was recorded (e.g., a triple net lease, a gross lease, a property operating agreement, or some other type of agreement); the tenant’s reason for slow payment; industry influences under which the tenant operates; evidence of willingness and ability of the tenant to pay the receivable; credit-worthiness of the tenant; collateral, security deposit, letters of credit or other monies held as security; tenant’s historical payment pattern; other contractual agreements between the tenant and the Company; relationship between the tenant and the Company; the state in which the tenant operates; and the existence of a guarantor and the willingness and ability of the guarantor to pay the receivable. Considering these factors and others, management concludes whether all or some of the aged receivable balance is likely uncollectible. Upon determining that some portion of the receivable is likely uncollectible, the Company records a provision for bad debts for the amount it expects will be uncollectible. When efforts to collect a receivable are exhausted, the receivable amount is charged off against the allowance. The Company does not hold any accounts receivable for sale. Mortgage Notes The Company had no mortgage notes receivable outstanding as of December 31, 2017 and 2016 and no allowances were recorded on mortgage notes receivables during 2017 or 2016 . The Company evaluates collectibility of any mortgage notes and records allowances on the notes as necessary. A loan is impaired when it is probable that a creditor will be unable to collect all amounts due according to the contractual terms of the loan as scheduled, including both contractual interest and principal payments. This assessment also includes an evaluation of the loan collateral. If a mortgage loan becomes past due, the Company will review the specific circumstances and may discontinue the accrual of interest on the loan. The loan is not returned to accrual status until the debtor has demonstrated the ability to continue debt service in accordance with the contractual terms. Loans placed on non-accrual status will be accounted for either on a cash basis, in which income is recognized only upon receipt of cash, or on a cost-recovery basis, in which all cash receipts reduce the carrying value of the loan, based on the Company’s expectation of future collectibility. Goodwill and Other Intangible Assets Goodwill and intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present. Identifiable intangible assets of the Company are comprised of enterprise goodwill, in-place lease intangible assets, customer relationship intangible assets, and deferred financing costs. In-place lease and customer relationship intangible assets are amortized on a straight-line basis over the applicable lives of the assets. Deferred financing costs are amortized over the term of the related credit facility or other debt instrument under the straight-line method, which approximates amortization under the effective interest method. Goodwill is not amortized but is evaluated annually as of December 31 for impairment. Both the 2017 and 2016 impairment evaluations indicated that no impairment had occurred with respect to the $3.5 million goodwill asset. See Note 8 for more detail on the Company’s intangible assets. Contingent Liabilities From time to time, the Company may be subject to loss contingencies arising from legal proceedings and similar matters. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or underinsured damages. The Company continually monitors any matters that may present a contingent liability, and, on a quarterly basis, management reviews the Company’s reserves and accruals in relation to each of them, adjusting provisions as necessary in view of changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be reasonably estimated. Changes in estimates regarding the exposure to a contingent loss are reflected as adjustments to the related liability in the periods when they occur. Because of uncertainties inherent in the estimation of contingent liabilities, it is possible that the Company’s provision for contingent losses could change materially in the near term. To the extent that any significant losses, in addition to amounts recognized, are at least reasonably possible, such amounts will be disclosed in the notes to the Consolidated Financial Statements. Stock-Based Compensation The Company has various employee and director stock-based awards outstanding. These awards include non-vested common stock and options to purchase common stock granted to employees pursuant to the 2015 Stock Incentive Plan and its predecessor plans (the “2015 Incentive Plan”) and the 2000 Employee Stock Purchase Plan (the “Employee Stock Purchase Plan”). The Company recognizes share-based payments to employees and directors in the Consolidated Statements of Income on a straight-line basis over the requisite service period based on the fair value of the award on the measurement date. The Employee Stock Purchase Plan features a “look-back” provision which enables the employee to purchase a fixed number of common shares at the lesser of 85% of the market price on the date of grant or 85% of the market price on the date of exercise, with optional purchase dates occurring once each quarter for 27 months . The Company accounts for awards to its employees under the Employee Stock Purchase Plan based on fair value, using the Black-Scholes model, and generally recognizes expense over the award’s vesting period, net of estimated forfeitures. Since the options granted under the Employee Stock Purchase Plan immediately vest, the Company records compensation expense for those options when they are granted in the first quarter of each year and then may record additional compensation expense in subsequent quarters as warranted. In each of the years ended December 31, 2017 , 2016 and 2015 , the Company recognized in general and administrative expenses approximately $0.2 million of compensation expense related to the annual grant of options to its employees to purchase shares under the Employee Stock Purchase Plan. See Note 13 for details on the Company’s stock-based awards. Accumulated Other Comprehensive Income (Loss) Certain items must be included in comprehensive income, including items such as foreign currency translation adjustments, minimum pension liability adjustments, derivative instruments and unrealized gains or losses on available-for-sale securities. The Company’s accumulated other comprehensive income (loss) as of December 31, 2017 consists of the loss for changes in the fair value of active derivatives designated as cash flow hedges and the loss on the unamortized settlement of four forward starting swaps. As of December 31, 2016, the Company's accumulated other comprehensive income (loss) consisted only of the loss on the unamortized settlement of four forward starting swaps. See Note 10 for more details on the Company's derivative financial instruments. Revenue Recognition The Company recognizes revenue when it is realized or realizable and earned. There are four criteria that must all be met before a Company may recognize revenue, including that persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered (i.e., the tenant has taken possession of and controls the physical use of the leased asset), the price has been fixed or is determinable, and collectibility is reasonably assured. Income received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities on the Consolidated Balance Sheets, was $36.0 million and $32.4 million , respectively, as of December 31, 2017 and 2016 which includes deferred tenant improvement reimbursements of $20.1 million and $20.6 million , respectively, which will be recognized as revenue over the life of each respective lease. The Company derives most of its revenues from its real estate property portfolio. The Company’s rental and mortgage interest income is recognized based on contractual arrangements with its tenants, sponsoring health systems or borrowers. These contractual arrangements fall into three categories: leases, mortgage notes receivable, and property operating agreements as described in the following paragraphs. The Company may accrue late fees based on the contractual terms of a lease or note. Such fees, if accrued, are included in rental income or mortgage interest income on the Company’s Consolidated Statements of Income, based on the type of contractual agreement. Rental Income Rental income related to non-cancelable operating leases is recognized as earned over the life of the lease agreements on a straight-line basis. The Company's lease agreements generally include provisions for stated annual increases or increases based on a Consumer Price Index ("CPI"). Rental income from properties under multi-tenant office lease arrangements and rental income from properties with single-tenant lease arrangements are included in rental income on the Company's Consolidated Statements of Income. The components of rental income are as follows: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Property operating income $ 363,907 $ 336,409 $ 306,550 Single-tenant net lease 52,873 63,871 67,238 Straight-line rent 6,072 7,201 9,545 Rental income $ 422,852 $ 407,481 $ 383,333 Operating expense recoveries, included in property operating income, were approximately $73.4 million , $66.0 million and $58.9 million , respectively, for the years ended December 31, 2017 , 2016 and 2015 . Mortgage Interest Income Interest income on the Company’s mortgage notes receivable is recognized based on the interest rates, maturity dates and amortization periods in accordance with each note agreement. The Company has no outstanding mortgage notes receivable as of December 31, 2017 , 2016 and 2015. The Company amortizes any fees paid related to its mortgage notes receivable to mortgage interest income over the term of the loan on a straight-line basis which approximates amortization under the effective interest method. Other Operating Income Other operating income on the Company’s Consolidated Statements of Income was comprised of the following: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Property lease guaranty revenue $ 726 $ 3,058 $ 3,890 Interest income 361 473 579 Management fee income 276 369 370 Other 284 249 208 $ 1,647 $ 4,149 $ 5,047 One , two and five of the Company’s owned real estate properties as of December 31, 2017 , 2016 and 2015, respectively, were covered under property operating agreements between the Company and a sponsoring health system, which contractually obligate the sponsoring health system to provide to the Company a minimum return on the Company’s investment in the property in exchange for the right to be involved in the operating decisions of the property, including tenancy. If the minimum return is not achieved through normal operations of the property, the Company calculates and accrues to property lease guaranty revenue, each quarter, any shortfalls due from the sponsoring health systems under the terms of the property operating agreement. Interest income generally relates to interest on tenant improvement reimbursements as defined in each note or lease agreement. Management fees for property management services provided to third parties are generally calculated, accrued and billed monthly based on a percentage of cash collections of tenant receivables for the month or a stated amount per square foot. Internal management fee income, where the Company manages its owned properties, is eliminated in consolidation. Federal Income Taxes No provision has been made for federal income taxes. The Company intends at all times to qualify as a REIT under Sections 856 through 860 of the Internal Revenue Code. The Company must distribute at least 90% per annum of its real estate investment trust taxable income to its stockholders and meet other requirements to continue to qualify as a real estate investment trust. See Note 16 for further discussion. The Company classifies interest and penalties related to uncertain tax positions, if any, in the Consolidated Financial Statements as a component of general and administrative expenses. No such amounts were recognized during the three years ended December 31, 2017. Federal tax returns for the years 2014, 2015 , 2016 and 2017 are currently subject to examination by taxing authorities. State Income Taxes The Company must pay certain state income taxes and the provisions for such taxes are generally included in general and administrative expense on the Company’s Consolidated Statements of Income. See Note 16 for further discussion. Sales and Use Taxes The Company must pay sales and use taxes to certain state tax authorities based on rents collected from tenants in properties located in those states. The Company is generally reimbursed for these taxes by the tenant. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis in revenues in the Company’s Consolidated Statements of Income. Discontinued Operations The Company sells properties from time to time due to a variety of factors, including among other things, market conditions or the exercise of purchase options by tenants. The Company does not expect these dispositions to meet the amended definition of a discontinued operation as defined in Accounting Standards Update ("ASU") No. 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity." The Company adopted ASU No. 2014-08 on a prospective basis beginning January 1, 2015 which excluded properties previously in discontinued operations prior to adoption. However, if a sale were to meet the amended definition representing a strategic shift that has or will have a major effect on the Company's operations and financial results, the operating results of the properties that have been sold or are held for sale will be reported as discontinued operations in the Company’s Consolidated Statements of Income for all periods presented. Assets Held for Sale Long-lived assets held for sale are reported at the lower of their carrying amount or their fair value less cost to sell estimate. Further, depreciation of these assets ceases at the time the assets are classified as held for sale. Losses resulting from the sale of such properties are characterized as impairment losses in the Consolidated Statements of Income. See Note 5 for more detail on discontinued operations and assets held for sale. Earnings per Share The Company uses the two-class method of computing net earnings per common share. Earnings per common share is calculated by considering share-based payment awards that contain nonforfeitable rights to dividends or dividend equivalents as participating securities. Undistributed earnings (excess net income over dividend payments) are allocated on a prorata basis to common shareholders and restricted shareholders. Undistributed losses (dividends in excess of net income) do not get allocated to restricted stockholders as they do not have the contractual obligation to share in losses. The amount of undistributed losses that applies to the restricted stockholders is allocated to the common stockholder. Basic earnings per common share is calculated using weighted average shares outstanding less issued and outstanding non-vested shares of common stock. Diluted earnings per common share is calculated using weighted average shares outstanding plus the dilutive effect of the outstanding stock options from the Employee Stock Purchase Plan using the treasury stock method and the average stock price during the period. See Note 14 for the calculations of earnings per share. Reclassifications Condensed Consolidated Statements of Income Certain reclassifications have been made on the Company's Condensed Consolidated Statements of Income. The Company reclassified acquisition and pursuit costs from the general and administrative line item to a separate line item. The acquisition and pursuit costs line item includes direct third party and travel costs related to the Company's pursuit of acquisitions and developments. In addition, the Company combined the line items labeled depreciation and amortization into one line item. These reclassifications are as follows: Year Ended December 31, 2016 2015 (in thousands) As Previously Reported As Reclassified As Previously Reported As Reclassified General and administrative $ 35,805 $ 31,309 $ 26,925 $ 24,716 Acquisition and pursuit costs — 4,496 — 2,209 Total $ 35,805 $ 35,805 $ 26,925 $ 26,925 Depreciation $ 116,483 $ — $ 106,530 $ — Amortization 11,207 — 10,084 — Depreciation and amortization — 127,690 — 116,614 Total $ 127,690 $ 127,690 $ 116,614 $ 116,614 New A |
Property Investments
Property Investments | 12 Months Ended |
Dec. 31, 2017 | |
Real Estate Investment Property, Net [Abstract] | |
Property Investments | Property Investments The Company invests in healthcare-related properties located throughout the United States. The Company provides management, leasing, development and redevelopment services, and capital for the construction of new facilities as well as for the acquisition of existing properties. The Company had gross investments of approximately $3.8 billion in 201 real estate properties, land held for development and corporate property as of December 31, 2017 . The following table summarizes the Company’s investments at December 31, 2017. (Dollars in thousands) Number of Facilities Land Buildings, Improvements,and Lease Intangibles Personal Property Total Accumulated Depreciation Medical office/outpatient: Seattle, Washington 17 $ 24,560 $ 403,614 $ 378 $ 428,552 $ (52,457 ) Dallas, Texas 24 12,472 365,657 416 378,545 (128,557 ) Atlanta, Georgia 8 1,015 187,042 — 188,057 (1,203 ) Los Angeles, California 11 27,709 141,681 277 169,667 (71,808 ) Charlotte, North Carolina 16 4,200 163,603 95 167,898 (56,355 ) Nashville, Tennessee 5 3,143 149,859 278 153,280 (43,000 ) Richmond, Virginia 7 — 146,176 98 146,274 (32,299 ) Honolulu, Hawaii 3 8,327 132,847 159 141,333 (30,066 ) Denver, Colorado 6 4,086 122,689 271 127,046 (18,736 ) San Francisco, California 3 14,054 103,938 43 118,035 (12,223 ) Oklahoma City, Oklahoma 2 7,673 101,432 6 109,111 (10,890 ) Washington, D.C. 4 — 100,570 — 100,570 (15,826 ) Austin, Texas 4 12,756 85,961 105 98,822 (17,498 ) San Antonio, Texas 7 6,647 88,129 370 95,146 (34,514 ) Memphis, Tennessee 7 5,241 88,517 160 93,918 (31,675 ) Des Moines, Iowa 6 12,665 79,214 94 91,973 (18,263 ) Chicago, Illinois 3 5,859 79,295 200 85,354 (15,476 ) Indianapolis, Indiana 3 3,299 71,641 — 74,940 (18,742 ) Other (22 markets) 52 38,598 678,196 1,163 717,957 (206,844 ) 188 192,304 3,290,061 4,113 3,486,478 (816,432 ) Inpatient: Springfield, Missouri 1 1,989 109,304 — 111,293 (12,046 ) Dallas, Texas 1 4,442 92,990 — 97,432 (19,538 ) Erie, Pennsylvania 1 — 21,355 — 21,355 (15,152 ) Los Angeles, California 1 — 12,688 — 12,688 (7,606 ) Denver, Colorado 1 623 10,788 — 11,411 (1,781 ) 5 7,054 247,125 — 254,179 (56,123 ) Other: Des Moines, Iowa 1 — 40,354 5 40,359 (7,704 ) Johnson City, Tennessee 1 253 7,319 408 7,980 (2,798 ) Austin, Texas 1 1,480 3,872 2 5,354 (164 ) Fenton, Michigan 1 40 3,468 32 3,540 (2,738 ) Ovid, Michigan 1 62 3,188 49 3,299 (2,096 ) Fremont, Michigan 1 7 3,242 35 3,284 (2,565 ) St. Louis, Michigan 1 31 1,735 33 1,799 (1,341 ) Detroit, Michigan 1 52 1,096 34 1,182 (829 ) 8 1,925 64,274 598 66,797 (20,235 ) Land Held for Development — 20,123 — — 20,123 (239 ) Construction in Progress — — 5,458 — 5,458 — Corporate Property — — — 5,603 5,603 (4,401 ) — 20,123 5,458 5,603 31,184 (4,640 ) Total real estate investments 201 $ 221,406 $ 3,606,918 $ 10,314 $ 3,838,638 $ (897,430 ) |
Real Estate Leases
Real Estate Leases | 12 Months Ended |
Dec. 31, 2017 | |
Leases [Abstract] | |
Real Estate Leases | Real Estate Leases Real Estate Leases The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2036 . Some leases and financial arrangements provide for fixed rent renewal terms in addition to market rent renewal terms. Some leases provide the lessee, during the term of the lease and for a short period thereafter, with an option or a right of first refusal to purchase the leased property. The Company’s portfolio of single-tenant net leases generally requires the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property. Future minimum lease payments under the non-cancelable operating leases and guaranteed amounts payable to the Company under property operating agreements as of December 31, 2017 are as follows (in thousands): 2018 $ 330,526 2019 282,910 2020 236,454 2021 196,346 2022 168,183 2023 and thereafter 544,677 $ 1,759,096 Revenue Concentrations The Company’s real estate portfolio is leased to a diverse tenant base. The Company's largest revenue concentration is with Baylor Scott & White Health and its affiliates which accounted for 9.7% , 9.8% and 9.8% of the Company's consolidated revenues for the years ended December 31, 2017 , 2016 and 2015 , respectively. Purchase Option Provisions Certain of the Company’s leases include purchase option provisions. The provisions vary by agreement but generally allow the lessee to purchase the property covered by the agreement at fair market value or an amount equal to the Company’s gross investment . The Company expects that the purchase price from its purchase options will be greater than its net investment in the properties at the time of potential exercise by the lessee. The Company had approximately $95.2 million in four real estate properties as of December 31, 2017 that were subject to purchase options that were exercisable. |
Acquisitions, Dispositions and
Acquisitions, Dispositions and Mortgage Repayments | 12 Months Ended |
Dec. 31, 2017 | |
Acquisitions and Dispositions and Mortgage Repayments [Abstract] | |
Acquisitions, Dispositions and Mortgage Repayments | Acquisitions, Dispositions and Mortgage Repayments 2017 Real Estate Acquisitions The following table details the Company's acquisitions for the year ended December 31, 2017 : (Dollars in millions) Type (1) Date Purchase Price Mortgage (2) Cash (3) Real Other (4) Square (Unaudited) Real estate acquisitions St. Paul, Minnesota MOB 3/6/17 $ 13.5 $ — $ 13.5 $ 13.3 $ 0.2 34,608 San Francisco, California MOB 6/12/17 26.8 — 26.8 26.8 — 75,649 Washington, D.C. MOB 6/13/17 24.0 (12.1 ) 12.5 24.8 (0.2 ) 62,379 Los Angeles, California MOB 7/31/17 16.3 — 16.7 16.9 (0.2 ) 42,780 Atlanta, Georgia MOB 11/1/17 25.5 — 25.5 26.3 (0.8 ) 76,944 Atlanta, Georgia MOB 11/1/17 30.3 — 30.7 30.7 — 74,024 Atlanta, Georgia (5) MOB 11/1/17 49.7 — 50.9 47.5 3.4 118,180 Atlanta, Georgia MOB 11/1/17 6.7 — 6.7 6.7 — 19,732 Seattle, Washington MOB 11/1/17 12.7 — 12.6 12.8 (0.2 ) 26,345 Atlanta, Georgia (5) MOB 12/13/17 25.8 (10.5 ) 15.3 22.0 3.8 59,427 Atlanta, Georgia MOB 12/13/17 15.4 (4.7 ) 10.8 15.7 (0.2 ) 40,171 Atlanta, Georgia (5) MOB 12/18/17 26.3 (11.8 ) 14.5 24.6 1.7 66,984 Atlanta, Georgia MOB 12/18/17 14.2 (6.7 ) 7.6 14.5 (0.2 ) 40,324 Chicago, Illinois MOB 12/18/17 28.7 — 27.7 28.5 (0.8 ) 99,526 Seattle, Washington MOB 12/18/17 8.8 — 8.8 9.0 (0.2 ) 32,828 Austin, Texas (6) MOB 12/21/17 2.5 — 2.5 2.5 — 7,972 $ 327.2 $ (45.8 ) $ 283.1 $ 322.6 $ 6.3 877,873 ______ (1) MOB = medical office building (2) The mortgage notes payable assumed in the acquisitions do not reflect the fair value adjustments totaling $0.6 million in aggregate recorded by the Company upon acquisition (included in Other). (3) Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. (4) Includes other assets acquired, liabilities assumed, intangibles recognized at acquisition and fair value adjustments on debt assumed. (5) The "Other" column includes the equity investment in limited liability companies that own two parking garages. (6) The Company acquired additional ownership interests in an existing building bringing the Company's ownership to 69.4% . The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2017 as of the acquisition date: Estimated Fair Value Estimated Useful Life (In millions) (In years) Building $ 272.1 15.0-37.0 Land 11.7 — Land Improvements 1.6 5.0-12.0 Intangibles: At-market lease intangibles 37.2 2.1-12.6 Below-market lease intangibles (0.9 ) 8.5-15.0 Below-market ground lease intangibles 0.4 36.8-99.0 Total intangibles 36.7 Mortgage notes payable assumed, including fair value adjustments (46.4 ) Other assets acquired 0.4 Equity investment in joint ventures 8.7 Accounts payable, accrued liabilities and other liabilities assumed (1.7 ) Total cash paid $ 283.1 2016 Real Estate Acquisitions The following table details the Company's acquisitions for the year ended December 31, 2016 : (Dollars in millions) Type (1) Date Purchase Price Mortgage (2) Cash (3) Real Other (4) Square (unaudited) Real estate acquisitions Seattle, Washington MOB 3/31/16 $ 38.3 $ — $ 37.7 $ 37.7 $ — 69,712 Seattle, Washington MOB 4/29/16 21.6 — 18.8 20.1 (1.3 ) 46,637 Los Angeles, California MOB 5/13/16 20.0 (13.2 ) 6.5 20.4 (0.7 ) 63,012 Seattle, Washington MOB 9/12/16 53.1 — 53.0 54.6 (1.6 ) 87,462 Washington, D.C. (5) MOB 9/26/16 45.2 — 45.1 43.7 1.4 103,783 Baltimore, Maryland (6) MOB 10/11/16 36.2 — 36.4 36.4 — 113,631 Seattle, Washington MOB 10/17/16 9.8 — 9.8 9.9 (0.1 ) 29,753 Seattle, Washington MOB 12/21/16 5.1 — 5.1 5.2 (0.1 ) 20,740 St. Paul, Minnesota MOB 12/21/16 12.6 — 12.5 11.3 1.2 48,281 $ 241.9 $ (13.2 ) $ 224.9 $ 239.3 $ (1.2 ) 583,011 ______ (1) MOB = medical office building (2) The mortgage notes payable assumed in the acquisitions do not reflect the fair value adjustments totaling $0.8 million recorded by the Company upon acquisition (included in Other). (3) Excludes prorations of revenue and expense due to/from seller at the time of the acquisition. (4) Includes other assets acquired, liabilities assumed, intangibles recognized at acquisition and fair value adjustments on debt assumed. (5) A director of the Company serves as the Chief Executive Officer of the Inova Health System. As part of this transaction, the Company assumed a ground lease and tenant leases with Loudon Hospital Center, an affiliate of Inova Health System. (6) Includes two properties. The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2016 as of the acquisition date: Estimated Fair Value Estimated Useful Life (In millions) (In years) Building $ 216.8 20.0-35.0 Land 9.7 — Intangibles: At-market lease intangibles 12.8 2.7-10.3 Above-market lease intangibles 0.9 0.7-3.8 Below-market lease intangibles (0.4 ) 1.4-9.4 Above-market ground lease intangibles (1.6 ) 99.0 Below-market ground lease intangibles 2.0 36.8-99.0 Total intangibles 13.7 Mortgage notes payable assumed, including fair value adjustments (14.0 ) Other assets acquired 0.5 Accounts payable, accrued liabilities and other liabilities assumed (1.8 ) Total cash paid $ 224.9 2017 Real Estate Asset Dispositions The following table details the Company's dispositions for the year ended December 31, 2017 : (Dollars in millions) Type (1) Date Sales Price Closing Adjustments Net Net Real Other (3) Gain/ Square Unaudited ) Real estate dispositions Evansville, Indiana OTH 3/6/17 $ 6.4 $ — $ 6.4 $ 1.1 $ — $ 5.3 29,500 Columbus, Georgia (2) MOB 3/7/17 0.6 — 0.6 0.6 — — 12,000 Las Vegas, Nevada (2) MOB 3/30/17 5.5 (0.7 ) 4.8 2.2 0.3 2.3 18,147 Texas (3 properties) IRF 3/31/17 69.5 (1.6 ) 67.9 46.9 5.2 15.8 169,722 Chicago, Illinois (4) MOB 6/16/17 0.5 (0.1 ) 0.4 0.4 — — 5,100 San Antonio, Texas IRF 6/29/17 14.5 (0.2 ) 14.3 5.1 0.9 8.3 39,786 Roseburg, Oregon MOB 6/29/17 23.2 (0.6 ) 22.6 14.5 0.3 7.8 62,246 St. Louis, Missouri MOB 9/7/17 2.5 (0.1 ) 2.4 7.4 0.1 (5.1 ) 79,980 Total dispositions $ 122.7 $ (3.3 ) $ 119.4 $ 78.2 $ 6.8 $ 34.4 416,481 ______ (1) MOB = medical office building; IRF = inpatient rehabilitation facility; OTH = other (2) Previously classified as held for sale. (3) Includes straight-line rent receivables, leasing commissions and lease inducements. (4) The Company recorded an impairment of approximately $0.3 million in the first quarter of 2017 upon management's decision to sell. 2016 Real Estate Asset Dispositions The following table details the Company's dispositions for the year ended December 31, 2016 : (Dollars in millions) Type (1) Date Sales Price Closing Adjustments Net Net Real Other (2) Gain Square Unaudited ) Real estate dispositions Kansas City, Kansas MOB 10/14/16 $ 15.1 $ — $ 15.1 $ 7.2 $ 0.3 $ 7.6 70,908 Nashville, Tennessee MOB 10/28/16 8.8 (0.2 ) 8.6 6.3 0.2 2.1 45,274 Altoona, Pennsylvania IRF 12/20/16 21.5 (0.4 ) 21.1 12.4 0.6 8.1 64,032 Harrisburg, Pennsylvania IRF 12/20/16 24.2 (0.6 ) 23.6 8.2 0.4 15.0 79,836 Phoenix, Arizona IRF 12/20/16 22.3 — 22.3 13.5 1.4 7.4 51,903 Atlanta, Georgia MOB 12/22/16 2.8 (0.2 ) 2.6 1.8 — 0.8 8,749 Total dispositions $ 94.7 $ (1.4 ) $ 93.3 $ 49.4 $ 2.9 $ 41.0 320,702 ______ (1) MOB = medical office building; IRF = inpatient rehabilitation facility (2) Includes straight-line rent receivables, leasing commissions and lease inducements. Potential Dispositions In October 2017, the Company received notice that a tenant is exercising a purchase option on seven properties, comprised of five single-tenant net leased buildings and two multi-tenanted buildings, covered by one purchase option with a stated purchase price of approximately $45.5 million , subject to certain contractual adjustments. The Company's aggregate net book value for these properties, which were classified as held for sale upon receiving notice of the purchase option exercise, was $23.9 million at December 31, 2017 . |
Held for Sale and Discontinued
Held for Sale and Discontinued Operations | 12 Months Ended |
Dec. 31, 2017 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Held for Sale and Discontinued Operations | Held for Sale and Discontinued Operations Assets and liabilities of properties sold or classified as held for sale are separately identified on the Company’s Consolidated Balance Sheets in the current period. During 2017, the Company reclassified eight properties to held for sale. See "Potential Dispositions" in Note 4 for more information regarding seven of these properties. As of December 31, 2017 and 2016 , the Company had eight and two properties, respectively, classified as held for sale. During 2017, the Company sold the property remaining in assets held for sale that was classified as discontinued operations prior to the adoption of Accounting Standards Update No. 2014-08, “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity”. None of the Company's 2016 or 2017 dispositions or assets classified as held for sale represented a strategic shift that had or will have a major effect on the Company's operations and financial results. Therefore, the 2016 and 2017 dispositions were not classified as discontinued operations. The table below reflects the assets and liabilities of the properties classified as held for sale and discontinued operations as of December 31, 2017 and 2016 . December 31, (Dollars in thousands) 2017 2016 Balance Sheet data Land $ 4,636 $ 1,362 Buildings, improvements and lease intangibles 63,654 4,410 Personal property 82 — 68,372 5,772 Accumulated depreciation (35,790 ) (2,977 ) Assets held for sale, net 32,582 2,795 Other assets, net (including receivables) 565 297 Assets of discontinued operations, net 565 297 Assets held for sale and discontinued operations, net $ 33,147 $ 3,092 Accounts payable and accrued liabilities $ 38 $ 22 Other liabilities 55 592 Liabilities of assets held for sale and discontinued operations $ 93 $ 614 The table below reflects the results of operations of the properties included in discontinued operations on the Company’s Consolidated Statements of Income for the years ended December 31, 2017 , 2016 and 2015 . Year Ended December 31, (Dollars in thousands, except per share data) 2017 2016 2015 Statements of Income data: Revenues (1) Rental income $ — $ — $ 752 Other operating — — — — — 752 Expenses (2) Property operating 19 71 58 Bad debt, net of recoveries (10 ) — (1 ) 9 71 57 Other Income (Expense) (3) Interest and other income, net — — 20 — — 20 Income (Loss) from Discontinued Operations (9 ) (71 ) 715 Impairments (4) — (121 ) (686 ) Gain on sales of real estate properties (5) 5 7 10,571 Income (Loss) from Discontinued Operations $ (4 ) $ (185 ) $ 10,600 Income (Loss) from Discontinued Operations per Common Share - Basic $ 0.00 $ 0.00 $ 0.11 Income (Loss) from Discontinued Operations per Common Share - Diluted $ 0.00 $ 0.00 $ 0.11 ______ (1) Total revenues for the year ended December 31, 2015 included $0.8 million related to properties sold. (2) Total expenses for the year ended December 31, 2016 included $0.1 million related to a property that is held for sale. Total expenses for the year ended December 31, 2015 included $0.1 million related to properties sold. (3) Other income (expense) for the year ended December 31, 2015 included income (expense) related to properties sold. (4) Impairments for the years ended December 31, 2016 and 2015 included $0.1 million and $0.7 million , respectively, related to one property sold. (5) Gain on sales of real estate properties for the year ended December 31, 2017 included a gain on the sale of one property sold in 2017. Gain on sales of real estate properties for the year ended December 31, 2016 included a gain on the sale of one property sold in 2015. Gains on the sales of real estate properties for the year ended December 31, 2015 included gains on the sale of one property. |
Impairment Charges
Impairment Charges | 12 Months Ended |
Dec. 31, 2017 | |
Property, Plant and Equipment [Abstract] | |
Impairment Charges | Impairment Charges An asset is impaired when undiscounted cash flows expected to be generated by the asset are less than the carrying value of the asset. The Company must assess the potential for impairment of its long-lived assets, including real estate properties, whenever events occur or there is a change in circumstances, such as the sale of a property or the decision to sell a property, that indicate that the recorded value might not be fully recoverable. The Company recorded impairment charges on properties sold or classified as held for sale, included in discontinued operations, for the years ended December 31, 2016 and 2015 totaling $0.1 million and $0.7 million , respectively. The Company recorded impairment charges on two properties sold in 2017 and two properties sold in 2015, included in continuing operations, for the years ended December 31, 2017 and 2015 totaling $5.4 million and $3.6 million , respectively. Both level 1 and level 3 fair value techniques were used to derive these impairment charges. |
Other Assets
Other Assets | 12 Months Ended |
Dec. 31, 2017 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Other Assets | Other Assets Other assets consist primarily of straight-line rent receivables, prepaids, intangible assets, deferred financing costs and accounts receivable. Items included in "Other assets, net" on the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 are detailed in the table below: December 31, (Dollars in millions) 2017 2016 Prepaid assets $ 65.2 $ 64.8 Equity investment in joint ventures 8.7 — Straight-line rent receivables 67.0 64.6 Above-market intangible assets, net 17.9 19.1 Additional long-lived assets, net 24.9 14.5 Ground lease modification, net 10.3 10.8 Accounts receivable 7.4 8.1 Allowance for uncollectible accounts (0.3 ) (0.1 ) Credit facility deferred financing costs 3.5 4.9 Goodwill 3.5 3.5 Customer relationship intangible assets, net 1.7 1.8 Other 3.2 3.7 $ 213.0 $ 195.7 Unconsolidated Joint Ventures During the fourth quarter of 2017, the Company purchased a non-managing membership interest in LLCs that own two parking garages in Atlanta, Georgia for $8.7 million which is included in the equity investment in joint ventures line in the table above. The parking garage interests were purchased in connection with three buildings that were acquired in the fourth quarter of 2017. The Company's investment in and income (loss) recognized for the year ended December 31, 2017 related to its LLCs accounted for under the equity method are shown in the table below: (Dollars in millions) December 31, 2017 Net LLC investment, beginning of period $ — New investments during the period 8.7 Equity income (loss) recognized during the period — Net LLC investments, end of period $ 8.7 |
Intangible Assets and Liabiliti
Intangible Assets and Liabilities | 12 Months Ended |
Dec. 31, 2017 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets and Liabilities | Intangible Assets and Liabilities The Company has several types of intangible assets and liabilities included in its Consolidated Balance Sheets, including goodwill, deferred financing costs, above-, below-, and at-market lease intangibles, and customer relationship intangibles. The Company’s intangible assets and liabilities as of December 31, 2017 and 2016 consisted of the following: Gross Balance at December 31, Accumulated Amortization at December 31, Weighted Avg. Remaining Life (Years) Balance Sheet Classification (Dollars in millions) 2017 2016 2017 2016 Goodwill $ 3.5 $ 3.5 $ — $ — N/A Other assets Credit facility deferred financing costs 5.4 5.4 1.9 0.5 2.6 Other assets Above-market lease intangibles 22.9 24.5 5.0 5.4 57.8 Other assets Customer relationship intangibles 2.6 2.6 0.9 0.8 25.6 Other assets Below-market lease intangibles (9.5 ) (8.8 ) (3.5 ) (3.2 ) 36.5 Other liabilities Deferred financing costs 9.3 9.4 1.8 4.0 4.5 Notes and Bonds Payable At-market lease intangibles 110.0 84.1 41.6 39.0 5.6 Real estate properties $ 144.2 $ 120.7 $ 47.7 $ 46.5 15.2 The following table represents expected amortization over the next five years of the Company’s intangible assets and liabilities in place as of December 31, 2017 : (Dollars in millions) Future Amortization of Intangibles, net 2018 $ 19.8 2019 17.6 2020 12.0 2021 6.8 2022 5.8 |
Notes and Bonds Payable
Notes and Bonds Payable | 12 Months Ended |
Dec. 31, 2017 | |
Debt Disclosure [Abstract] | |
Notes and Bonds Payable | Notes and Bonds Payable December 31, Maturity Dates Contractual Interest Rates Principal Payments Interest Payments (Dollars in thousands) 2017 2016 Unsecured Credit Facility $ 189,000 $ 107,000 7/20 LIBOR + 1.00% At maturity Monthly Unsecured Term Loan due 2022 (1) 148,994 149,491 12/22 LIBOR + 1.10% At maturity Monthly Senior Notes due 2021 (1) — 397,147 1/21 5.75 % At maturity Semi-Annual Senior Notes due 2023 (1) 247,703 247,296 4/23 3.75 % At maturity Semi-Annual Senior Notes due 2025 (1) 248,044 247,819 5/25 3.88 % At maturity Semi-Annual Senior Notes due 2028 (1) 294,757 — 1/28 3.63 % At maturity Semi-Annual Mortgage notes payable (2) 155,382 115,617 12/18-5/40 3.31%-6.88% Monthly Monthly $ 1,283,880 $ 1,264,370 ______ (1) Balances are shown net of discounts and unamortized issuance costs. (2) Balances are shown net of discounts and unamortized issuance costs and including premiums. The Company’s various debt agreements contain certain representations, warranties, and financial and other covenants customary in such loan agreements. Among other things, these provisions require the Company to maintain certain financial ratios and impose certain limits on the Company’s ability to incur indebtedness and create liens or encumbrances. As of December 31, 2017 , the Company was in compliance with its financial covenant provisions under its various debt instruments. Unsecured Credit Facility due 2020 On October 14, 2011, the Company entered into a $700.0 million unsecured credit facility with a syndicate of lenders (the "Unsecured Credit Facility"). On July 29, 2016, the Company entered into the third amendment to the Unsecured Credit Facility to extend the maturity date to July 2020. The credit facility agreement provides the Company with two six -month extension options that could extend the maturity date to July 2021. Each option is subject to an extension fee of 0.075% of the aggregate commitments. Amounts outstanding under the Unsecured Credit Facility bear interest at LIBOR plus an applicable margin rate. The margin rate, which depends on the Company's credit ratings, ranges from 0.83% to 1.55% ( 1.00% as of December 31, 2017 ). In addition, the Company pays a facility fee per annum on the aggregate amount of commitments ranging from 0.13% to 0.30% ( 0.20% as of December 31, 2017 ). As of December 31, 2017 , the Company had $189.0 million outstanding under the Unsecured Credit Facility with an effective interest rate of approximately 2.56% and had a remaining borrowing capacity of approximately $511.0 million . Unsecured Term Loan due 2022 In February 2014, the Company entered into a $200.0 million unsecured term loan with a syndicate of nine lenders. On July 5, 2016, the Company repaid $50.0 million of the outstanding principal. On December 18, 2017, the Company entered into an amendment to the unsecured term loan due 2022 (the "Unsecured Term Loan due 2022") with a syndicate of nine lenders to extend the maturity date to December 2022. The Unsecured Term Loan due 2022 bears interest at a rate equal to (x) LIBOR plus (y) a margin ranging from 0.90% to 1.75% ( 1.10% as of December 31, 2017 ) based upon the Company's unsecured debt ratings. Payments under the Unsecured Term Loan due 2022 are interest only, with the full amount of the principal due at maturity. The Unsecured Term Loan due 2022 may be prepaid at any time, without penalty. The proceeds from the Unsecured Term Loan due 2022 were used by the Company to repay borrowings on the Unsecured Credit Facility. The Unsecured Term Loan due 2022 has various financial covenant provisions that are required to be met on a quarterly and annual basis that are equivalent to those of the Unsecured Credit Facility. On December 20, 2017, the Company entered into two interest rate swaps totaling $25.0 million to hedge the 1-month LIBOR portion of the cost of borrowing under the Unsecured Term Loan due 2022 to a fixed interest rate of 2.18% (plus the applicable margin rate) through December 2022. On January 30, 2018, the Company entered into two additional interest rate swaps totaling $50.0 million to hedge the 1-month LIBOR portion of the cost of borrowing under the Unsecured Term Loan due 2022 to a fixed interest rate of 2.46% (plus the applicable margin rate) through December 2022. The outstanding balance on the Unsecured Term Loan due 2022 was $150.0 million as of December 31, 2017 with an effective interest rate of approximately 2.77% including the impact of the interest rate swaps. Senior Notes due 2021 Redemption During the fourth quarter of 2017, the Company redeemed the outstanding principal of $400.0 million on its Senior Notes due 2021 in two transactions. On November 1, 2017 and December 27, 2017, the Company redeemed $100.0 million and $300.0 million , respectively. The aggregate redemption price of $452.3 million , consisting of outstanding principal of $400.0 million , accrued interest of $9.5 million , and a "make-whole" amount of approximately $42.8 million for the early extinguishment of debt. The unaccreted discount and unamortized costs on these notes of $2.2 million was written off upon redemption. The Company recognized a loss on early extinguishment of debt of approximately $45.0 million related to this redemption. The following table reconciles the balance of the Senior Notes due 2021 on the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 : December 31, (Dollars in thousands) 2017 2016 Senior Notes due 2021 face value $ — $ 400,000 Unaccreted discount — (1,510 ) Issuance costs — (1,343 ) Senior Notes due 2021 carrying amount $ — $ 397,147 Senior Notes due 2023 On March 26, 2013, the Company issued $250.0 million of unsecured senior notes due 2023 (the "Senior Notes due 2023") in a registered public offering. The Senior Notes due 2023 bear interest at 3.75% , payable semi-annually on April 15 and October 15, beginning October 15, 2013, and are due on April 15, 2023, unless redeemed earlier by the Company. The notes were issued at a discount of approximately $2.1 million and the Company incurred debt issuance cost of $2.1 million , which yielded a 3.95% interest rate per annum upon issuance. For each of the years ended December 31, 2017 , 2016 and 2015 , the Company amortized approximately $0.2 million of the discount and $0.2 million of the debt issuance cost which are included in interest expense on the Company’s Consolidated Statements of Income. The following table reconciles the balance of the Senior Notes due 2023 on the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 : December 31, (Dollars in thousands) 2017 2016 Senior Notes due 2023 face value $ 250,000 $ 250,000 Unaccreted discount (1,178 ) (1,375 ) Issuance costs (1,119 ) (1,329 ) Senior Notes due 2023 carrying amount $ 247,703 $ 247,296 Senior Notes due 2025 On April 24, 2015, the Company issued $250.0 million of unsecured senior notes due 2025 (the "Senior Notes due 2025") in a registered public offering. The Senior Notes due 2025 bear interest at 3.875% , payable semi-annually on May 1 and November 1, beginning November 1, 2015, and are due on May 1, 2025, unless redeemed earlier by the Company. The notes were issued at a discount of approximately $0.2 million and the Company incurred approximately $2.3 million in debt issuance costs which yielded a 4.08% interest rate per annum upon issuance. For the years ended December 31, 2017 , 2016 , and 2015 the Company amortized approximately $0.2 million , $ 0.2 million , and $ 0.1 million , respectively, of the debt issuance costs which is included in interest expense on the Company's Consolidated Statements of Income. Concurrent with this transaction, the Company settled four forward starting swap agreements for $1.7 million . The Senior Notes due 2025 have various financial covenants that are required to be met on a quarterly and annual basis. The following table reconciles the balance of the Senior Notes due 2025 on the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 : December 31, (Dollars in thousands) 2017 2016 Senior Notes due 2025 face value $ 250,000 $ 250,000 Unaccreted discount (160 ) (178 ) Issuance costs (1,796 ) (2,003 ) Senior Notes due 2025 carrying amount $ 248,044 $ 247,819 Senior Notes due 2028 On December 11, 2017, the Company issued $300.0 million of unsecured Senior Notes due 2028 (the "Senior Notes due 2028") in a registered public offering. The Senior Notes due 2028 bear interest at 3.625% , payable semi-annually on January 15 and July 15, beginning July 15, 2018, and are due on January 15, 2028, unless redeemed earlier by the Company. The notes were issued at a discount of approximately $2.5 million and the Company incurred approximately $2.7 million in debt issuance costs which yielded a 3.84% interest rate per annum upon issuance. The Senior Notes due 2028 have various financial covenants that are required to be met on a quarterly and annual basis. The following table reconciles the balance of the Senior Notes due 2028 on the Company’s Consolidated Balance Sheets as of December 31, 2017 : (Dollars in thousands) December 31, 2017 Senior Notes due 2028 face value $ 300,000 Unaccreted discount (2,529 ) Issuance costs $ (2,714 ) Senior Notes due 2028 carrying amount $ 294,757 Mortgage Notes Payable The following table reconciles the Company’s aggregate mortgage notes principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 . For the years ended December 31, 2017 , 2016 and 2015 , the Company amortized approximately $0.3 million , $0.3 million and $0.8 million of the discount and $0.7 million , $0.9 million , and $1.0 million of the premium. For the years ended December 31, 2017, 2016 and 2015, the Company also amortized approximately $0.1 million , $0.2 million , and $0.2 million of the debt issuance costs, respectively, on the mortgage notes payable which is included in interest expense on the Company’s Consolidated Statements of Income. December 31, (Dollars in thousands) 2017 2016 Mortgage notes payable principal balance $ 154,916 $ 114,934 Unamortized premium 2,651 2,569 Unaccreted discount (1,332 ) (1,450 ) Issuance costs (853 ) (436 ) Mortgage notes payable carrying amount $ 155,382 $ 115,617 The following table details the Company’s mortgage notes payable, with related collateral. Original Balance Effective Interest Rate (23) Maturity Date Collateral (24) Principal and Interest Payments (22) Investment in Collateral at December 31, Balance at December 31, (Dollars in millions) 2017 2017 2016 Life Insurance Co. (1) 7.0 5.53 % 1/18 MOB Monthly/15-yr amort. $ — $ — $ 0.7 Commercial Bank (2) 1.8 5.55 % 10/30 OTH Monthly/27-yr amort. — — 1.3 Insurance Co. (3) 7.3 5.54 % 12/18 MOB Monthly/25-yr amort. 14.3 6.0 6.2 Commercial Bank (4) 9.5 5.07 % 3/19 MOB Monthly/5-yr amort. 13.9 9.3 9.5 Commercial Bank (5) 9.4 4.55 % 7/19 MOB Monthly/8-yr amort 27.8 9.2 9.3 Commercial Bank (6) 15.2 7.65 % 7/20 MOB (21) 20.2 12.7 12.7 Life Insurance Co. (7) 7.9 4.00 % 8/20 MOB Monthly/15-yr amort. 20.7 2.0 2.7 Life Insurance Co. (8) 7.3 5.25 % 8/20 MOB Monthly/27-yr amort. 17.9 6.5 6.7 Life Insurance Co. (9) 5.6 4.27 % 1/21 MOB Monthly/10-yr amort. 15.7 4.8 — Commercial Bank (10) 12.9 6.43 % 2/21 MOB Monthly/12-yr amort. 54.9 10.5 10.7 Life Insurance Co. (11) 11.0 3.85 % 11/22 MOB Monthly/7-yr amort. 22.0 10.4 — Life Insurance Co. (12) 12.3 3.85 % 8/23 MOB Monthly/7-yr amort. 24.6 11.5 — Financial Services (13) 12.4 4.27 % 10/23 MOB Monthly/10-yr amort. 24.7 12.2 — Life Insurance Co. (14) 13.3 4.13 % 1/24 MOB Monthly/10-yr amort. 21.1 13.3 13.6 Life Insurance Co. (15) 6.8 3.94 % 2/24 MOB Monthly/7-yr amort. 14.5 6.7 — Financial Services (16) 9.7 4.32 % 9/24 MOB Monthly/10-yr amort. 16.4 8.8 9.1 Commercial Bank 11.5 3.71 % 1/26 MOB Monthly/10-yr amort. 37.9 10.5 11.0 Commercial Bank (17) 15.0 5.25 % 4/27 MOB Monthly/20-yr amort. 33.4 9.6 10.4 Municipal Government (18) (19) 11.0 4.79 % (20) MOB Semi-Annual (20) 20.9 11.4 11.7 $ 400.9 $ 155.4 $ 115.6 ______ (1) The Company repaid this mortgage note in October 2017. The Company's unencumbered gross investment was $14.3 million at December 31, 2017. (2) The Company repaid this mortgage note in September 2017. The Company's unencumbered gross investment was $8.0 million at December 31, 2017. (3) The unamortized portion of the $0.6 million premium recorded on this note upon acquisition is included in the balance above. (4) The unamortized portion of the $0.2 million premium recorded on this note upon acquisition is included in the balance above. (5) The unamortized portion of the $0.3 million premium recorded on this note upon acquisition is included in the balance above. (6) The unaccreted portion of the $2.4 million discount recorded on this note upon acquisition is included in the balance above. (7) The unamortized portion of the $0.3 million premium recorded on this note upon acquisition is included in the balance above. (8) The unamortized portion of the $0.4 million premium recorded on this note upon acquisition is included in the balance above. (9) The unamortized portion of the $0.2 million premium recorded on this note upon acquisition is included in the balance above. (10) The unaccreted portion of the $1.0 million discount recorded on this note upon acquisition is included in the balance above. (11) The unaccreted portion of the $0.1 million discount recorded on this note upon acquisition is included in the balance above. (12) The unaccreted portion of the $0.2 million discount recorded on this note upon acquisition is included in the balance above. (13) The unamortized portion of the $0.4 million premium recorded upon acquisition is included in the balance above. (14) The unamortized portion of the $0.8 million premium recorded on this note upon acquisition is included in the balance above. (15) The unamortized portion of the $0.2 million premium recorded on this note upon acquisition is included in the balance above. (16) The unamortized portion of the $0.1 million premium recorded on this note upon acquisition is included in the balance above. (17) The unamortized portion of the $0.7 million premium recorded on this note upon acquisition is included in the balance above. (18) Balance consists of three notes secured by the same building. (19) The unamortized portion of the $1.0 million premium recorded on the three notes upon acquisition is included in the balance above. (20) These three mortgage notes payable are series municipal bonds that have maturity dates ranging from from May 2022 to May 2040. One of the four original notes payable was repaid upon maturity in May 2017. The remaining three require interest only payments and have future maturity dates but allow repayment after May 2020 without penalty. The Company intends on repaying all three notes payable at that time. (21) Payable in monthly installments of interest only for 24 months and then installments of principal and interest based on an 11 -year amortization with the final payment due at maturity. (22) Payable in monthly installments of principal and interest with the final payment due at maturity (unless otherwise noted). (23) The contractual interest rates for the 19 outstanding mortgage notes ranged from 3.3% to 6.9% as of December 31, 2017 . (24) MOB-Medical office building; OTH-Other. Other Long-Term Debt Information Future maturities of the Company’s notes and bonds payable as of December 31, 2017 were as follows: (Dollars in thousands) Principal Maturities Net Accretion/ Amortization (1) Debt Issuance Costs (2) Notes and Bonds Payable % 2018 $ 10,605 $ (18 ) $ (1,051 ) 9,536 0.7 % 2019 22,711 (224 ) (1,044 ) 21,443 1.7 % 2020 211,803 (382 ) (1,039 ) 210,382 16.4 % 2021 17,321 (312 ) (1,025 ) 15,984 1.2 % 2022 162,692 (328 ) (1,037 ) 161,327 12.6 % 2023 and thereafter 868,784 (1,284 ) (2,292 ) 865,208 67.4 % $ 1,293,916 $ (2,548 ) $ (7,488 ) 1,283,880 100.0 % ______ (1) Includes discount accretion and premium amortization related to the Company’s Senior Notes due 2023, Senior Notes due 2025, Senior Notes due 2028 and 18 mortgage notes payable. (2) Excludes approximately $3.5 million in debt issuance costs related to the Company's Unsecured Credit Facility due 2020 included in other assets. |
Derivative Financial Instrument
Derivative Financial Instruments | 12 Months Ended |
Dec. 31, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Financial Instruments | Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During 2017, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. During the year ended December 31, 2017 , the Company entered into two outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk: Interest Rate Derivative Number of Instruments Notional (in millions) Interest rate swaps 2 $25.0 During the year ended December 31, 2015, the Company entered into four forward starting interest rate swaps with a total notional value of $225.0 million to hedge the risk of changes in the interest-related cash flows associated with the potential issuance of long-term debt. That debt was issued in April 2015, as discussed in Note 9, and the forward starting interest rate swaps were terminated. As a result, the Company realized a loss at the termination date which was deferred and is being amortized over the term of the Senior Notes due 2025. Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Company's derivative financial instruments, as well as, their classification on the Consolidated Balance Sheets as of December 31, 2017. Liability Derivatives As of December 31, 2017 (Dollars in thousands) Balance Sheet Location Fair Value Derivatives designated as hedging instruments Interest rate swaps Other liabilities $ 67 Total derivatives designated as hedging instruments $ 67 Tabular Disclosure of the Effect of Fair Value and Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) The table below presents the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income (Loss) as of December 31, 2017 related to the Company's outstanding interest rate swaps. Amount of Loss Recognized in OCI on Derivative Amount of Loss Reclassified from OCI into Income (Dollars in thousands) 2017 2017 2016 Interest rate products $ 74 Interest expense $ 7 $ — Settled interest rate swaps — Interest expense 169 168 $ 74 Total interest expense $ 176 $ 168 Credit-risk-related Contingent Features The Company has agreements with each of its derivative counterparties that contain a provision where the Company could be declared in default on its derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to the Company's default on the indebtedness. As of December 31, 2017, the fair value of derivatives in a net liability position, which includes accrued interest but excludes any adjustment for nonperformance risk, related to these agreements was $0.1 million . If the Company had breached any of these provisions at December 31, 2017, it could have been required to settle its obligations under the agreements at their termination value of $0.1 million . The Company estimates that an additional $0.3 million will be reclassified from accumulated other comprehensive loss as an increase to interest expense over the next 12 months. Subsequent Activity On January 30, 2018, the Company entered into two interest rate derivatives that were designated as cash flow hedges of interest rate risk totaling $50.0 million . These derivatives were used to hedge variable cash flows associated with variable-rate debt. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2017 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders’ Equity Common Stock The Company had no preferred shares outstanding and had common shares outstanding for the three years ended December 31, 2017 as follows: Year Ended December 31, 2017 2016 2015 Balance, beginning of year 116,416,900 101,517,009 98,828,098 Issuance of common stock 8,395,607 14,063,100 2,493,171 Non-vested stock-based awards, net of withheld shares and forfeitures 319,086 836,791 195,740 Balance, end of year 125,131,593 116,416,900 101,517,009 Equity Offering On August 14, 2017, the Company issued 8,337,500 shares of common stock par value $0.01 per share, at $30.90 per share in an underwritten public offering pursuant to the Company's existing effective registration statement. The net proceeds of the offering, after underwriting discount and offering expenses, were approximately $247.1 million . At-The-Market Equity Offering Program The Company has in place an at-the-market equity offering program to sell shares of the Company’s common stock from time to time in at-the-market sales transactions. The following table details the shares sold under this program. Shares Sold Sales Price Per Share Net Proceeds (in millions) 2017 — NA $ — 2016 4,795,601 $28.31 - $33.66 $ 144.6 2015 2,434,239 $25.00 - $29.15 $ 65.8 On February 19, 2016, the Company entered into sales agreements with five investment banks to allow sales under its at-the-market equity offering program of up to 10,000,000 shares of common stock. A previous sales agreement with one investment bank was terminated effective February 17, 2016. No shares were sold related to this program during 2017. On May 5, 2017, the Company entered into a sales agreement with a sixth investment bank in connection with the same allotment of shares. The Company has 5,868,697 authorized shares remaining available to be sold under the current sales agreements as of February 14, 2018 . Dividends Declared During 2017 , the Company declared and paid common stock dividends aggregating $1.20 per share ( $0.30 per share per quarter). On February 13, 2018, the Company declared a quarterly common stock dividend in the amount of $0.30 per share payable on March 6, 2018 to stockholders of record on February 23, 2018. Common Stock Authorization On May 2, 2017, the Company's shareholders approved an amendment to the Company's Articles of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 300,000,000 . Authorization to Repurchase Common Stock The Company’s Board of Directors has authorized management to repurchase up to 3,000,000 shares of the Company’s common stock. As of December 31, 2017 , the Company had not repurchased any shares under this authorization. The Company may elect, from time to time, to repurchase shares either when market conditions are appropriate or as a means to reinvest excess cash flows. Such purchases, if any, may be made either in the open market or through privately negotiated transactions. Accumulated Other Comprehensive Income (Loss) During the year ended December 31, 2017, the Company entered into two interest rate swaps to hedge the variable cash flows associated with existing variable-rate debt. The Company recorded a loss in accumulated other comprehensive loss of approximately $0.1 million as of December 31, 2017. The Company continues to amortize the 2015 settlement of forward-starting interest rate swaps. This amount will be reclassified out of accumulated other comprehensive loss impacting net income over the 10 -year term of the associated senior note issuance. See Note 10 for more information regarding the Company's derivative instruments. The following table represents the changes in accumulated other comprehensive loss during the year ended December 31, 2017 : (Dollars in thousands) Interest Rate Swaps Beginning balance $ (1,401 ) Other comprehensive loss before reclassifications 176 Amounts reclassified from accumulated other comprehensive income (loss) (74 ) Net current-period other comprehensive income 102 Ending balance $ (1,299 ) The following table represents the details regarding the reclassifications from Accumulated other comprehensive income (loss) during the year ended December 31, 2017 : Details about accumulated other comprehensive income (loss) components Amount reclassified from accumulated other comprehensive income (loss) Affected line item in the statement where net income is presented (Dollars in thousands) Amounts reclassified from accumulated other comprehensive income (loss) related to settled interest rate swaps $ 169 Interest Expense Amounts reclassified from accumulated other comprehensive income (loss) related to current interest rate swaps 7 Interest Expense $ 176 |
Benefit Plans
Benefit Plans | 12 Months Ended |
Dec. 31, 2017 | |
Retirement Benefits [Abstract] | |
Benefit Plans | Benefit Plans Executive Retirement Plan Effective May 5, 2015, the Company terminated its Executive Retirement Plan and recorded a charge of approximately $5.3 million , inclusive of the acceleration of $2.5 million recorded in accumulated other comprehensive loss on the Company's Consolidated Balance Sheet that was being amortized resulting in a total benefit obligation of $19.6 million in connection with the termination of the Executive Retirement Plan. The charge includes amounts resulting from assumed additional years of service for two plan participants who had not reached age 65 and payments associated with FICA and other tax obligations. On May 6, 2016, the Company paid the total benefit obligation of $19.6 million which reduced Other liabilities on the Company's Consolidated Balance Sheets. As a result of the termination of the plan, and included in the payment of the total benefit obligation, Mr. Emery received a lump sum amount equal to his accrued benefit under the plan of approximately $14.4 million in May 2016. Net periodic benefit cost for the Executive Retirement Plan for the three years in the period ended December 31, 2017 is comprised of the following: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Service cost $ — $ — $ 29 Interest cost — — 225 Amortization of prior service cost (benefit) — — (198 ) Amortization of net gain — — 343 — — 399 Net loss recognized in Accumulated other comprehensive income (loss) — — — Total recognized in net periodic benefit gain and Accumulated other comprehensive income (1) $ — $ — $ 399 _____ (1) 2015 is a partial year due to the termination of the Executive Retirement Plan during the year. The Company had no benefit obligations as of December 31, 2017 and 2016 . |
Stock and Other Incentive Plans
Stock and Other Incentive Plans | 12 Months Ended |
Dec. 31, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock and Other Incentive Plans | Stock and Other Incentive Plans Stock Incentive Plan In May 2015, the Company's stockholders approved the 2015 Stock Incentive Plan (the "2015 Incentive Plan") which authorizes the Company to issue 3,500,000 shares of common stock to its employees and directors. The 2015 Incentive Plan, which superseded the 2007 Employee Stock Incentive Plan (the "Predecessor Plan"), will continue until terminated by the Company’s Board of Directors. As of December 31, 2017 and 2016 , the Company had issued a total of 1,438,228 and 1,024,739 restricted shares, respectively, under the 2015 Incentive Plan for compensation-related awards to employees and directors, with a total of 2,061,772 and 2,475,261 , respectively, remaining which had not been issued. Under the Predecessor Plan for compensation-related awards to employees and directors, the Company had issued, net of forfeitures, a total of 1,878,637 restricted shares for the year ended December 31, 2015. Non-vested shares issued under the 2015 Incentive Plan are generally subject to fixed vesting periods varying from three to eight years beginning on the date of issue. If a recipient voluntarily terminates his or her relationship with the Company or is terminated for cause before the end of the vesting period, the shares are forfeited, at no cost to the Company. The Company recognizes the impact of forfeitures as they occur. Once the shares have been issued, the recipient has the right to receive dividends and the right to vote the shares. Compensation expense recognized during the years ended December 31, 2017 , 2016 and 2015 from the amortization of the value of shares over the vesting period issued to employees and directors was $9.8 million , $7.4 million and $5.9 million , respectively. The following table represents expected amortization of the Company's non-vested shares issued: (Dollars in millions) Future Amortization of Non-Vested Shares 2018 $ 9.4 2019 7.0 2020 6.7 2021 5.7 2022 3.2 2023 and thereafter 3.6 Total $ 35.6 Executive Incentive Plan On July 31, 2012, the Company adopted an Executive Incentive Plan, which was amended and restated on February 16, 2016 ("Executive Incentive Plan"), to provide specific award criteria with respect to incentive awards made under the 2015 Incentive Plan subject to the discretion of the Compensation Committee. No new shares of common stock were authorized in connection with the Executive Incentive Plan. Under the terms of the Executive Incentive Plan, the Company's named executive officers, and certain other members of senior management, may earn incentive awards in the form of cash and non-vested stock. Cash incentive awards are based on individual and Company performance. Company performance is measured over a four-quarter period against targeted financial and operational metrics set in advance by the Compensation Committee. Non-vested stock awards are based on the Company's relative total shareholder return ("TSR") performance over one -year and three -year periods, measured against the Company's peer group. For 2017 , 2016 and 2015 , compensation expense resulting from the amortization of non-vested share grants to officers was approximately $5.0 million , $4.0 million , and $2.7 million , respectively. Details of the awards that have been earned from this plan are as follows: • On December 11, 2017, the Company granted non-vested stock awards for TSR performance to its five named executive officers and four senior vice presidents with a grant date fair value totaling $10.1 million , which were granted in the form of 309,874 non-vested shares, with a five -year vesting period, which will result in annual compensation expense of $2.0 million for the each of 2018, 2019, 2020, and 2021, and $1.9 million for 2022, respectively. • On December 16, 2016, the Company granted non-vested stock awards for TSR performance to its five named executive officers and five senior vice presidents with a grant date fair value totaling $6.3 million , which were granted in the form of 213,639 non-vested shares, with a five -year vesting period, which will result in annual compensation expense of $1.3 million each of 2018, 2019, and 2020, and $1.2 million for 2021, respectively. • On February 16, 2016, the Company granted cash incentive and non-vested performance-based awards totaling $5.8 million to its five named executive officers and five senior vice presidents. The officers could elect cash based awards or non-vested stock awards. Cash awards totaled $1.1 million . The non-vested awards, which the officers elected to receive in lieu of cash, had a grant date fair value totaling $4.7 million , which were granted in the form of 163,788 non-vested shares, with either a three - or five -year vesting period, resulting in annual compensation expense of $1.1 million for the year 2018 and $0.7 million for each of 2019 and 2020, respectively. • On December 18, 2015, the Company granted non-vested stock awards for TSR performance to its five named executive officers and five senior vice presidents with a grant date fair value totaling $3.9 million . The awards were granted in the form of 139,000 non-vested shares, with a three -year vesting period, which will result in annual compensation expense of $1.3 million for 2018. Long-Term Incentive Program In the first quarter of 2017 and 2016 , the Company granted a performance-based award to officers, excluding the five named executive officers and four senior vice presidents, under the Long-term Incentive Program adopted under the 2015 Incentive Plan (the "LTIP") totaling approximately $1.3 million per award, which was granted in the form of 41,368 non-vested shares and 44,162 non-vested shares, respectively. The shares have vesting periods ranging from three to eight years with a weighted average vesting period of approximately six years. Beginning in 2012, the Company's executive officers were no longer eligible to participate in the LTIP and beginning in 2013, five senior vice presidents were also no longer eligible to participate. For 2017 , 2016 and 2015 , compensation expense resulting from the amortization of non-vested share grants to officers was approximately $1.1 million . Salary Deferral Plan The Company's salary deferral plan allows certain of its officers to elect to defer up to 50% of their base salary in the form of non-vested shares issued under the 2015 Incentive Plan subject to long-term vesting. The number of shares will be increased through a Company match depending on the length of the vesting period selected by the officer. The officer's vesting period choices are: three years for a 30% match; five years for a 50% match; and eight years for a 100% match. During 2017 , 2016 and 2015 , the Company issued 39,016 shares, 42,256 shares and 55,923 shares, respectively, to its officers through the salary deferral plan. For 2017 , 2016 and 2015 , compensation expense resulting from the amortization of non-vested share grants to officers was approximately $1.2 million , $1.2 million , and $1.1 million , respectively. Non-employee Directors Incentive Plan The Company issues non-vested shares to its non-employee directors under the 2015 Incentive Plan. The directors’ shares issued have a one -year vesting period beginning with the May 2015 grant (previously a three -year vesting period) and are subject to forfeiture prior to such date upon termination of the director’s service, at no cost to the Company. During 2017 , 2016 and 2015 , the Company issued 23,231 shares, 21,374 shares, and 23,201 shares, respectively, to its non-employee directors through the 2015 Incentive Plan. For 2017 , 2016 and 2015 , compensation expense resulting from the amortization of non-vested share grants to directors was approximately $0.8 million , $1.0 million , and $1.0 million , respectively. Other Grants The Company issued three one-time non-vested share grants related to executive management transition in 2016. For 2017 and 2016 , compensation expense resulting from the amortization of these non-vested share grants to officers was approximately $1.7 million and $0.1 million , respectively. The following information provides information about each grant: • On March 1, 2016, the Company issued 50,000 shares to the Chief Financial Officer with a 10 -year vesting period, resulting in compensation expense of $0.2 million per year. • On December 30, 2016, the Company issued 200,000 shares to the President and Chief Executive Officer with a 10 -year vesting period, resulting in compensation expense of $0.6 million per year. • On December 30, 2016, the Company issued 150,000 shares to the Executive Chairman with a 5 -year vesting period, resulting in compensation expense of $0.9 million per year. A summary of the activity under the 2015 Incentive Plan and related information for the three years in the period ended December 31, 2017 follows: Year Ended December 31, (Dollars in thousands, except per share data) 2017 2016 2015 Stock-based awards, beginning of year 1,786,497 1,092,262 1,057,732 Granted 413,489 885,219 251,789 Vested (292,341 ) (190,984 ) (210,955 ) Forfeited — — (6,304 ) Stock-based awards, end of year 1,907,645 1,786,497 1,092,262 Weighted-average grant date fair value of: Stock-based awards, beginning of year $ 27.18 $ 24.72 $ 24.01 Stock-based awards granted during the year $ 32.05 $ 29.60 $ 27.70 Stock-based awards vested during the year $ 25.88 $ 24.34 $ 25.05 Stock-based awards forfeited during the year $ — $ — $ 24.80 Stock-based awards, end of year $ 28.44 $ 27.18 $ 24.72 Grant date fair value of shares granted during the year $ 13,254 $ 26,204 $ 6,975 The vesting periods for the non-vested shares granted during 2017 ranged from one to eight years with a weighted-average amortization period remaining as of December 31, 2017 of approximately 5.1 years. During 2017 , 2016 and 2015 , the Company withheld 94,403 shares, 48,248 shares and 49,225 shares, respectively, of common stock from its officers to pay estimated withholding taxes related to the vesting of shares. 401(k) Plan The Company maintains a 401(k) plan that allows eligible employees to defer salary, subject to certain limitations imposed by the Internal Revenue Code. The Company provides a matching contribution of up to 3% of each eligible employee’s salary, subject to certain limitations. The Company’s matching contributions were approximately $0.4 million for each year during 2017 , 2016 and 2015 . Dividend Reinvestment Plan The Company is authorized to issue 1,000,000 shares of common stock to stockholders under the Dividend Reinvestment Plan. As of December 31, 2017 , the Company had issued 581,627 shares under the plan of which 26,031 shares were issued in 2017 , 9,575 shares were issued in 2016 and 13,950 shares were issued in 2015 . Employee Stock Purchase Plan The Company has an Employee Stock Purchase Plan, pursuant to which the Company is authorized to issue shares of common stock. As of December 31, 2017 , 2016 and 2015 , the Company had a total of 25,535 shares, 63,690 shares and 96,977 shares authorized under the Employee Stock Purchase Plan, respectively, which had not been issued or optioned. Under the Employee Stock Purchase Plan, each eligible employee in January of each year is able to purchase up to $25,000 of common stock at the lesser of 85% of the market price on the date of grant or 85% of the market price on the date of exercise of such option. The number of shares subject to each year’s option becomes fixed on the date of grant. Options granted under the Employee Stock Purchase Plan expire if not exercised 27 months after each such option’s date of grant. Cash received from employees upon exercising options under the Employee Stock Purchase Plan was approximately $0.8 million for the year ended December 31, 2017 , $1.2 million for the year ended December 31, 2016 , and $0.9 million for the year ended December 31, 2015 . A summary of the Employee Stock Purchase Plan activity and related information for the three years in the period ended December 31, 2017 is as follows: Year Ended December 31, (Dollars in thousands, except per share data) 2017 2016 2015 Options outstanding, beginning of year 316,321 340,958 393,902 Granted 206,824 198,450 197,640 Exercised (32,076 ) (57,924 ) (44,462 ) Forfeited (40,659 ) (22,081 ) (47,176 ) Expired (132,310 ) (143,082 ) (158,946 ) Options outstanding and exercisable, end of year 318,100 316,321 340,958 Weighted-average exercise price of: Options outstanding, beginning of year $ 23.69 $ 20.70 $ 19.17 Options granted during the year $ 25.77 $ 24.07 $ 23.22 Options exercised during the year $ 24.31 $ 21.40 $ 19.41 Options forfeited during the year $ 25.01 $ 23.16 $ 19.90 Options expired during the year $ 23.22 $ 18.11 $ 20.41 Options outstanding, end of year $ 25.00 $ 23.69 $ 20.70 Weighted-average fair value of options granted during the year (calculated as of the grant date) $ 6.31 $ 5.37 $ 5.39 Intrinsic value of options exercised during the year $ 271 $ 634 $ 381 Intrinsic value of options outstanding and exercisable (calculated as of December 31) $ 2,683 $ 2,098 $ 2,597 Exercise prices of options outstanding (calculated as of December 31) $ 25.00 $ 23.69 $ 20.70 Weighted-average contractual life of outstanding options (calculated as of December 31, in years) 0.8 0.8 0.8 The fair values for these options were estimated at the date of grant using a Black-Scholes options pricing model with the weighted-average assumptions for the options granted during the period noted in the following table. The risk-free interest rate was based on the U.S. Treasury constant maturity-nominal two-year rate whose maturity is nearest to the date of the expiration of the latest option outstanding and exercisable; the expected dividend yield was based on the expected dividends of the current year as a percentage of the average stock price of the prior year; the expected life of each option was estimated using the historical exercise behavior of employees; expected volatility was based on historical volatility of the Company’s common stock; and expected forfeitures were based on historical forfeiture rates within the look-back period. 2017 2016 2015 Risk-free interest rates 1.20 % 1.06 % 0.67 % Expected dividend yields 3.70 % 4.64 % 4.79 % Expected life (in years) 1.45 1.42 1.38 Expected volatility 20.4 % 17.6 % 21.0 % Expected forfeiture rates 85 % 85 % 80 % |
Earnings Per Share
Earnings Per Share | 12 Months Ended |
Dec. 31, 2017 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share The Company uses the two-class method of computing net earnings per common shares. Non-vested share-based awards containing non-forfeitable rights to dividends are considered participating securities pursuant to the two-class method. The table below sets forth the computation of basic and diluted earnings per common share for the three years in the period ended December 31, 2017 . Year Ended December 31, (Dollars in thousands, except per share data) 2017 2016 2015 Weighted Average Common Shares Weighted average Common Shares outstanding 119,739,216 109,861,580 100,280,059 Non-vested shares (1,813,058 ) (1,289,478 ) (1,108,707 ) Weighted average Common Shares - Basic 117,926,158 108,572,102 99,171,352 Weighted average Common Shares - Basic 117,926,158 108,572,102 99,171,352 Dilutive effect of non-vested shares — 709,559 623,212 Dilutive effect of employee stock purchase plan 91,007 105,336 85,738 Weighted average Common Shares - Diluted 118,017,165 109,386,997 99,880,302 Net Income Income from continuing operations $ 23,096 $ 85,756 $ 58,836 Dividends paid on nonvested share-based awards (2,149 ) — — Income from continuing operations applicable to common stockholders 20,947 85,756 58,836 Discontinued operations (4 ) (185 ) 10,600 Net income applicable to common stockholders $ 20,943 $ 85,571 $ 69,436 Basic Earnings Per Common Share Income from continuing operations $ 0.18 $ 0.79 $ 0.59 Income from discontinued operations 0.00 0.00 0.11 Net income $ 0.18 $ 0.79 $ 0.70 Diluted Earnings Per Common Share Income from continuing operations $ 0.18 $ 0.78 $ 0.59 Income from discontinued operations 0.00 0.00 0.11 Net income $ 0.18 $ 0.78 $ 0.70 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Redevelopment Activity The Company completed the redevelopment and expansion of one medical office building in Nashville, Tennessee in 2017. The Company spent approximately $12.6 million on the redevelopment of this property during the year ended December 31, 2017 , including approximately $3.2 million related to overages on tenant improvement projects that have been or will be reimbursed by the tenant. During 2017, the Company began the redevelopment of a medical office building in Charlotte, North Carolina, which includes a 38,000 square foot vertical expansion. The Company spent approximately $3.3 million on the redevelopment during the year ended December 31, 2017. Development Activity The Company completed the development of a 99,957 square foot medical office building in Denver, Colorado. The Company spent approximately $14.6 million during the year ended December 31, 2017 , including approximately $2.8 million related to overages on tenant improvement projects that have been or will be reimbursed by the tenant. The Company anticipates funding additional tenant improvements throughout 2018 and 2019. The Company began the development of a 151,000 square foot medical office building in Seattle, Washington during 2017. The Company spent approximately $1.8 million on the development during the year ended December 31, 2017. The Company expects the project to be completed in the second quarter of 2019. The table below details the Company’s construction activity as of December 31, 2017 . The information included in the table below represents management’s estimates and expectations at December 31, 2017 , which are subject to change. The Company’s disclosures regarding certain projections or estimates of completion dates may not reflect actual results. December 31, 2017 (Dollars in thousands) Number of Properties Estimated Completion Date Construction in Progress Balance Total Funded During the Year Total Amount Funded Estimated Remaining Fundings (unaudited) Estimated Total Investment (unaudited) Approximate Square Feet (unaudited) Construction Activity Charlotte, NC 1 Q1 2019 $ 3,487 $ 3,264 $ 3,487 8,513 $ 12,000 204,000 Seattle, WA 1 Q2 2019 1,971 1,809 2,272 61,848 64,120 151,000 Total $ 5,458 $ 5,073 $ 5,759 $ 70,361 $ 76,120 355,000 Tenant Improvements The Company may provide a tenant improvement allowance in new or renewal leases for the purpose of refurbishing or renovating tenant space. As of December 31, 2017 , the Company had commitments of approximately $27.8 million that is expected to be spent on tenant improvements throughout the portfolio, excluding development properties currently under construction. Land Held for Development Land held for development includes parcels of land owned by the Company, upon which the Company intends to develop and own outpatient healthcare facilities. The Company’s investment in six parcels of land held for development located adjacent to certain of the Company's existing medical office buildings in Texas, Iowa and Tennessee totaled approximately $20.1 million as of December 31, 2017 and 2016 . Operating Leases As of December 31, 2017 , the Company was obligated under operating lease agreements consisting primarily of the Company’s corporate office lease and ground leases. At December 31, 2017 , the Company had 109 properties totaling 8.9 million square feet that were held under ground leases with a remaining weighted average term of 68.7 years, including renewal options. These ground leases typically have initial terms of 50 to 75 years with one to two renewal options extending the terms to 75 to 100 years, with expiration dates through 2117 . The Company’s ground leases generally increase annually based on increases in the Consumer Price Index. Rental expense relating to the operating leases for the years ended December 31, 2017 , 2016 and 2015 was $6.3 million , $5.7 million and $5.1 million , respectively. The Company prepaid 48 ground leases, which represented approximately $0.5 million of the Company’s rental expense for the years ended December 31, 2017 , 2016 , and 2015 . The Company’s corporate office lease currently covers approximately 36,653 square feet of rented space and expires on October 31, 2020. The Company’s future minimum lease payments for its corporate office lease and 61 ground leases, excluding leases that the Company has prepaid and leases in which an operator pays or fully reimburses the Company, as of December 31, 2017 were as follows (in thousands): 2018 $ 5,341 2019 5,420 2020 5,459 2021 5,488 2022 5,516 2023 and thereafter 283,056 $ 310,280 |
Other Data
Other Data | 12 Months Ended |
Dec. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Other Data | Other Data Taxable Income (unaudited) The Company has elected to be taxed as a REIT, as defined under the Internal Revenue Code. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement that it currently distribute at least 90% of its taxable income to its stockholders. As a REIT, the Company generally will not be subject to federal income tax on taxable income it distributes currently to its stockholders. Accordingly, no provision for federal income taxes has been made in the accompanying Consolidated Financial Statements. If the Company fails to qualify as a REIT for any taxable year, then it will be subject to federal income taxes at regular corporate rates, including any applicable alternative minimum tax, and may not be able to qualify as a REIT for four subsequent taxable years. Even if the Company qualifies as a REIT, it may be subject to certain state and local taxes on its income and property and to federal income and excise tax on its undistributed taxable income. Earnings and profits (as defined under the Internal Revenue Code), the current and accumulated amounts of which determine the taxability of distributions to stockholders, vary from net income attributable to common stockholders and taxable income because of different depreciation recovery periods, depreciation methods, and other items. On a tax-basis, the Company’s gross real estate assets totaled approximately $4.0 billion , $3.7 billion , and $3.4 billion as of December 31, 2017 , 2016 and 2015, respectively. The following table reconciles the Company’s consolidated net income attributable to common stockholders to taxable income for the three years ended December 31, 2017 : Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Net income $ 23,092 $ 85,571 $ 69,436 Reconciling items to taxable income: Depreciation and amortization 46,426 38,260 30,457 Gain or loss on disposition of depreciable assets 1,570 (32,103 ) 1,659 Impairments — 121 687 Straight-line rent (4,551 ) (7,101 ) (8,833 ) Receivable allowances 1,680 2,067 571 Stock-based compensation 1,855 1,301 7,518 Other 6,552 2,236 4,304 53,532 4,781 36,363 Taxable income (1) $ 76,624 $ 90,352 $ 105,799 Dividends paid $ 142,327 $ 131,759 $ 120,266 ______ (1) Before REIT dividend paid deduction. Characterization of Distributions (unaudited) Distributions in excess of earnings and profits generally constitute a return of capital. The following table gives the characterization of the distributions on the Company’s common stock for the three years ended December 31, 2017 . For the three years ended December 31, 2017 , there were no preferred shares outstanding. As such, no dividends were distributed related to preferred shares for those periods. 2017 2016 2015 Per Share % Per Share % Per Share % Common stock: Ordinary income $ 0.42 34.5 % $ 0.78 65.0 % $ 0.61 51.0 % Return of capital 0.50 42.0 % 0.35 29.5 % 0.08 6.7 % Unrecaptured section 1250 gain 0.28 23.5 % 0.07 5.5 % 0.51 42.3 % Common stock distributions $ 1.20 100.0 % $ 1.20 100.0 % $ 1.20 100.0 % State Income Taxes The Company must pay certain state income taxes, which are included in general and administrative expense on the Company’s Consolidated Statements of Income. The State of Texas gross margins tax on gross receipts from operations is disclosed in the table below as an income tax because it is considered such by the Securities and Exchange Commission. State income tax expense and state income tax payments for the three years ended December 31, 2017 are detailed in the table below: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 State income tax expense: Texas gross margins tax (1) $ 608 $ 562 $ 528 Other — 2 37 Total state income tax expense $ 608 $ 564 $ 565 State income tax payments, net of refunds and collections $ 555 $ 544 $ 758 ______ (1) In the table above, income tax expense for 2015 includes approximately $50 thousand that was recorded to the gain on sale of real estate properties sold, which is included in discontinued operations rather than general and administrative expenses on the Company’s Consolidated Statements of Income. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 12 Months Ended |
Dec. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value. Cash, cash equivalents and restricted cash - The carrying amount approximates fair value. Mortgage notes receivable - The fair value of mortgage notes receivable is estimated based either on cash flow analyses at an assumed market rate of interest or at a rate consistent with the rates on mortgage notes acquired by the Company recently, if any. Borrowings under the Unsecured Credit Facility due 2020 and Unsecured Term Loan due 2022 - The carrying amount approximates fair value because the borrowings are based on variable market interest rates. Senior unsecured notes payable - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company’s current interest rates for similar types of borrowing arrangements. Mortgage notes payable - The fair value is estimated using cash flow analyses, based on the Company’s current interest rates for similar types of borrowing arrangements. Interest rate swap agreements - Interest rate swap agreements are recorded in other liabilities on the Company's Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models that consider forward yield curves and discount rates. The table below details the fair value and carrying values for notes and bonds payable as of December 31, 2017 and 2016 . December 31, 2017 December 31, 2016 (Dollars in millions) Carrying Value Fair Value Carrying Value Fair Value Notes and bonds payable (1) $ 1,283.9 $ 1,269.7 $ 1,264.4 $ 1,265.1 ______ (1) Level 2 – model-derived valuations in which significant inputs and significant value drivers are observable in active markets. |
Selected Quarterly Financial Da
Selected Quarterly Financial Data (unaudited) | 12 Months Ended |
Dec. 31, 2017 | |
Selected Quarterly Financial Information [Abstract] | |
Selected Quarterly Financial Data (unaudited) | Selected Quarterly Financial Data (unaudited) Quarterly financial information for the year ended December 31, 2017 is summarized below. Quarter Ended (Dollars in thousands, except per share data) March 31 (1) June 30 (2) September 30 (3) December 31 (4) 2017 Revenues from continuing operations $ 104,569 $ 105,245 $ 106,953 $ 107,731 Income (loss) from continuing operations 31,858 25,224 3,165 (37,151 ) Income (loss) from discontinued operations (13 ) — 8 — Net income (loss) attributable to common stockholders $ 31,845 $ 25,224 $ 3,173 $ (37,151 ) Net income attributable to common stockholders per share: Basic earnings per common share $ 0.28 $ 0.22 $ 0.02 $ (0.31 ) Diluted earnings per common share $ 0.28 $ 0.22 $ 0.02 $ (0.31 ) ______ (1) The increases in net income and amounts per share for the first quarter of 2017 are primarily attributable to gains of $23.4 million on the sale of six properties. (2) The increases in net income and amounts per share for the second quarter of 2017 are primarily attributable to gains of $16.1 million on the sale of three properties. (3) The decreases in net income and amounts per share for the third quarter of 2017 are primarily attributable to impairment charges of $5.1 million . (4) The decreases in net income and amounts per share for the fourth quarter of 2017 are primarily attributable to a loss on the extinguishment of debt of $45.0 million . Quarterly financial information for the year ended December 31, 2016 is summarized below. Quarter Ended (Dollars in thousands, except per share data) March 31 June 30 September 30 December 31 (1) 2016 Revenues from continuing operations $ 100,021 $ 102,642 $ 103,659 $ 105,309 Income from continuing operations 9,163 12,157 11,857 52,580 Loss from discontinued operations (7 ) (12 ) (23 ) (143 ) Net income attributable to common stockholders $ 9,156 $ 12,145 $ 11,834 $ 52,437 Net income attributable to common stockholders per share: Basic earnings per common share $ 0.09 $ 0.12 $ 0.10 $ 0.46 Diluted earnings per common share $ 0.09 $ 0.12 $ 0.10 $ 0.45 ______ (1) The increases in net income and amounts per share for the fourth quarter of 2016 are primarily attributable to gains of $41.0 million on the sale of six properties. |
Schedule II - Valuation and Qua
Schedule II - Valuation and Qualifying Accounts | 12 Months Ended |
Dec. 31, 2017 | |
Valuation and Qualifying Accounts [Abstract] | |
Valuation and Qualifying Accounts | Schedule II – Valuation and Qualifying Accounts for the years ended December 31, 2017 , 2016 and 2015 (Dollars in thousands) Balance at Beginning of Period Additions and Deductions Uncollectible Accounts Written-off Balance at End of Period Description Charged /(Credited) to Costs and Expenses Charged to Other Accounts 2017 Accounts and notes receivable allowance $ 148 $ 159 $ — $ 51 $ 256 2016 Accounts and notes receivable allowance $ 179 $ (21 ) $ — $ 10 $ 148 2015 Accounts and notes receivable allowance $ 465 $ (194 ) $ — $ 92 $ 179 |
Schedule III - Real Estate and
Schedule III - Real Estate and Accumulated Depreciation | 12 Months Ended |
Dec. 31, 2017 | |
SEC Schedule III, Real Estate and Accumulated Depreciation Disclosure [Abstract] | |
Real Estate and Accumulated Depreciation | Schedule III – Real Estate and Accumulated Depreciation as of December 31, 2017 (Dollars in thousands) Land (1) Buildings, Improvements, Lease Intangibles and CIP (1) Property Type Number of Properties State Initial Investment Cost Capitalized Subsequent to Acquisition Total Initial Investment Cost Capitalized Subsequent to Acquisition Total Personal Property (2) (3) (5) Total Property (1) (3) Accumulated Depreciation (4) Encumbrances Date Acquired Date Constructed Medical office/outpatient 193 AL, AZ, CA, CO, DC, FL, GA, HI, IA, IL, IN, LA, MD, MI, MN, MO, MS, NC, OH, OK, SC, SD, TN, TX, VA, WA $ 190,813 $ 3,862 $ 194,675 $ 2,823,611 $ 502,564 $ 3,326,175 $ 4,193 $ 3,525,043 $ 835,768 $ 154,916 1993-2017 1906 -2015 Inpatient 6 CA, CO, MO, PA, TX 8,179 — 8,179 255,495 9,861 265,356 — 273,535 66,780 — 1994-2013 1986 -2013 Other 10 IA, MI, TN, TX, VA 2,992 73 3,065 66,440 7,143 73,583 600 77,248 26,032 — 1993-2015 1964 - 2015 Total Real Estate 209 201,984 3,935 205,919 3,145,546 519,568 3,665,114 4,793 3,875,826 928,580 154,916 Land Held for Develop. — 20,123 — 20,123 — — — — 20,123 239 — Construction in Progress (5) — — — — — — 5,458 — 5,458 — — Corporate Property — — — — — — — 5,603 5,603 4,401 — Total Properties 209 $ 222,107 $ 3,935 $ 226,042 $ 3,145,546 $ 519,568 $ 3,670,572 $ 10,396 $ 3,907,010 $ 933,220 $ 154,916 (1) Includes eight assets held for sale as of December 31, 2017 of approximately $68.4 million (gross) and accumulated depreciation of $35.8 million . (2) Total properties as of December 31, 2017 have an estimated aggregate total cost of $ 4.0 billion for federal income tax purposes. (3) Depreciation is provided for on a straight-line basis on buildings and improvements over 3.3 to 39.0 years , lease intangibles over to 2.1 to 99.0 years , personal property over 2.8 to 20.0 years, and land improvements over 5.0 to 39.0 years. (4) Includes unamortized premium of $2.7 million and unaccreted discount of $1.3 million and issuance costs of $0.9 million as of December 31, 2017 . (5) Rollforward of Total Property and Accumulated Depreciation for the year ended December 31, 2017 , 2016 and 2015 follows: Year Ended December 31, 2017 Year Ended December 31, 2016 Year Ended December 31, 2015 (Dollars in thousands) Total Property Accumulated Depreciation Total Property Accumulated Depreciation Total Property Accumulated Depreciation Beginning Balance $ 3,633,993 $ 843,816 $ 3,382,680 $ 762,996 $ 3,271,536 $ 705,135 Additions during the period: Real Estate acquired 322,616 4,206 239,265 3,898 183,478 3,048 Other improvements 59,442 135,807 70,595 121,592 47,985 111,625 Land held for development — 74 — 26 500 26 Construction in Progress 14,598 — 35,596 — 19,024 — Retirement/dispositions: Real Estate (123,639 ) (50,683 ) (94,143 ) (44,696 ) (139,741 ) (56,838 ) Land held for development — — — — (102 ) — Ending Balance $ 3,907,010 $ 933,220 $ 3,633,993 $ 843,816 $ 3,382,680 $ 762,996 |
Schedule IV - Mortgage Loans on
Schedule IV - Mortgage Loans on Real Estate | 12 Months Ended |
Dec. 31, 2017 | |
Mortgage Loans on Real Estate [Abstract] | |
Mortgage Loans on Real Estate | Schedule IV – Mortgage Loans on Real Estate as of December 31, 2017 The Company had no mortgage notes receivable outstanding as of December 31, 2017 . A rollforward of mortgage loans on real estate for the three years ended December 31, 2017 follows: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Balance at beginning of period $ — $ — $ 1,900 Deductions during period: Principal repayments and reductions (1) — — (1,900 ) — — (1,900 ) Balance at end of period $ — $ — $ — (1) Principal repayments for the year ended December 31, 2015 includes unscheduled principal reductions on the mortgage note of $1.9 million . |
Summary of Significant Accoun30
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2017 | |
Accounting Policies [Abstract] | |
Business Overview | Business Overview Healthcare Realty Trust Incorporated (the “Company”) is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The Company had gross investments of approximately $3.8 billion in 201 real estate properties, construction in progress, land held for development and corporate property as of December 31, 2017 . The Company’s 201 owned real estate properties are located in 27 states and total approximately 14.6 million square feet. The Company provided property management services to approximately 11.5 million square feet nationwide. Square footage and property count disclosures in this Annual Report on Form 10-K are unaudited. |
Principles of Consolidation | Principles of Consolidation The Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, joint ventures, partnerships and consolidated variable interest entities (“VIE”) where the Company controls the operating activities of the VIE. In accordance with the consolidation accounting standards, the Company must evaluate each contractual relationship it has with its lessees, borrowers, or others to determine whether or not the contractual arrangement creates a variable interest in those entities. If the Company determines that it has a variable interest and the entity is a VIE, then management must determine whether or not the Company is the primary beneficiary of the VIE, resulting in consolidation of the VIE if the Company is the primary beneficiary. A primary beneficiary has the power to direct those activities of the VIE that most significantly impact its economic performance and has the obligation to absorb the losses of, or receive the benefits from, the VIE. The Company had no VIEs as of December 31, 2017 and 2016 . The Company's investments in its unconsolidated joint ventures are included in other assets and the related equity income is recognized in other income (expense) on the Company's Consolidated Financial Statements. See Note 7 for additional information. All significant intercompany accounts, transactions and balances have been eliminated upon consolidation in the Consolidated Financial Statements. |
Use of Estimates in the Consolidated Financial Statements | Use of Estimates in the Consolidated Financial Statements Preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates. |
Segment Reporting | Segment Reporting The Company owns, leases, acquires, manages, finances, develops and redevelops outpatient and other healthcare-related properties. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single reportable segment. |
Real Estate Properties | Real Estate Properties Real estate properties are recorded at cost or at fair value if acquired in a transaction that is a business combination under Accounting Standards Codification Topic 805, Business Combinations . Cost or fair value at the time of acquisition is allocated among land, buildings, tenant improvements, lease and other intangibles, and personal property as applicable. The Company’s gross real estate assets, on a financial reporting basis, totaled approximately $3.8 billion as of December 31, 2017 and $3.6 billion as of December 31, 2016 . During 2017 and 2016 , the Company eliminated against accumulated depreciation approximately $10.2 million and $6.7 million , respectively, of fully amortized real estate intangibles that were initially recorded as a component of certain real estate acquisitions. Also during 2017 and 2016 , approximately $2.6 million and $0.1 million of fully depreciated tenant and capital improvements that were no longer in service were eliminated against accumulated depreciation. Depreciation expense for the three years ended December 31, 2017, 2016 and 2015 was $129.4 million , $116.5 million and $106.5 million , respectively. Depreciation and amortization of real estate assets and liabilities in place as of December 31, 2017 , is provided for on a straight-line basis over the asset’s estimated useful life: Land improvements 5.0 to 39.0 years Buildings and improvements 3.3 to 39.0 years Lease intangibles (including ground lease intangibles) 2.1 to 99.0 years Personal property 2.8 to 20.0 years The Company capitalizes direct costs, including costs such as construction costs and professional services, and indirect costs, including capitalized interest and overhead costs, associated with the development and construction of real estate assets while substantive activities are ongoing to prepare the assets for their intended use. Capitalized interest cost is calculated using the weighted average interest rate of the Company's unsecured debt or the interest rate on project specific debt, if applicable. The Company continues to capitalize interest on the unoccupied portion of the properties in stabilization for up to one year after the buildings have been placed into service, at which time the capitalization of interest must cease. |
Land Held for Development | Land Held for Development Land held for development includes parcels of land owned by the Company, upon which the Company intends to develop and own outpatient healthcare facilities. The Company’s investment in six parcels of land held for development located adjacent to certain of the Company's existing medical office buildings in Texas, Iowa and Tennessee totaled approximately $20.1 million as of December 31, 2017 and 2016 |
Asset Impairment | Assets Held for Sale Long-lived assets held for sale are reported at the lower of their carrying amount or their fair value less cost to sell estimate. Further, depreciation of these assets ceases at the time the assets are classified as held for sale. Losses resulting from the sale of such properties are characterized as impairment losses in the Consolidated Statements of Income. Asset Impairment The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its operators. In addition, the Company reviews for possible impairment, those assets subject to purchase options and those impacted by casualties, such as tornadoes and hurricanes. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property or the estimated fair value less costs to sell the property. |
Acquisitions of Real Estate Properties with In-Place Leases | Acquisitions of Real Estate Properties with In-Place Leases Acquisitions of real estate properties with in-place leases are accounted for at relative fair value. When a building with in-place leases is acquired, the cost of the acquisition must be allocated between the tangible real estate assets "as-if-vacant" and the intangible real estate assets related to in-place leases based on their estimated fair values. Where appropriate, the intangible assets recorded could include goodwill or customer relationship assets. The values related to above- or below-market in-place lease intangibles are amortized over the remaining term of the leases upon acquisition to rental income where the Company is the lessor and to property operating expense where the Company is the lessee, and are amortized over the remaining term of the leases upon acquisition. The Company considers whether any of the in-place lease rental rates are above- or below-market. An asset (if the actual rental rate is above-market) or a liability (if the actual rental rate is below-market) is calculated and recorded in an amount equal to the present value of the future cash flows that represent the difference between the actual lease rate and the average market rate. If an in-place lease is identified as a below-market rental rate, the Company would also evaluate any renewal options associated with that lease to determine if the intangible should include those periods. The Company also estimates an absorption period, which can vary by property, assuming the building is vacant and must be leased up to the actual level of occupancy when acquired. During that absorption period, the owner would incur direct costs, such as tenant improvements, and would suffer lost rental income. Likewise, the owner would have acquired a measurable asset in that, assuming the building was vacant, certain fixed costs would be avoided because the actual in-place lessees would reimburse a certain portion of fixed costs through expense reimbursements during the absorption period. All of these intangible assets (above- or below-market lease, tenant improvement costs avoided, leasing costs avoided, rental income lost, and expenses recovered through in-place lessee reimbursements) are estimated and recorded in amounts equal to the present value of estimated future cash flows. The actual purchase price is allocated based on the various asset fair values described above. The building and tenant improvement components of the purchase price are depreciated over the estimated useful life of the building or the weighted average remaining term of the in-places leases. The at-market, in-place lease intangibles are amortized to amortization expense over the weighted average remaining term of the leases, customer relationship assets are amortized to amortization expense over terms applicable to each acquisition, and any goodwill recorded would be reviewed for impairment at least annually. The fair values of at-market in-place lease and other intangible assets are amortized and reflected in amortization expense in the Company’s Consolidated Statements of Income. See Note 8 for more details on the Company’s intangible assets. |
Fair Value Measurements | Fair Value Measurements Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements. A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: • Level 1 – quoted prices for identical instruments in active markets; • Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Executed purchase and sale agreements, that are binding agreements, are categorized as level one inputs. Brokerage estimates, letters of intent, or unexecuted purchase and sale agreements are considered to be level three as they are nonbinding in nature. During 2017 , in connection with the sale of a medical office building, the Company recorded an impairment charge in continuing operations of approximately $5.1 million based on the contractual sales price, a level one input. The Company used level one inputs to record an impairment charge in continuing operations of approximately $0.3 million related to another property sold during 2017, reducing the Company's carrying value to the estimated fair value of the property less costs to sell prior to sale. |
Fair Value of Derivative Financial Instruments | Fair Value of Derivative Financial Instruments Derivative financial instruments are recorded at fair value on the Company's Consolidated Balance Sheets as other assets or other liabilities. The valuation of derivative instruments requires the Company to make estimates and judgments that affect the fair value of the instruments. Fair values of derivatives are estimated by pricing models that consider the forward yield curves and discount rates. The fair value of the Company's forward starting interest rate swap contracts are estimated by pricing models that consider foreign trade rates and discount rates. Such amounts and the recognition of such amounts are subject to significant estimates that may change in the future. For derivatives designated in qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive income (loss). Gains and losses are reclassified from accumulated other comprehensive income (loss) into earnings once the underlying hedged transaction is recognized in earnings. As of December 31, 2017 and 2016, the Company had $1.3 million and $1.4 million , respectively recorded in accumulated other comprehensive loss related to forward starting interest rate swaps entered into and settled during 2015 and a hedge of the Company's variable rate debt. |
Cash and Cash Equivalents | Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. Restricted cash includes cash held in escrow in connection with proceeds from the sales of certain real estate properties. The carrying amount approximates fair value due to the short term maturity of these investments. |
Allowance for Doubtful Accounts and Credit Losses | Allowance for Doubtful Accounts and Credit Losses Accounts Receivable Management monitors the aging and collectibility of its accounts receivable balances on an ongoing basis. Whenever deterioration in the timeliness of payment from a tenant or sponsoring health system is noted, management investigates and determines the reason or reasons for the delay. Considering all information gathered, management’s judgment is exercised in determining whether a receivable is potentially uncollectible and, if so, how much or what percentage may be uncollectible. Among the factors management considers in determining collectibility are: the type of contractual arrangement under which the receivable was recorded (e.g., a triple net lease, a gross lease, a property operating agreement, or some other type of agreement); the tenant’s reason for slow payment; industry influences under which the tenant operates; evidence of willingness and ability of the tenant to pay the receivable; credit-worthiness of the tenant; collateral, security deposit, letters of credit or other monies held as security; tenant’s historical payment pattern; other contractual agreements between the tenant and the Company; relationship between the tenant and the Company; the state in which the tenant operates; and the existence of a guarantor and the willingness and ability of the guarantor to pay the receivable. Considering these factors and others, management concludes whether all or some of the aged receivable balance is likely uncollectible. Upon determining that some portion of the receivable is likely uncollectible, the Company records a provision for bad debts for the amount it expects will be uncollectible. When efforts to collect a receivable are exhausted, the receivable amount is charged off against the allowance. The Company does not hold any accounts receivable for sale. Mortgage Notes The Company had no mortgage notes receivable outstanding as of December 31, 2017 and 2016 and no allowances were recorded on mortgage notes receivables during 2017 or 2016 . The Company evaluates collectibility of any mortgage notes and records allowances on the notes as necessary. A loan is impaired when it is probable that a creditor will be unable to collect all amounts due according to the contractual terms of the loan as scheduled, including both contractual interest and principal payments. This assessment also includes an evaluation of the loan collateral. If a mortgage loan becomes past due, the Company will review the specific circumstances and may discontinue the accrual of interest on the loan. The loan is not returned to accrual status until the debtor has demonstrated the ability to continue debt service in accordance with the contractual terms. Loans placed on non-accrual status will be accounted for either on a cash basis, in which income is recognized only upon receipt of cash, or on a cost-recovery basis, in which all cash receipts reduce the carrying value of the loan, based on the Company’s expectation of future collectibility. |
Goodwill and Other Intangible Assets | Goodwill and Other Intangible Assets Goodwill and intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present. Identifiable intangible assets of the Company are comprised of enterprise goodwill, in-place lease intangible assets, customer relationship intangible assets, and deferred financing costs. In-place lease and customer relationship intangible assets are amortized on a straight-line basis over the applicable lives of the assets. Deferred financing costs are amortized over the term of the related credit facility or other debt instrument under the straight-line method, which approximates amortization under the effective interest method. Goodwill is not amortized but is evaluated annually as of December 31 for impairment. Both the 2017 and 2016 impairment evaluations indicated that no impairment had occurred with respect to the $3.5 million goodwill asset. |
Contingent Liabilities | Contingent Liabilities From time to time, the Company may be subject to loss contingencies arising from legal proceedings and similar matters. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or underinsured damages. The Company continually monitors any matters that may present a contingent liability, and, on a quarterly basis, management reviews the Company’s reserves and accruals in relation to each of them, adjusting provisions as necessary in view of changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be reasonably estimated. Changes in estimates regarding the exposure to a contingent loss are reflected as adjustments to the related liability in the periods when they occur. Because of uncertainties inherent in the estimation of contingent liabilities, it is possible that the Company’s provision for contingent losses could change materially in the near term. To the extent that any significant losses, in addition to amounts recognized, are at least reasonably possible, such amounts will be disclosed in the notes to the Consolidated Financial Statements. |
Stock-based Compensation | Stock-Based Compensation The Company has various employee and director stock-based awards outstanding. These awards include non-vested common stock and options to purchase common stock granted to employees pursuant to the 2015 Stock Incentive Plan and its predecessor plans (the “2015 Incentive Plan”) and the 2000 Employee Stock Purchase Plan (the “Employee Stock Purchase Plan”). The Company recognizes share-based payments to employees and directors in the Consolidated Statements of Income on a straight-line basis over the requisite service period based on the fair value of the award on the measurement date. The Employee Stock Purchase Plan features a “look-back” provision which enables the employee to purchase a fixed number of common shares at the lesser of 85% of the market price on the date of grant or 85% of the market price on the date of exercise, with optional purchase dates occurring once each quarter for 27 months . The Company accounts for awards to its employees under the Employee Stock Purchase Plan based on fair value, using the Black-Scholes model, and generally recognizes expense over the award’s vesting period, net of estimated forfeitures. Since the options granted under the Employee Stock Purchase Plan immediately vest, the Company records compensation expense for those options when they are granted in the first quarter of each year and then may record additional compensation expense in subsequent quarters as warranted. In each of the years ended December 31, 2017 , 2016 and 2015 , the Company recognized in general and administrative expenses approximately $0.2 million of compensation expense related to the annual grant of options to its employees to purchase shares under the Employee Stock Purchase Plan. |
Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss) Certain items must be included in comprehensive income, including items such as foreign currency translation adjustments, minimum pension liability adjustments, derivative instruments and unrealized gains or losses on available-for-sale securities. The Company’s accumulated other comprehensive income (loss) as of December 31, 2017 consists of the loss for changes in the fair value of active derivatives designated as cash flow hedges and the loss on the unamortized settlement of four forward starting swaps. As of December 31, 2016, the Company's accumulated other comprehensive income (loss) consisted only of the loss on the unamortized settlement of four forward starting swaps. |
Revenue Recognition | Revenue Recognition The Company recognizes revenue when it is realized or realizable and earned. There are four criteria that must all be met before a Company may recognize revenue, including that persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered (i.e., the tenant has taken possession of and controls the physical use of the leased asset), the price has been fixed or is determinable, and collectibility is reasonably assured. Income received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities on the Consolidated Balance Sheets, was $36.0 million and $32.4 million , respectively, as of December 31, 2017 and 2016 which includes deferred tenant improvement reimbursements of $20.1 million and $20.6 million , respectively, which will be recognized as revenue over the life of each respective lease. The Company derives most of its revenues from its real estate property portfolio. The Company’s rental and mortgage interest income is recognized based on contractual arrangements with its tenants, sponsoring health systems or borrowers. These contractual arrangements fall into three categories: leases, mortgage notes receivable, and property operating agreements as described in the following paragraphs. The Company may accrue late fees based on the contractual terms of a lease or note. Such fees, if accrued, are included in rental income or mortgage interest income on the Company’s Consolidated Statements of Income, based on the type of contractual agreement. Rental Income Rental income related to non-cancelable operating leases is recognized as earned over the life of the lease agreements on a straight-line basis. The Company's lease agreements generally include provisions for stated annual increases or increases based on a Consumer Price Index ("CPI"). Rental income from properties under multi-tenant office lease arrangements and rental income from properties with single-tenant lease arrangements are included in rental income on the Company's Consolidated Statements of Income. The components of rental income are as follows: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Property operating income $ 363,907 $ 336,409 $ 306,550 Single-tenant net lease 52,873 63,871 67,238 Straight-line rent 6,072 7,201 9,545 Rental income $ 422,852 $ 407,481 $ 383,333 Operating expense recoveries, included in property operating income, were approximately $73.4 million , $66.0 million and $58.9 million , respectively, for the years ended December 31, 2017 , 2016 and 2015 . Mortgage Interest Income Interest income on the Company’s mortgage notes receivable is recognized based on the interest rates, maturity dates and amortization periods in accordance with each note agreement. The Company has no outstanding mortgage notes receivable as of December 31, 2017 , 2016 and 2015. The Company amortizes any fees paid related to its mortgage notes receivable to mortgage interest income over the term of the loan on a straight-line basis which approximates amortization under the effective interest method. |
Other operating income | Other Operating Income Other operating income on the Company’s Consolidated Statements of Income was comprised of the following: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Property lease guaranty revenue $ 726 $ 3,058 $ 3,890 Interest income 361 473 579 Management fee income 276 369 370 Other 284 249 208 $ 1,647 $ 4,149 $ 5,047 One , two and five of the Company’s owned real estate properties as of December 31, 2017 , 2016 and 2015, respectively, were covered under property operating agreements between the Company and a sponsoring health system, which contractually obligate the sponsoring health system to provide to the Company a minimum return on the Company’s investment in the property in exchange for the right to be involved in the operating decisions of the property, including tenancy. If the minimum return is not achieved through normal operations of the property, the Company calculates and accrues to property lease guaranty revenue, each quarter, any shortfalls due from the sponsoring health systems under the terms of the property operating agreement. Interest income generally relates to interest on tenant improvement reimbursements as defined in each note or lease agreement. Management fees for property management services provided to third parties are generally calculated, accrued and billed monthly based on a percentage of cash collections of tenant receivables for the month or a stated amount per square foot. Internal management fee income, where the Company manages its owned properties, is eliminated in consolidation. |
Federal Income Taxes | Federal Income Taxes No provision has been made for federal income taxes. The Company intends at all times to qualify as a REIT under Sections 856 through 860 of the Internal Revenue Code. The Company must distribute at least 90% per annum of its real estate investment trust taxable income to its stockholders and meet other requirements to continue to qualify as a real estate investment trust. See Note 16 for further discussion. The Company classifies interest and penalties related to uncertain tax positions, if any, in the Consolidated Financial Statements as a component of general and administrative expenses. No such amounts were recognized during the three years ended December 31, 2017. Federal tax returns for the years 2014, 2015 , 2016 and 2017 are currently subject to examination by taxing authorities. |
State Income Taxes | State Income Taxes The Company must pay certain state income taxes and the provisions for such taxes are generally included in general and administrative expense on the Company’s Consolidated Statements of Income. |
Sales and Use Taxes | Sales and Use Taxes The Company must pay sales and use taxes to certain state tax authorities based on rents collected from tenants in properties located in those states. The Company is generally reimbursed for these taxes by the tenant. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis in revenues in the Company’s Consolidated Statements of Income. |
Discontinued Operations | Discontinued Operations The Company sells properties from time to time due to a variety of factors, including among other things, market conditions or the exercise of purchase options by tenants. The Company does not expect these dispositions to meet the amended definition of a discontinued operation as defined in Accounting Standards Update ("ASU") No. 2014-08, "Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity." The Company adopted ASU No. 2014-08 on a prospective basis beginning January 1, 2015 which excluded properties previously in discontinued operations prior to adoption. However, if a sale were to meet the amended definition representing a strategic shift that has or will have a major effect on the Company's operations and financial results, the operating results of the properties that have been sold or are held for sale will be reported as discontinued operations in the Company’s Consolidated Statements of Income for all periods presented. |
Earning Per Share | Earnings per Share The Company uses the two-class method of computing net earnings per common share. Earnings per common share is calculated by considering share-based payment awards that contain nonforfeitable rights to dividends or dividend equivalents as participating securities. Undistributed earnings (excess net income over dividend payments) are allocated on a prorata basis to common shareholders and restricted shareholders. Undistributed losses (dividends in excess of net income) do not get allocated to restricted stockholders as they do not have the contractual obligation to share in losses. The amount of undistributed losses that applies to the restricted stockholders is allocated to the common stockholder. Basic earnings per common share is calculated using weighted average shares outstanding less issued and outstanding non-vested shares of common stock. Diluted earnings per common share is calculated using weighted average shares outstanding plus the dilutive effect of the outstanding stock options from the Employee Stock Purchase Plan using the treasury stock method and the average stock price during the period. |
Reclassifications | Reclassifications Condensed Consolidated Statements of Income Certain reclassifications have been made on the Company's Condensed Consolidated Statements of Income. The Company reclassified acquisition and pursuit costs from the general and administrative line item to a separate line item. The acquisition and pursuit costs line item includes direct third party and travel costs related to the Company's pursuit of acquisitions and developments. In addition, the Company combined the line items labeled depreciation and amortization into one line item. |
New Accounting Pronouncements | New Accounting Pronouncements Accounting Standards Update No. 2014-09 and No. 2015-14 In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU No. 2014-09, "Revenue from Contracts with Customers," a comprehensive new revenue recognition standard that supersedes most existing revenue recognition guidance, including sales of real estate. This standard's core principle is that a company will recognize revenue when it transfers goods or services to customers in amounts that reflect the consideration to which the company expects to be entitled in exchange for those goods and services. However, leasing contracts, representing the major source of the Company's revenues, are not within the scope of the new standard and will continue to be accounted for under other standards. In August 2015, the FASB issued ASU No. 2015-14, "Revenue from Contracts with Customers (Topic 606); Deferral of the Effective Date." This standard is effective for the Company for annual and interim periods beginning after December 15, 2017. The Company adopted this standard by using the full retrospective adoption method beginning on January 1, 2018. The Company's revenue-producing contracts are primarily leases that are not within the scope of this standard. As a result, the adoption of this standard did not have a material impact on the timing and measurement of the Company's leasing revenues. The Company has identified that parking income, rental lease guaranty income and management fee income will be within the scope of Topic 606. However, these items were determined to have the same pattern of revenue recognition that the Company had historically recognized. The Company reclassified these amounts along with all other items that are accounted for within the scope of Topic 606 into the Other operating line item on the Company's Consolidated Statements of Income. This line item historically contained the revenue associated with rental lease guaranty income, management fee income and other non-lease revenue. The Company reclassified parking income from rental income to other operating income. The following table represents the impact of the adoption of this standard on the Company's Consolidated Statements of Income for the years ended December 31, 2017 and 2016: Year Ended December 31, 2017 2016 (in thousands) As Reported As Reclassified As Previously Reported As Reclassified REVENUES Rental income $ 422,852 $ 416,727 $ 407,481 $ 401,989 Other operating 1,647 8,011 4,149 9,966 $ 424,499 $ 424,738 $ 411,630 $ 411,955 OTHER INCOME (EXPENSE) Interest and other income, net $ 896 $ 658 $ 375 $ 50 INCOME FROM CONTINUING OPERATIONS $ 23,096 $ 23,096 $ 85,756 $ 85,756 Accounting Standards Update No. 2016-02 In February 2016, the FASB issued ASU No. 2016-02, "Leases." For lessees, the new standard establishes a right-of-use ("ROU") model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The Company expects that all of the leases where the Company is the lessee will be recorded on the Company's balance sheet. See Note 15 for a discussion of leases where the Company is the lessee. For lessors, the new standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as financing. If the lessor doesn't convey risks and rewards or control, then the lease would be classified as an operating lease. The Company has historically only entered into operating leases. The new standard is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years with early adoption permitted. A modified retrospective transition approach is required for lessors for sales-type, direct financing, and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is evaluating the impact from the adoption of this new standard on the Consolidated Financial Statements and related notes. Accounting Standards Update No. 2016-13 In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments." This update is intended to improve financial reporting by requiring timelier recognition of credit losses on loans and other financial instruments that are not accounted for at fair value through net income, including loans held for investment, held-to-maturity debt securities, trade and other receivables, net investment in leases and other such commitments. This update requires that financial statement assets measured at an amortized cost and certain other financial instruments be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. This standard is effective for annual and interim periods beginning after December 15, 2019 with early adoption permitted. The Company is in the initial stages of evaluating the impact from the adoption of this new standard on the Consolidated Financial Statements and related notes. Accounting Standards Update No. 2016-15 In August 2016, the FASB issued ASU No. 2016-15, "Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments." This update clarifies whether the following items should be classified as operating, investing or financing in the statement of cash flows: (i) debt prepayments and extinguishment costs, (ii) settlement of zero-coupon debt, (iii) settlement of contingent consideration, (iv) insurance proceeds, (v) settlement of corporate-owned life insurance and bank-owned life insurance policies, (vi) distributions from equity method investees, (vii) beneficial interest in securitization transactions and (viii) receipts and payments with aspects of more than one class of cash flows. This standard is effective for the Company for annual and interim periods beginning on January 1, 2018 with early adoption permitted on a retrospective transition method to each period presented. The Company adopted this standard effective January 1, 2017. In connection with the adoption of this update, the Company elected to use the cumulative earnings approach to classify distributions when received related to the Company's equity method investments. There was not a material impact on the Company's Consolidated Financial Statements and related notes resulting from the adoption of this standard. However, the Company made the following reclassification of accrued interest related to the early extinguishment of debt on its Statements of Cash Flows for the year ended December 31, 2015: Year Ended December 31, 2015 (in thousands) As Previously Reported As Reclassified Cash flows used in financing activities $ (94,010 ) $ (87,618 ) Cash flows provided by operating activities $ 160,375 $ 153,983 Accounting Standards Update No. 2017-01 In January 2017, the FASB issued ASU No. 2017-01, "Business Combinations: Clarifying the Definition of a Business." This update modifies the requirements to meet the definition of a business under Topic 805, "Business Combinations." The amendments provide a screen to determine when an integrated set of assets and activities is not a business. The screen requires that when substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or group of similar identifiable assets, the set is not a business. The Company believes that this amendment will result in most of its real estate acquisitions being accounted for as asset acquisitions rather than business combinations. This standard is effective for the Company for annual and interim periods beginning after December 15, 2017 with early adoption permitted. The Company adopted this standard effective January 1, 2017 and has accounted for acquisitions that occurred during the year as asset acquisitions. The impact to the Consolidated Financial Statements and related notes as a result of the adoption of this standard is primarily related to the difference in the accounting of acquisition costs. When accounting for these costs as a part of an asset acquisition, the Company will be permitted to capitalize the costs. The adoption of this standard did not have a material impact on the Consolidated Financial Statements and related notes. Accounting Standards Update No. 2017-04 In January 2017, the FASB issued ASU 2017-04, "Simplifying the Test for Goodwill Impairment." This update eliminates Step 2 of the goodwill impairment test. As such, an entity will perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize a goodwill impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value. This standard is effective for the Company for annual and interim periods beginning after December 15, 2019. The Company does not expect a material impact on the Consolidated Financial Statements and related notes from the adoption of this standard. Accounting Standards Update No. 2017-05 In February 2017, the FASB issued ASU 2017-05, "Other Income - Gains and Losses from the Derecognition of Nonfinancial Assets." This update defines an in-substance nonfinancial asset, unifies guidance related to partial sales of nonfinancial assets, eliminates rules specifically addressing the sales of real estate, removes exception to the financial asset derecognition model and clarifies the accounting for contributions of nonfinancial assets to joint ventures. This standard is effective for the Company for annual and interim periods beginning after December 15, 2017 with early adoption permitted. The Company adopted this standard as of January 1, 2018 on the full retrospective adoption method. However, there was no impact to the Company's Consolidated Financial Statements from the adoption of this standard. Accounting Standards Update No. 2017-09 In May 2017, the FASB issued ASU 2017-09, "Compensation - Stock Compensation - Scope of Modification Accounting." This update provides guidance about which changes to the terms and conditions of share-based awards require an entity to apply modification accounting in Topic 718. This standard is effective for the Company for the annual and interim periods beginning after December 15, 2017 with early adoption permitted. The Company adopted this standard on January 1, 2018. The Company does not expect a material impact to the Consolidated Financial Statements from the adoption of this standard. Accounting Standards Update No. 2017-12 In August 2017, the FASB issued ASU 2017-12, "Derivatives and Hedging - Targeted Improvements to Accounting for Hedging Activities." The purpose of this updated guidance is to better align a company’s financial reporting for hedging activities with the economic objectives of those activities. The transition guidance allows for early adoption of the new standard using a modified retrospective transition method in any interim period after issuance of the update, or alternatively requires adoption for fiscal years beginning after December 15, 2018. The modified retrospective transition method will require the Company to recognize the cumulative effect of initially applying this standard as an adjustment to accumulated other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year that an entity adopts the update. The Company adopted this standard in the fourth quarter of 2017. The Company entered into two interest rate swaps in December 2017 in which the Company elected hedge accounting in compliance with this standard. The Company had no active hedging relationships upon the adoption of this standard and therefore, the adoption of the standard did not have an impact on the Company's Consolidated Financial Statements. |
Summary of Significant Accoun31
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Accounting Policies [Abstract] | |
Assets' estimated useful life | Depreciation expense for the three years ended December 31, 2017, 2016 and 2015 was $129.4 million , $116.5 million and $106.5 million , respectively. Depreciation and amortization of real estate assets and liabilities in place as of December 31, 2017 , is provided for on a straight-line basis over the asset’s estimated useful life: Land improvements 5.0 to 39.0 years Buildings and improvements 3.3 to 39.0 years Lease intangibles (including ground lease intangibles) 2.1 to 99.0 years Personal property 2.8 to 20.0 years |
Schedule of cash and cash equivalents | The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Company's Consolidated Balance Sheets with the same amounts shown on the Company's Consolidated Statements of Cash Flows: December 31, (Dollars in thousands) 2017 2016 Cash and cash equivalents $ 6,215 $ 5,409 Restricted cash — 49,098 Total cash, cash equivalents and restricted cash $ 6,215 $ 54,507 |
Schedule of rental income | The components of rental income are as follows: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Property operating income $ 363,907 $ 336,409 $ 306,550 Single-tenant net lease 52,873 63,871 67,238 Straight-line rent 6,072 7,201 9,545 Rental income $ 422,852 $ 407,481 $ 383,333 |
Other operating income | Other operating income on the Company’s Consolidated Statements of Income was comprised of the following: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Property lease guaranty revenue $ 726 $ 3,058 $ 3,890 Interest income 361 473 579 Management fee income 276 369 370 Other 284 249 208 $ 1,647 $ 4,149 $ 5,047 |
Schedule of reclassified expenses | These reclassifications are as follows: Year Ended December 31, 2016 2015 (in thousands) As Previously Reported As Reclassified As Previously Reported As Reclassified General and administrative $ 35,805 $ 31,309 $ 26,925 $ 24,716 Acquisition and pursuit costs — 4,496 — 2,209 Total $ 35,805 $ 35,805 $ 26,925 $ 26,925 Depreciation $ 116,483 $ — $ 106,530 $ — Amortization 11,207 — 10,084 — Depreciation and amortization — 127,690 — 116,614 Total $ 127,690 $ 127,690 $ 116,614 $ 116,614 |
Schedule of previously reported balances | The following table represents the impact of the adoption of this standard on the Company's Consolidated Statements of Income for the years ended December 31, 2017 and 2016: Year Ended December 31, 2017 2016 (in thousands) As Reported As Reclassified As Previously Reported As Reclassified REVENUES Rental income $ 422,852 $ 416,727 $ 407,481 $ 401,989 Other operating 1,647 8,011 4,149 9,966 $ 424,499 $ 424,738 $ 411,630 $ 411,955 OTHER INCOME (EXPENSE) Interest and other income, net $ 896 $ 658 $ 375 $ 50 INCOME FROM CONTINUING OPERATIONS $ 23,096 $ 23,096 $ 85,756 $ 85,756 |
Schedule of reclassification of accrued interest related to the early extinguishment of debt | However, the Company made the following reclassification of accrued interest related to the early extinguishment of debt on its Statements of Cash Flows for the year ended December 31, 2015: Year Ended December 31, 2015 (in thousands) As Previously Reported As Reclassified Cash flows used in financing activities $ (94,010 ) $ (87,618 ) Cash flows provided by operating activities $ 160,375 $ 153,983 |
Property Investments (Tables)
Property Investments (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Real Estate Investment Property, Net [Abstract] | |
Property Investment | The following table summarizes the Company’s investments at December 31, 2017. (Dollars in thousands) Number of Facilities Land Buildings, Improvements,and Lease Intangibles Personal Property Total Accumulated Depreciation Medical office/outpatient: Seattle, Washington 17 $ 24,560 $ 403,614 $ 378 $ 428,552 $ (52,457 ) Dallas, Texas 24 12,472 365,657 416 378,545 (128,557 ) Atlanta, Georgia 8 1,015 187,042 — 188,057 (1,203 ) Los Angeles, California 11 27,709 141,681 277 169,667 (71,808 ) Charlotte, North Carolina 16 4,200 163,603 95 167,898 (56,355 ) Nashville, Tennessee 5 3,143 149,859 278 153,280 (43,000 ) Richmond, Virginia 7 — 146,176 98 146,274 (32,299 ) Honolulu, Hawaii 3 8,327 132,847 159 141,333 (30,066 ) Denver, Colorado 6 4,086 122,689 271 127,046 (18,736 ) San Francisco, California 3 14,054 103,938 43 118,035 (12,223 ) Oklahoma City, Oklahoma 2 7,673 101,432 6 109,111 (10,890 ) Washington, D.C. 4 — 100,570 — 100,570 (15,826 ) Austin, Texas 4 12,756 85,961 105 98,822 (17,498 ) San Antonio, Texas 7 6,647 88,129 370 95,146 (34,514 ) Memphis, Tennessee 7 5,241 88,517 160 93,918 (31,675 ) Des Moines, Iowa 6 12,665 79,214 94 91,973 (18,263 ) Chicago, Illinois 3 5,859 79,295 200 85,354 (15,476 ) Indianapolis, Indiana 3 3,299 71,641 — 74,940 (18,742 ) Other (22 markets) 52 38,598 678,196 1,163 717,957 (206,844 ) 188 192,304 3,290,061 4,113 3,486,478 (816,432 ) Inpatient: Springfield, Missouri 1 1,989 109,304 — 111,293 (12,046 ) Dallas, Texas 1 4,442 92,990 — 97,432 (19,538 ) Erie, Pennsylvania 1 — 21,355 — 21,355 (15,152 ) Los Angeles, California 1 — 12,688 — 12,688 (7,606 ) Denver, Colorado 1 623 10,788 — 11,411 (1,781 ) 5 7,054 247,125 — 254,179 (56,123 ) Other: Des Moines, Iowa 1 — 40,354 5 40,359 (7,704 ) Johnson City, Tennessee 1 253 7,319 408 7,980 (2,798 ) Austin, Texas 1 1,480 3,872 2 5,354 (164 ) Fenton, Michigan 1 40 3,468 32 3,540 (2,738 ) Ovid, Michigan 1 62 3,188 49 3,299 (2,096 ) Fremont, Michigan 1 7 3,242 35 3,284 (2,565 ) St. Louis, Michigan 1 31 1,735 33 1,799 (1,341 ) Detroit, Michigan 1 52 1,096 34 1,182 (829 ) 8 1,925 64,274 598 66,797 (20,235 ) Land Held for Development — 20,123 — — 20,123 (239 ) Construction in Progress — — 5,458 — 5,458 — Corporate Property — — — 5,603 5,603 (4,401 ) — 20,123 5,458 5,603 31,184 (4,640 ) Total real estate investments 201 $ 221,406 $ 3,606,918 $ 10,314 $ 3,838,638 $ (897,430 ) |
Real Estate Leases (Tables)
Real Estate Leases (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Leases [Abstract] | |
Future minimum lease payments due to the Company under property operating agreements | Future minimum lease payments under the non-cancelable operating leases and guaranteed amounts payable to the Company under property operating agreements as of December 31, 2017 are as follows (in thousands): 2018 $ 330,526 2019 282,910 2020 236,454 2021 196,346 2022 168,183 2023 and thereafter 544,677 $ 1,759,096 |
Acquisitions, Dispositions an34
Acquisitions, Dispositions and Mortgage Repayments (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Acquisitions and Dispositions and Mortgage Repayments [Abstract] | |
Summary of acquisitions | The following table details the Company's acquisitions for the year ended December 31, 2016 : (Dollars in millions) Type (1) Date Purchase Price Mortgage (2) Cash (3) Real Other (4) Square (unaudited) Real estate acquisitions Seattle, Washington MOB 3/31/16 $ 38.3 $ — $ 37.7 $ 37.7 $ — 69,712 Seattle, Washington MOB 4/29/16 21.6 — 18.8 20.1 (1.3 ) 46,637 Los Angeles, California MOB 5/13/16 20.0 (13.2 ) 6.5 20.4 (0.7 ) 63,012 Seattle, Washington MOB 9/12/16 53.1 — 53.0 54.6 (1.6 ) 87,462 Washington, D.C. (5) MOB 9/26/16 45.2 — 45.1 43.7 1.4 103,783 Baltimore, Maryland (6) MOB 10/11/16 36.2 — 36.4 36.4 — 113,631 Seattle, Washington MOB 10/17/16 9.8 — 9.8 9.9 (0.1 ) 29,753 Seattle, Washington MOB 12/21/16 5.1 — 5.1 5.2 (0.1 ) 20,740 St. Paul, Minnesota MOB 12/21/16 12.6 — 12.5 11.3 1.2 48,281 $ 241.9 $ (13.2 ) $ 224.9 $ 239.3 $ (1.2 ) 583,011 ______ (1) MOB = medical office building (2) The mortgage notes payable assumed in the acquisitions do not reflect the fair value adjustments totaling $0.8 million recorded by the Company upon acquisition (included in Other). (3) Excludes prorations of revenue and expense due to/from seller at the time of the acquisition. (4) Includes other assets acquired, liabilities assumed, intangibles recognized at acquisition and fair value adjustments on debt assumed. (5) A director of the Company serves as the Chief Executive Officer of the Inova Health System. As part of this transaction, the Company assumed a ground lease and tenant leases with Loudon Hospital Center, an affiliate of Inova Health System. (6) Includes two properties. The following table details the Company's acquisitions for the year ended December 31, 2017 : (Dollars in millions) Type (1) Date Purchase Price Mortgage (2) Cash (3) Real Other (4) Square (Unaudited) Real estate acquisitions St. Paul, Minnesota MOB 3/6/17 $ 13.5 $ — $ 13.5 $ 13.3 $ 0.2 34,608 San Francisco, California MOB 6/12/17 26.8 — 26.8 26.8 — 75,649 Washington, D.C. MOB 6/13/17 24.0 (12.1 ) 12.5 24.8 (0.2 ) 62,379 Los Angeles, California MOB 7/31/17 16.3 — 16.7 16.9 (0.2 ) 42,780 Atlanta, Georgia MOB 11/1/17 25.5 — 25.5 26.3 (0.8 ) 76,944 Atlanta, Georgia MOB 11/1/17 30.3 — 30.7 30.7 — 74,024 Atlanta, Georgia (5) MOB 11/1/17 49.7 — 50.9 47.5 3.4 118,180 Atlanta, Georgia MOB 11/1/17 6.7 — 6.7 6.7 — 19,732 Seattle, Washington MOB 11/1/17 12.7 — 12.6 12.8 (0.2 ) 26,345 Atlanta, Georgia (5) MOB 12/13/17 25.8 (10.5 ) 15.3 22.0 3.8 59,427 Atlanta, Georgia MOB 12/13/17 15.4 (4.7 ) 10.8 15.7 (0.2 ) 40,171 Atlanta, Georgia (5) MOB 12/18/17 26.3 (11.8 ) 14.5 24.6 1.7 66,984 Atlanta, Georgia MOB 12/18/17 14.2 (6.7 ) 7.6 14.5 (0.2 ) 40,324 Chicago, Illinois MOB 12/18/17 28.7 — 27.7 28.5 (0.8 ) 99,526 Seattle, Washington MOB 12/18/17 8.8 — 8.8 9.0 (0.2 ) 32,828 Austin, Texas (6) MOB 12/21/17 2.5 — 2.5 2.5 — 7,972 $ 327.2 $ (45.8 ) $ 283.1 $ 322.6 $ 6.3 877,873 ______ (1) MOB = medical office building (2) The mortgage notes payable assumed in the acquisitions do not reflect the fair value adjustments totaling $0.6 million in aggregate recorded by the Company upon acquisition (included in Other). (3) Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. (4) Includes other assets acquired, liabilities assumed, intangibles recognized at acquisition and fair value adjustments on debt assumed. (5) The "Other" column includes the equity investment in limited liability companies that own two parking garages. (6) The Company acquired additional ownership interests in an existing building bringing the Company's ownership to 69.4% . |
Summary of assets acquired and liabilities assumed | The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2016 as of the acquisition date: Estimated Fair Value Estimated Useful Life (In millions) (In years) Building $ 216.8 20.0-35.0 Land 9.7 — Intangibles: At-market lease intangibles 12.8 2.7-10.3 Above-market lease intangibles 0.9 0.7-3.8 Below-market lease intangibles (0.4 ) 1.4-9.4 Above-market ground lease intangibles (1.6 ) 99.0 Below-market ground lease intangibles 2.0 36.8-99.0 Total intangibles 13.7 Mortgage notes payable assumed, including fair value adjustments (14.0 ) Other assets acquired 0.5 Accounts payable, accrued liabilities and other liabilities assumed (1.8 ) Total cash paid $ 224.9 The following table summarizes the estimated relative fair values of the assets acquired and liabilities assumed in the real estate acquisitions for 2017 as of the acquisition date: Estimated Fair Value Estimated Useful Life (In millions) (In years) Building $ 272.1 15.0-37.0 Land 11.7 — Land Improvements 1.6 5.0-12.0 Intangibles: At-market lease intangibles 37.2 2.1-12.6 Below-market lease intangibles (0.9 ) 8.5-15.0 Below-market ground lease intangibles 0.4 36.8-99.0 Total intangibles 36.7 Mortgage notes payable assumed, including fair value adjustments (46.4 ) Other assets acquired 0.4 Equity investment in joint ventures 8.7 Accounts payable, accrued liabilities and other liabilities assumed (1.7 ) Total cash paid $ 283.1 |
Summary of dispositions | 2017 Real Estate Asset Dispositions The following table details the Company's dispositions for the year ended December 31, 2017 : (Dollars in millions) Type (1) Date Sales Price Closing Adjustments Net Net Real Other (3) Gain/ Square Unaudited ) Real estate dispositions Evansville, Indiana OTH 3/6/17 $ 6.4 $ — $ 6.4 $ 1.1 $ — $ 5.3 29,500 Columbus, Georgia (2) MOB 3/7/17 0.6 — 0.6 0.6 — — 12,000 Las Vegas, Nevada (2) MOB 3/30/17 5.5 (0.7 ) 4.8 2.2 0.3 2.3 18,147 Texas (3 properties) IRF 3/31/17 69.5 (1.6 ) 67.9 46.9 5.2 15.8 169,722 Chicago, Illinois (4) MOB 6/16/17 0.5 (0.1 ) 0.4 0.4 — — 5,100 San Antonio, Texas IRF 6/29/17 14.5 (0.2 ) 14.3 5.1 0.9 8.3 39,786 Roseburg, Oregon MOB 6/29/17 23.2 (0.6 ) 22.6 14.5 0.3 7.8 62,246 St. Louis, Missouri MOB 9/7/17 2.5 (0.1 ) 2.4 7.4 0.1 (5.1 ) 79,980 Total dispositions $ 122.7 $ (3.3 ) $ 119.4 $ 78.2 $ 6.8 $ 34.4 416,481 ______ (1) MOB = medical office building; IRF = inpatient rehabilitation facility; OTH = other (2) Previously classified as held for sale. (3) Includes straight-line rent receivables, leasing commissions and lease inducements. (4) The Company recorded an impairment of approximately $0.3 million in the first quarter of 2017 upon management's decision to sell. 2016 Real Estate Asset Dispositions The following table details the Company's dispositions for the year ended December 31, 2016 : (Dollars in millions) Type (1) Date Sales Price Closing Adjustments Net Net Real Other (2) Gain Square Unaudited ) Real estate dispositions Kansas City, Kansas MOB 10/14/16 $ 15.1 $ — $ 15.1 $ 7.2 $ 0.3 $ 7.6 70,908 Nashville, Tennessee MOB 10/28/16 8.8 (0.2 ) 8.6 6.3 0.2 2.1 45,274 Altoona, Pennsylvania IRF 12/20/16 21.5 (0.4 ) 21.1 12.4 0.6 8.1 64,032 Harrisburg, Pennsylvania IRF 12/20/16 24.2 (0.6 ) 23.6 8.2 0.4 15.0 79,836 Phoenix, Arizona IRF 12/20/16 22.3 — 22.3 13.5 1.4 7.4 51,903 Atlanta, Georgia MOB 12/22/16 2.8 (0.2 ) 2.6 1.8 — 0.8 8,749 Total dispositions $ 94.7 $ (1.4 ) $ 93.3 $ 49.4 $ 2.9 $ 41.0 320,702 ______ (1) MOB = medical office building; IRF = inpatient rehabilitation facility (2) Includes straight-line rent receivables, leasing commissions and lease inducements. |
Held for Sale and Discontinue35
Held for Sale and Discontinued Operations (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures | The table below reflects the assets and liabilities of the properties classified as held for sale and discontinued operations as of December 31, 2017 and 2016 . December 31, (Dollars in thousands) 2017 2016 Balance Sheet data Land $ 4,636 $ 1,362 Buildings, improvements and lease intangibles 63,654 4,410 Personal property 82 — 68,372 5,772 Accumulated depreciation (35,790 ) (2,977 ) Assets held for sale, net 32,582 2,795 Other assets, net (including receivables) 565 297 Assets of discontinued operations, net 565 297 Assets held for sale and discontinued operations, net $ 33,147 $ 3,092 Accounts payable and accrued liabilities $ 38 $ 22 Other liabilities 55 592 Liabilities of assets held for sale and discontinued operations $ 93 $ 614 The table below reflects the results of operations of the properties included in discontinued operations on the Company’s Consolidated Statements of Income for the years ended December 31, 2017 , 2016 and 2015 . Year Ended December 31, (Dollars in thousands, except per share data) 2017 2016 2015 Statements of Income data: Revenues (1) Rental income $ — $ — $ 752 Other operating — — — — — 752 Expenses (2) Property operating 19 71 58 Bad debt, net of recoveries (10 ) — (1 ) 9 71 57 Other Income (Expense) (3) Interest and other income, net — — 20 — — 20 Income (Loss) from Discontinued Operations (9 ) (71 ) 715 Impairments (4) — (121 ) (686 ) Gain on sales of real estate properties (5) 5 7 10,571 Income (Loss) from Discontinued Operations $ (4 ) $ (185 ) $ 10,600 Income (Loss) from Discontinued Operations per Common Share - Basic $ 0.00 $ 0.00 $ 0.11 Income (Loss) from Discontinued Operations per Common Share - Diluted $ 0.00 $ 0.00 $ 0.11 ______ (1) Total revenues for the year ended December 31, 2015 included $0.8 million related to properties sold. (2) Total expenses for the year ended December 31, 2016 included $0.1 million related to a property that is held for sale. Total expenses for the year ended December 31, 2015 included $0.1 million related to properties sold. (3) Other income (expense) for the year ended December 31, 2015 included income (expense) related to properties sold. (4) Impairments for the years ended December 31, 2016 and 2015 included $0.1 million and $0.7 million , respectively, related to one property sold. (5) Gain on sales of real estate properties for the year ended December 31, 2017 included a gain on the sale of one property sold in 2017. Gain on sales of real estate properties for the year ended December 31, 2016 included a gain on the sale of one property sold in 2015. Gains on the sales of real estate properties for the year ended December 31, 2015 included gains on the sale of one property |
Other Assets (Tables)
Other Assets (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Items included in other assets | Other assets consist primarily of straight-line rent receivables, prepaids, intangible assets, deferred financing costs and accounts receivable. Items included in "Other assets, net" on the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 are detailed in the table below: December 31, (Dollars in millions) 2017 2016 Prepaid assets $ 65.2 $ 64.8 Equity investment in joint ventures 8.7 — Straight-line rent receivables 67.0 64.6 Above-market intangible assets, net 17.9 19.1 Additional long-lived assets, net 24.9 14.5 Ground lease modification, net 10.3 10.8 Accounts receivable 7.4 8.1 Allowance for uncollectible accounts (0.3 ) (0.1 ) Credit facility deferred financing costs 3.5 4.9 Goodwill 3.5 3.5 Customer relationship intangible assets, net 1.7 1.8 Other 3.2 3.7 $ 213.0 $ 195.7 |
Equity Method Investments | The Company's investment in and income (loss) recognized for the year ended December 31, 2017 related to its LLCs accounted for under the equity method are shown in the table below: (Dollars in millions) December 31, 2017 Net LLC investment, beginning of period $ — New investments during the period 8.7 Equity income (loss) recognized during the period — Net LLC investments, end of period $ 8.7 |
Intangible Assets and Liabili37
Intangible Assets and Liabilities (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of finite lived intangible assets and liabilities | The Company’s intangible assets and liabilities as of December 31, 2017 and 2016 consisted of the following: Gross Balance at December 31, Accumulated Amortization at December 31, Weighted Avg. Remaining Life (Years) Balance Sheet Classification (Dollars in millions) 2017 2016 2017 2016 Goodwill $ 3.5 $ 3.5 $ — $ — N/A Other assets Credit facility deferred financing costs 5.4 5.4 1.9 0.5 2.6 Other assets Above-market lease intangibles 22.9 24.5 5.0 5.4 57.8 Other assets Customer relationship intangibles 2.6 2.6 0.9 0.8 25.6 Other assets Below-market lease intangibles (9.5 ) (8.8 ) (3.5 ) (3.2 ) 36.5 Other liabilities Deferred financing costs 9.3 9.4 1.8 4.0 4.5 Notes and Bonds Payable At-market lease intangibles 110.0 84.1 41.6 39.0 5.6 Real estate properties $ 144.2 $ 120.7 $ 47.7 $ 46.5 15.2 |
Schedule of expected net future amortization expense | The following table represents expected amortization over the next five years of the Company’s intangible assets and liabilities in place as of December 31, 2017 : (Dollars in millions) Future Amortization of Intangibles, net 2018 $ 19.8 2019 17.6 2020 12.0 2021 6.8 2022 5.8 |
Notes and Bonds Payable (Tables
Notes and Bonds Payable (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Debt Instrument [Line Items] | |
Schedule of debt | December 31, Maturity Dates Contractual Interest Rates Principal Payments Interest Payments (Dollars in thousands) 2017 2016 Unsecured Credit Facility $ 189,000 $ 107,000 7/20 LIBOR + 1.00% At maturity Monthly Unsecured Term Loan due 2022 (1) 148,994 149,491 12/22 LIBOR + 1.10% At maturity Monthly Senior Notes due 2021 (1) — 397,147 1/21 5.75 % At maturity Semi-Annual Senior Notes due 2023 (1) 247,703 247,296 4/23 3.75 % At maturity Semi-Annual Senior Notes due 2025 (1) 248,044 247,819 5/25 3.88 % At maturity Semi-Annual Senior Notes due 2028 (1) 294,757 — 1/28 3.63 % At maturity Semi-Annual Mortgage notes payable (2) 155,382 115,617 12/18-5/40 3.31%-6.88% Monthly Monthly $ 1,283,880 $ 1,264,370 ______ (1) Balances are shown net of discounts and unamortized issuance costs. (2) Balances are shown net of discounts and unamortized issuance costs and including premiums. |
Schedule of Mortgage Notes Payable | The following table details the Company’s mortgage notes payable, with related collateral. Original Balance Effective Interest Rate (23) Maturity Date Collateral (24) Principal and Interest Payments (22) Investment in Collateral at December 31, Balance at December 31, (Dollars in millions) 2017 2017 2016 Life Insurance Co. (1) 7.0 5.53 % 1/18 MOB Monthly/15-yr amort. $ — $ — $ 0.7 Commercial Bank (2) 1.8 5.55 % 10/30 OTH Monthly/27-yr amort. — — 1.3 Insurance Co. (3) 7.3 5.54 % 12/18 MOB Monthly/25-yr amort. 14.3 6.0 6.2 Commercial Bank (4) 9.5 5.07 % 3/19 MOB Monthly/5-yr amort. 13.9 9.3 9.5 Commercial Bank (5) 9.4 4.55 % 7/19 MOB Monthly/8-yr amort 27.8 9.2 9.3 Commercial Bank (6) 15.2 7.65 % 7/20 MOB (21) 20.2 12.7 12.7 Life Insurance Co. (7) 7.9 4.00 % 8/20 MOB Monthly/15-yr amort. 20.7 2.0 2.7 Life Insurance Co. (8) 7.3 5.25 % 8/20 MOB Monthly/27-yr amort. 17.9 6.5 6.7 Life Insurance Co. (9) 5.6 4.27 % 1/21 MOB Monthly/10-yr amort. 15.7 4.8 — Commercial Bank (10) 12.9 6.43 % 2/21 MOB Monthly/12-yr amort. 54.9 10.5 10.7 Life Insurance Co. (11) 11.0 3.85 % 11/22 MOB Monthly/7-yr amort. 22.0 10.4 — Life Insurance Co. (12) 12.3 3.85 % 8/23 MOB Monthly/7-yr amort. 24.6 11.5 — Financial Services (13) 12.4 4.27 % 10/23 MOB Monthly/10-yr amort. 24.7 12.2 — Life Insurance Co. (14) 13.3 4.13 % 1/24 MOB Monthly/10-yr amort. 21.1 13.3 13.6 Life Insurance Co. (15) 6.8 3.94 % 2/24 MOB Monthly/7-yr amort. 14.5 6.7 — Financial Services (16) 9.7 4.32 % 9/24 MOB Monthly/10-yr amort. 16.4 8.8 9.1 Commercial Bank 11.5 3.71 % 1/26 MOB Monthly/10-yr amort. 37.9 10.5 11.0 Commercial Bank (17) 15.0 5.25 % 4/27 MOB Monthly/20-yr amort. 33.4 9.6 10.4 Municipal Government (18) (19) 11.0 4.79 % (20) MOB Semi-Annual (20) 20.9 11.4 11.7 $ 400.9 $ 155.4 $ 115.6 ______ (1) The Company repaid this mortgage note in October 2017. The Company's unencumbered gross investment was $14.3 million at December 31, 2017. (2) The Company repaid this mortgage note in September 2017. The Company's unencumbered gross investment was $8.0 million at December 31, 2017. (3) The unamortized portion of the $0.6 million premium recorded on this note upon acquisition is included in the balance above. (4) The unamortized portion of the $0.2 million premium recorded on this note upon acquisition is included in the balance above. (5) The unamortized portion of the $0.3 million premium recorded on this note upon acquisition is included in the balance above. (6) The unaccreted portion of the $2.4 million discount recorded on this note upon acquisition is included in the balance above. (7) The unamortized portion of the $0.3 million premium recorded on this note upon acquisition is included in the balance above. (8) The unamortized portion of the $0.4 million premium recorded on this note upon acquisition is included in the balance above. (9) The unamortized portion of the $0.2 million premium recorded on this note upon acquisition is included in the balance above. (10) The unaccreted portion of the $1.0 million discount recorded on this note upon acquisition is included in the balance above. (11) The unaccreted portion of the $0.1 million discount recorded on this note upon acquisition is included in the balance above. (12) The unaccreted portion of the $0.2 million discount recorded on this note upon acquisition is included in the balance above. (13) The unamortized portion of the $0.4 million premium recorded upon acquisition is included in the balance above. (14) The unamortized portion of the $0.8 million premium recorded on this note upon acquisition is included in the balance above. (15) The unamortized portion of the $0.2 million premium recorded on this note upon acquisition is included in the balance above. (16) The unamortized portion of the $0.1 million premium recorded on this note upon acquisition is included in the balance above. (17) The unamortized portion of the $0.7 million premium recorded on this note upon acquisition is included in the balance above. (18) Balance consists of three notes secured by the same building. (19) The unamortized portion of the $1.0 million premium recorded on the three notes upon acquisition is included in the balance above. (20) These three mortgage notes payable are series municipal bonds that have maturity dates ranging from from May 2022 to May 2040. One of the four original notes payable was repaid upon maturity in May 2017. The remaining three require interest only payments and have future maturity dates but allow repayment after May 2020 without penalty. The Company intends on repaying all three notes payable at that time. (21) Payable in monthly installments of interest only for 24 months and then installments of principal and interest based on an 11 -year amortization with the final payment due at maturity. (22) Payable in monthly installments of principal and interest with the final payment due at maturity (unless otherwise noted). (23) The contractual interest rates for the 19 outstanding mortgage notes ranged from 3.3% to 6.9% as of December 31, 2017 . (24) MOB-Medical office building; OTH-Other. |
Future contractual maturities of the Company's notes and bonds payable | Future maturities of the Company’s notes and bonds payable as of December 31, 2017 were as follows: (Dollars in thousands) Principal Maturities Net Accretion/ Amortization (1) Debt Issuance Costs (2) Notes and Bonds Payable % 2018 $ 10,605 $ (18 ) $ (1,051 ) 9,536 0.7 % 2019 22,711 (224 ) (1,044 ) 21,443 1.7 % 2020 211,803 (382 ) (1,039 ) 210,382 16.4 % 2021 17,321 (312 ) (1,025 ) 15,984 1.2 % 2022 162,692 (328 ) (1,037 ) 161,327 12.6 % 2023 and thereafter 868,784 (1,284 ) (2,292 ) 865,208 67.4 % $ 1,293,916 $ (2,548 ) $ (7,488 ) 1,283,880 100.0 % ______ (1) Includes discount accretion and premium amortization related to the Company’s Senior Notes due 2023, Senior Notes due 2025, Senior Notes due 2028 and 18 mortgage notes payable. (2) Excludes approximately $3.5 million in debt issuance costs related to the Company's Unsecured Credit Facility due 2020 included in other assets. |
Senior Notes [Member] | Senior Notes due 2021 [Member] | |
Debt Instrument [Line Items] | |
Schedule of debt | The following table reconciles the balance of the Senior Notes due 2021 on the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 : December 31, (Dollars in thousands) 2017 2016 Senior Notes due 2021 face value $ — $ 400,000 Unaccreted discount — (1,510 ) Issuance costs — (1,343 ) Senior Notes due 2021 carrying amount $ — $ 397,147 |
Senior Notes [Member] | Senior Notes due 2023 [Member] | |
Debt Instrument [Line Items] | |
Schedule of debt | The following table reconciles the balance of the Senior Notes due 2023 on the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 : December 31, (Dollars in thousands) 2017 2016 Senior Notes due 2023 face value $ 250,000 $ 250,000 Unaccreted discount (1,178 ) (1,375 ) Issuance costs (1,119 ) (1,329 ) Senior Notes due 2023 carrying amount $ 247,703 $ 247,296 |
Senior Notes [Member] | Senior Notes due 2025 [Member] | |
Debt Instrument [Line Items] | |
Schedule of debt | The following table reconciles the balance of the Senior Notes due 2025 on the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 : December 31, (Dollars in thousands) 2017 2016 Senior Notes due 2025 face value $ 250,000 $ 250,000 Unaccreted discount (160 ) (178 ) Issuance costs (1,796 ) (2,003 ) Senior Notes due 2025 carrying amount $ 248,044 $ 247,819 |
Senior Notes [Member] | Senior Notes due 2028 [Member] | |
Debt Instrument [Line Items] | |
Schedule of debt | The following table reconciles the balance of the Senior Notes due 2028 on the Company’s Consolidated Balance Sheets as of December 31, 2017 : (Dollars in thousands) December 31, 2017 Senior Notes due 2028 face value $ 300,000 Unaccreted discount (2,529 ) Issuance costs $ (2,714 ) Senior Notes due 2028 carrying amount $ 294,757 |
Mortgage Notes [Member] | Mortgage notes payable [Member] | |
Debt Instrument [Line Items] | |
Schedule of debt | The following table reconciles the Company’s aggregate mortgage notes principal balance with the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 . For the years ended December 31, 2017 , 2016 and 2015 , the Company amortized approximately $0.3 million , $0.3 million and $0.8 million of the discount and $0.7 million , $0.9 million , and $1.0 million of the premium. For the years ended December 31, 2017, 2016 and 2015, the Company also amortized approximately $0.1 million , $0.2 million , and $0.2 million of the debt issuance costs, respectively, on the mortgage notes payable which is included in interest expense on the Company’s Consolidated Statements of Income. December 31, (Dollars in thousands) 2017 2016 Mortgage notes payable principal balance $ 154,916 $ 114,934 Unamortized premium 2,651 2,569 Unaccreted discount (1,332 ) (1,450 ) Issuance costs (853 ) (436 ) Mortgage notes payable carrying amount $ 155,382 $ 115,617 |
Derivative Financial Instrume39
Derivative Financial Instruments (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) | During the year ended December 31, 2017 , the Company entered into two outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk: Interest Rate Derivative Number of Instruments Notional (in millions) Interest rate swaps 2 $25.0 |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The table below presents the fair value of the Company's derivative financial instruments, as well as, their classification on the Consolidated Balance Sheets as of December 31, 2017. Liability Derivatives As of December 31, 2017 (Dollars in thousands) Balance Sheet Location Fair Value Derivatives designated as hedging instruments Interest rate swaps Other liabilities $ 67 Total derivatives designated as hedging instruments $ 67 |
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) | The table below presents the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income (Loss) as of December 31, 2017 related to the Company's outstanding interest rate swaps. Amount of Loss Recognized in OCI on Derivative Amount of Loss Reclassified from OCI into Income (Dollars in thousands) 2017 2017 2016 Interest rate products $ 74 Interest expense $ 7 $ — Settled interest rate swaps — Interest expense 169 168 $ 74 Total interest expense $ 176 $ 168 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Equity [Abstract] | |
Reconciliation of the beginning and ending common stock outstanding | The Company had no preferred shares outstanding and had common shares outstanding for the three years ended December 31, 2017 as follows: Year Ended December 31, 2017 2016 2015 Balance, beginning of year 116,416,900 101,517,009 98,828,098 Issuance of common stock 8,395,607 14,063,100 2,493,171 Non-vested stock-based awards, net of withheld shares and forfeitures 319,086 836,791 195,740 Balance, end of year 125,131,593 116,416,900 101,517,009 |
Schedule of sale of stock under market equity offering Program | The following table details the shares sold under this program. Shares Sold Sales Price Per Share Net Proceeds (in millions) 2017 — NA $ — 2016 4,795,601 $28.31 - $33.66 $ 144.6 2015 2,434,239 $25.00 - $29.15 $ 65.8 |
Reconciliation of beginning and ending balances of accumulated other comprehensive income | The following table represents the changes in accumulated other comprehensive loss during the year ended December 31, 2017 : (Dollars in thousands) Interest Rate Swaps Beginning balance $ (1,401 ) Other comprehensive loss before reclassifications 176 Amounts reclassified from accumulated other comprehensive income (loss) (74 ) Net current-period other comprehensive income 102 Ending balance $ (1,299 ) |
Reclassifications out of accumulated other comprehensive income | The following table represents the details regarding the reclassifications from Accumulated other comprehensive income (loss) during the year ended December 31, 2017 : Details about accumulated other comprehensive income (loss) components Amount reclassified from accumulated other comprehensive income (loss) Affected line item in the statement where net income is presented (Dollars in thousands) Amounts reclassified from accumulated other comprehensive income (loss) related to settled interest rate swaps $ 169 Interest Expense Amounts reclassified from accumulated other comprehensive income (loss) related to current interest rate swaps 7 Interest Expense $ 176 |
Benefit Plans (Tables)
Benefit Plans (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Retirement Benefits [Abstract] | |
Net periodic benefit cost for both the Executive Retirement Plan and the Outside Director Plan | Net periodic benefit cost for the Executive Retirement Plan for the three years in the period ended December 31, 2017 is comprised of the following: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Service cost $ — $ — $ 29 Interest cost — — 225 Amortization of prior service cost (benefit) — — (198 ) Amortization of net gain — — 343 — — 399 Net loss recognized in Accumulated other comprehensive income (loss) — — — Total recognized in net periodic benefit gain and Accumulated other comprehensive income (1) $ — $ — $ 399 _____ (1) 2015 is a partial year due to the termination of the Executive Retirement Plan during the year. |
Stock and Other Incentive Pla42
Stock and Other Incentive Plans (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Schedule of Unrecognized Compensation Cost, Nonvested Awards | The following table represents expected amortization of the Company's non-vested shares issued: (Dollars in millions) Future Amortization of Non-Vested Shares 2018 $ 9.4 2019 7.0 2020 6.7 2021 5.7 2022 3.2 2023 and thereafter 3.6 Total $ 35.6 |
Summary of the activity under the Incentive Plan the previous directors' plan | A summary of the activity under the 2015 Incentive Plan and related information for the three years in the period ended December 31, 2017 follows: Year Ended December 31, (Dollars in thousands, except per share data) 2017 2016 2015 Stock-based awards, beginning of year 1,786,497 1,092,262 1,057,732 Granted 413,489 885,219 251,789 Vested (292,341 ) (190,984 ) (210,955 ) Forfeited — — (6,304 ) Stock-based awards, end of year 1,907,645 1,786,497 1,092,262 Weighted-average grant date fair value of: Stock-based awards, beginning of year $ 27.18 $ 24.72 $ 24.01 Stock-based awards granted during the year $ 32.05 $ 29.60 $ 27.70 Stock-based awards vested during the year $ 25.88 $ 24.34 $ 25.05 Stock-based awards forfeited during the year $ — $ — $ 24.80 Stock-based awards, end of year $ 28.44 $ 27.18 $ 24.72 Grant date fair value of shares granted during the year $ 13,254 $ 26,204 $ 6,975 |
Summary of the Employee Stock Purchase Plan activity | A summary of the Employee Stock Purchase Plan activity and related information for the three years in the period ended December 31, 2017 is as follows: Year Ended December 31, (Dollars in thousands, except per share data) 2017 2016 2015 Options outstanding, beginning of year 316,321 340,958 393,902 Granted 206,824 198,450 197,640 Exercised (32,076 ) (57,924 ) (44,462 ) Forfeited (40,659 ) (22,081 ) (47,176 ) Expired (132,310 ) (143,082 ) (158,946 ) Options outstanding and exercisable, end of year 318,100 316,321 340,958 Weighted-average exercise price of: Options outstanding, beginning of year $ 23.69 $ 20.70 $ 19.17 Options granted during the year $ 25.77 $ 24.07 $ 23.22 Options exercised during the year $ 24.31 $ 21.40 $ 19.41 Options forfeited during the year $ 25.01 $ 23.16 $ 19.90 Options expired during the year $ 23.22 $ 18.11 $ 20.41 Options outstanding, end of year $ 25.00 $ 23.69 $ 20.70 Weighted-average fair value of options granted during the year (calculated as of the grant date) $ 6.31 $ 5.37 $ 5.39 Intrinsic value of options exercised during the year $ 271 $ 634 $ 381 Intrinsic value of options outstanding and exercisable (calculated as of December 31) $ 2,683 $ 2,098 $ 2,597 Exercise prices of options outstanding (calculated as of December 31) $ 25.00 $ 23.69 $ 20.70 Weighted-average contractual life of outstanding options (calculated as of December 31, in years) 0.8 0.8 0.8 |
Fair value of options issued based on weighted-average assumptions | 2017 2016 2015 Risk-free interest rates 1.20 % 1.06 % 0.67 % Expected dividend yields 3.70 % 4.64 % 4.79 % Expected life (in years) 1.45 1.42 1.38 Expected volatility 20.4 % 17.6 % 21.0 % Expected forfeiture rates 85 % 85 % 80 % |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Earnings Per Share [Abstract] | |
Earnings per share | The table below sets forth the computation of basic and diluted earnings per common share for the three years in the period ended December 31, 2017 . Year Ended December 31, (Dollars in thousands, except per share data) 2017 2016 2015 Weighted Average Common Shares Weighted average Common Shares outstanding 119,739,216 109,861,580 100,280,059 Non-vested shares (1,813,058 ) (1,289,478 ) (1,108,707 ) Weighted average Common Shares - Basic 117,926,158 108,572,102 99,171,352 Weighted average Common Shares - Basic 117,926,158 108,572,102 99,171,352 Dilutive effect of non-vested shares — 709,559 623,212 Dilutive effect of employee stock purchase plan 91,007 105,336 85,738 Weighted average Common Shares - Diluted 118,017,165 109,386,997 99,880,302 Net Income Income from continuing operations $ 23,096 $ 85,756 $ 58,836 Dividends paid on nonvested share-based awards (2,149 ) — — Income from continuing operations applicable to common stockholders 20,947 85,756 58,836 Discontinued operations (4 ) (185 ) 10,600 Net income applicable to common stockholders $ 20,943 $ 85,571 $ 69,436 Basic Earnings Per Common Share Income from continuing operations $ 0.18 $ 0.79 $ 0.59 Income from discontinued operations 0.00 0.00 0.11 Net income $ 0.18 $ 0.79 $ 0.70 Diluted Earnings Per Common Share Income from continuing operations $ 0.18 $ 0.78 $ 0.59 Income from discontinued operations 0.00 0.00 0.11 Net income $ 0.18 $ 0.78 $ 0.70 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of construction activity | The table below details the Company’s construction activity as of December 31, 2017 . The information included in the table below represents management’s estimates and expectations at December 31, 2017 , which are subject to change. The Company’s disclosures regarding certain projections or estimates of completion dates may not reflect actual results. December 31, 2017 (Dollars in thousands) Number of Properties Estimated Completion Date Construction in Progress Balance Total Funded During the Year Total Amount Funded Estimated Remaining Fundings (unaudited) Estimated Total Investment (unaudited) Approximate Square Feet (unaudited) Construction Activity Charlotte, NC 1 Q1 2019 $ 3,487 $ 3,264 $ 3,487 8,513 $ 12,000 204,000 Seattle, WA 1 Q2 2019 1,971 1,809 2,272 61,848 64,120 151,000 Total $ 5,458 $ 5,073 $ 5,759 $ 70,361 $ 76,120 355,000 |
Minimum lease payments for its operating leases | The Company’s future minimum lease payments for its corporate office lease and 61 ground leases, excluding leases that the Company has prepaid and leases in which an operator pays or fully reimburses the Company, as of December 31, 2017 were as follows (in thousands): 2018 $ 5,341 2019 5,420 2020 5,459 2021 5,488 2022 5,516 2023 and thereafter 283,056 $ 310,280 |
Other Data (Tables)
Other Data (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Taxable Income | The following table reconciles the Company’s consolidated net income attributable to common stockholders to taxable income for the three years ended December 31, 2017 : Year Ended December 31, (Dollars in thousands) 2017 2016 2015 Net income $ 23,092 $ 85,571 $ 69,436 Reconciling items to taxable income: Depreciation and amortization 46,426 38,260 30,457 Gain or loss on disposition of depreciable assets 1,570 (32,103 ) 1,659 Impairments — 121 687 Straight-line rent (4,551 ) (7,101 ) (8,833 ) Receivable allowances 1,680 2,067 571 Stock-based compensation 1,855 1,301 7,518 Other 6,552 2,236 4,304 53,532 4,781 36,363 Taxable income (1) $ 76,624 $ 90,352 $ 105,799 Dividends paid $ 142,327 $ 131,759 $ 120,266 ______ (1) Before REIT dividend paid deduction |
Characterization of distributions on common stock | For the three years ended December 31, 2017 , there were no preferred shares outstanding. As such, no dividends were distributed related to preferred shares for those periods. 2017 2016 2015 Per Share % Per Share % Per Share % Common stock: Ordinary income $ 0.42 34.5 % $ 0.78 65.0 % $ 0.61 51.0 % Return of capital 0.50 42.0 % 0.35 29.5 % 0.08 6.7 % Unrecaptured section 1250 gain 0.28 23.5 % 0.07 5.5 % 0.51 42.3 % Common stock distributions $ 1.20 100.0 % $ 1.20 100.0 % $ 1.20 100.0 % |
State Income Taxes | State income tax expense and state income tax payments for the three years ended December 31, 2017 are detailed in the table below: Year Ended December 31, (Dollars in thousands) 2017 2016 2015 State income tax expense: Texas gross margins tax (1) $ 608 $ 562 $ 528 Other — 2 37 Total state income tax expense $ 608 $ 564 $ 565 State income tax payments, net of refunds and collections $ 555 $ 544 $ 758 ______ (1) In the table above, income tax expense for 2015 includes approximately $50 thousand that was recorded to the gain on sale of real estate properties sold, which is included in discontinued operations rather than general and administrative expenses on the Company’s Consolidated Statements of Income. |
Fair Value of Financial Instr46
Fair Value of Financial Instruments (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair value and carrying values for notes and bonds payable, mortgage notes receivable and notes receivable | The table below details the fair value and carrying values for notes and bonds payable as of December 31, 2017 and 2016 . December 31, 2017 December 31, 2016 (Dollars in millions) Carrying Value Fair Value Carrying Value Fair Value Notes and bonds payable (1) $ 1,283.9 $ 1,269.7 $ 1,264.4 $ 1,265.1 ______ (1) Level 2 – model-derived valuations in which significant inputs and significant value drivers are observable in active markets. |
Selected Quarterly Financial 47
Selected Quarterly Financial Data (unaudited) (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Selected Quarterly Financial Information [Abstract] | |
Summary of quarterly financial information | Quarterly financial information for the year ended December 31, 2017 is summarized below. Quarter Ended (Dollars in thousands, except per share data) March 31 (1) June 30 (2) September 30 (3) December 31 (4) 2017 Revenues from continuing operations $ 104,569 $ 105,245 $ 106,953 $ 107,731 Income (loss) from continuing operations 31,858 25,224 3,165 (37,151 ) Income (loss) from discontinued operations (13 ) — 8 — Net income (loss) attributable to common stockholders $ 31,845 $ 25,224 $ 3,173 $ (37,151 ) Net income attributable to common stockholders per share: Basic earnings per common share $ 0.28 $ 0.22 $ 0.02 $ (0.31 ) Diluted earnings per common share $ 0.28 $ 0.22 $ 0.02 $ (0.31 ) ______ (1) The increases in net income and amounts per share for the first quarter of 2017 are primarily attributable to gains of $23.4 million on the sale of six properties. (2) The increases in net income and amounts per share for the second quarter of 2017 are primarily attributable to gains of $16.1 million on the sale of three properties. (3) The decreases in net income and amounts per share for the third quarter of 2017 are primarily attributable to impairment charges of $5.1 million . (4) The decreases in net income and amounts per share for the fourth quarter of 2017 are primarily attributable to a loss on the extinguishment of debt of $45.0 million . Quarterly financial information for the year ended December 31, 2016 is summarized below. Quarter Ended (Dollars in thousands, except per share data) March 31 June 30 September 30 December 31 (1) 2016 Revenues from continuing operations $ 100,021 $ 102,642 $ 103,659 $ 105,309 Income from continuing operations 9,163 12,157 11,857 52,580 Loss from discontinued operations (7 ) (12 ) (23 ) (143 ) Net income attributable to common stockholders $ 9,156 $ 12,145 $ 11,834 $ 52,437 Net income attributable to common stockholders per share: Basic earnings per common share $ 0.09 $ 0.12 $ 0.10 $ 0.46 Diluted earnings per common share $ 0.09 $ 0.12 $ 0.10 $ 0.45 ______ (1) The increases in net income and amounts per share for the fourth quarter of 2016 are primarily attributable to gains of $41.0 million on the sale of six properties. |
Summary of Significant Accoun48
Summary of Significant Accounting Policies - Cash and cash equivalents (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2014 |
Accounting Policies [Abstract] | ||||
Cash and cash equivalents | $ 6,215 | $ 5,409 | ||
Restricted cash | 0 | 49,098 | ||
Total cash, cash equivalents and restricted cash | $ 6,215 | $ 54,507 | $ 4,102 | $ 3,519 |
Summary of Significant Accoun49
Summary of Significant Accounting Policies - Useful lives of real estate assets and liabilities (Details) | 12 Months Ended |
Dec. 31, 2017 | |
Land improvements [Member] | Minimum [Member] | |
Property, Plant and Equipment [Line Items] | |
Asset estimated useful life | 5 years |
Land improvements [Member] | Maximum [Member] | |
Property, Plant and Equipment [Line Items] | |
Asset estimated useful life | 39 years |
Building and improvements [Member] | Minimum [Member] | |
Property, Plant and Equipment [Line Items] | |
Asset estimated useful life | 3 years 3 months 18 days |
Building and improvements [Member] | Maximum [Member] | |
Property, Plant and Equipment [Line Items] | |
Asset estimated useful life | 39 years |
Lease intangibles (including ground lease intangibles) [Member] | Minimum [Member] | |
Property, Plant and Equipment [Line Items] | |
Asset estimated useful life | 2 years 1 month 6 days |
Intangible asset useful life | 2 years 1 month 6 days |
Lease intangibles (including ground lease intangibles) [Member] | Maximum [Member] | |
Property, Plant and Equipment [Line Items] | |
Asset estimated useful life | 99 years 6 days |
Intangible asset useful life | 99 years |
Personal property [Member] | Minimum [Member] | |
Property, Plant and Equipment [Line Items] | |
Asset estimated useful life | 2 years 9 months 18 days |
Personal property [Member] | Maximum [Member] | |
Property, Plant and Equipment [Line Items] | |
Asset estimated useful life | 20 years |
Summary of Significant Accoun50
Summary of Significant Accounting Policies - Components of rental income (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Accounting Policies [Abstract] | |||
Property operating income | $ 363,907 | $ 336,409 | $ 306,550 |
Single-tenant net lease | 52,873 | 63,871 | 67,238 |
Straight-line rent | 6,072 | 7,201 | 9,545 |
Rental income | $ 422,852 | $ 407,481 | $ 383,333 |
Summary of Significant Accoun51
Summary of Significant Accounting Policies - Components of other operating income (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Other Operating Income [Abstract] | |||
Property lease guaranty revenue | $ 726 | $ 3,058 | $ 3,890 |
Interest income | 361 | 473 | 579 |
Management fee income | 276 | 369 | 370 |
Other | 284 | 249 | 208 |
Other operating | $ 1,647 | $ 4,149 | $ 5,047 |
Summary of Significant Accoun52
Summary of Significant Accounting Policies - Reclassifications (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Property, Plant and Equipment [Line Items] | |||
General and administrative | $ 32,992 | $ 31,309 | $ 24,716 |
Acquisition and pursuit costs | 2,180 | 4,496 | 2,209 |
Total | 35,805 | 26,925 | |
Depreciation | 0 | 0 | |
Amortization | 0 | 0 | |
Depreciation and amortization | 142,472 | 127,690 | 116,614 |
Total | 127,690 | 116,614 | |
Cash flows used in financing activities | 31,390 | 136,957 | (87,618) |
Cash flows provided by operating activities | $ 179,766 | 151,272 | 153,983 |
As Previously Reported | |||
Property, Plant and Equipment [Line Items] | |||
General and administrative | 35,805 | 26,925 | |
Acquisition and pursuit costs | 0 | 0 | |
Total | 35,805 | 26,925 | |
Depreciation | 116,483 | 106,530 | |
Amortization | 11,207 | 10,084 | |
Depreciation and amortization | 0 | 0 | |
Total | $ 127,690 | 116,614 | |
Cash flows used in financing activities | (94,010) | ||
Cash flows provided by operating activities | $ 160,375 |
Summary of Significant Accoun53
Summary of Significant Accounting Policies - Narrative (Details) | 12 Months Ended | ||
Dec. 31, 2017USD ($)ft²land_parcelreporting_unitstatepropertyswap_agreement | Dec. 31, 2016USD ($)land_parcelpropertyswap_agreement | Dec. 31, 2015USD ($)propertyswap_agreement | |
Business Overview [Abstract] | |||
Gross investment, amount, total | $ 3,800,000,000 | ||
Real estate properties and mortgages | property | 201 | ||
Number of owned real estate properties | property | 201 | ||
Number of states that the Company owns real estate in | state | 27 | ||
Square footage of owned real estate properties | ft² | 14,600,000 | ||
Approximate square feet for which Nationwide property management services provided by company | ft² | 11,500,000 | ||
Segment Reporting [Abstract] | |||
Number of Reporting Units | reporting_unit | 1 | ||
Real Estate Properties [Abstract] | |||
Total real estate properties | $ 3,838,638,000 | $ 3,628,221,000 | |
Depreciation | $ 129,400,000 | $ 116,500,000 | $ 106,500,000 |
Maximum period up to which interest capitalize on properties in stabilization | 1 year | ||
Land Held for Development [Abstract] | |||
Number of land parcels held for development | land_parcel | 6 | 6 | |
Land held for development | $ 20,100,000 | $ 20,100,000 | |
Fair Value Measurements [Abstract] | |||
Impairment of real estate | 5,385,000 | 3,639,000 | |
Goodwill and Intangible Assets [Abstract] | |||
Goodwill impairment loss | 0 | 0 | |
Goodwill | $ 3,487,000 | 3,487,000 | |
Incentive Plans [Abstract] | |||
Discount on market price on the date of grant | 85.00% | ||
Discount on market price on the date of exercise | 85.00% | ||
Expiration date | 27 months | ||
General and administrative | $ 32,992,000 | $ 31,309,000 | $ 24,716,000 |
Accumulated Other Comprehensive Income (Loss) [Abstract] | |||
Number of forward starting swaps settled | swap_agreement | 4 | 4 | 4 |
Revenue Recognition [Abstract] | |||
Deferred revenue | $ 36,000,000 | $ 32,400,000 | |
Deferred revenue, tenant reimbursements | 20,100,000 | 20,600,000 | |
Rental Income [Abstract] | |||
Operating expense recoveries included in income from continuing operations | $ 73,400,000 | $ 66,000,000 | $ 58,900,000 |
Additional rental income, net of reserves included in income from continuing operations | $ 700,000 | ||
Other Operating Income [Abstract] | |||
Number of owned real estate properties to which property operating agreements between company and sponsoring health system is applicable | property | 1 | 2 | 5 |
Federal Income Taxes [Abstract] | |||
Percentage of distribution of taxable income for qualify as REIT | 90.00% | ||
At Market Lease Intangibles [Member] | |||
Real Estate Properties [Abstract] | |||
Elimination of real estate lease intangibles against accumulated depreciation | $ 10,200,000 | $ 6,700,000 | |
Employee Stock Purchase Plan [Member] | |||
Incentive Plans [Abstract] | |||
General and administrative | 200,000 | 200,000 | $ 200,000 |
Tenant and Capital Improvements [Member] | |||
Real Estate Properties [Abstract] | |||
Fully depreciated tenant and capital improvements eliminated against accumulated depreciation | 2,600,000 | 100,000 | |
Forward Starting Interest Rate Swap [Member] | |||
Derivative Instrument Detail [Abstract] | |||
Accumulated other comprehensive income (loss), net of tax | $ 1,300,000 | $ 1,400,000 | |
Customer Concentration Risk [Member] | Revenue [Member] | |||
Risks and Uncertainties [Abstract] | |||
Concentration risk (percent) | 9.70% | 9.80% | 9.80% |
Medical Office Building [Member] | |||
Business Overview [Abstract] | |||
Square footage of owned real estate properties | ft² | 355,000 | ||
Medical Office Building [Member] | Level 1 [Member] | |||
Fair Value Measurements [Abstract] | |||
Impairment of real estate | $ 5,100,000 | ||
Real estate dispositions [Member] | Level 1 [Member] | |||
Fair Value Measurements [Abstract] | |||
Impairment of real estate | $ 300,000 |
Summary of Significant Accoun54
Summary of Significant Accounting Policies - Impact of new accounting pronouncements (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||||
Rental income | $ 422,852 | $ 407,481 | $ 383,333 | ||||||||
Other operating | 1,647 | 4,149 | 5,047 | ||||||||
Revenues | $ 107,731 | $ 106,953 | $ 105,245 | $ 104,569 | $ 105,309 | $ 103,659 | $ 102,642 | $ 100,021 | 424,499 | 411,630 | 388,471 |
Interest and other income, net | 896 | 375 | 389 | ||||||||
Income from continuing operations | $ (37,151) | $ 3,165 | $ 25,224 | $ 31,858 | $ 52,580 | $ 11,857 | $ 12,157 | $ 9,163 | 23,096 | 85,756 | $ 58,836 |
As Reclassified | |||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||||||
Rental income | 416,727 | 401,989 | |||||||||
Other operating | 8,011 | 9,966 | |||||||||
Revenues | 424,738 | 411,955 | |||||||||
Interest and other income, net | 658 | 50 | |||||||||
Income from continuing operations | $ 23,096 | $ 85,756 |
Property Investments (Details)
Property Investments (Details) $ in Thousands | Dec. 31, 2017USD ($)property | Dec. 31, 2016USD ($) |
Summary of Company's investment | ||
Number of facilities | property | 201 | |
Number of real estate investments | property | 201 | |
Land | $ 221,406 | |
Buildings, Improvements,and Lease Intangibles | 3,601,460 | $ 3,386,480 |
Buildings, Improvements, and Lease Intangibles, including Construction in Progress | 3,606,918 | |
Personal Property | 10,314 | 10,291 |
Total real estate properties | 3,838,638 | 3,628,221 |
Accumulated Depreciation | (897,430) | $ (840,839) |
Total real estate investments | 3,838,638 | |
Wholly Owned Properties [Member] | ||
Summary of Company's investment | ||
Accumulated Depreciation | $ (897,430) | |
Land Held for Development and Corporate Property [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 0 | |
Land | $ 20,123 | |
Buildings, Improvements,and Lease Intangibles | 5,458 | |
Personal Property | 5,603 | |
Total real estate properties | 31,184 | |
Accumulated Depreciation | $ (4,640) | |
Land Held for Development [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 0 | |
Land | $ 20,123 | |
Buildings, Improvements,and Lease Intangibles | 0 | |
Personal Property | 0 | |
Total real estate properties | 20,123 | |
Accumulated Depreciation | (239) | |
Construction in Progress [Member] | ||
Summary of Company's investment | ||
Buildings, Improvements,and Lease Intangibles | 5,458 | |
Total real estate properties | $ 5,458 | |
Corporate Property [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 0 | |
Land | $ 0 | |
Buildings, Improvements,and Lease Intangibles | 0 | |
Personal Property | 5,603 | |
Total real estate properties | 5,603 | |
Accumulated Depreciation | $ (4,401) | |
Medical office/outpatient [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 188 | |
Land | $ 192,304 | |
Buildings, Improvements,and Lease Intangibles | 3,290,061 | |
Personal Property | 4,113 | |
Total real estate properties | 3,486,478 | |
Accumulated Depreciation | $ (816,432) | |
Medical office/outpatient [Member] | Colorado [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 6 | |
Land | $ 4,086 | |
Buildings, Improvements,and Lease Intangibles | 122,689 | |
Personal Property | 271 | |
Total real estate properties | 127,046 | |
Accumulated Depreciation | $ (18,736) | |
Medical office/outpatient [Member] | DISTRICT OF COLUMBIA | ||
Summary of Company's investment | ||
Number of facilities | property | 4 | |
Land | $ 0 | |
Buildings, Improvements,and Lease Intangibles | 100,570 | |
Personal Property | 0 | |
Total real estate properties | 100,570 | |
Accumulated Depreciation | $ (15,826) | |
Medical office/outpatient [Member] | Georgia [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 8 | |
Land | $ 1,015 | |
Buildings, Improvements,and Lease Intangibles | 187,042 | |
Personal Property | 0 | |
Total real estate properties | 188,057 | |
Accumulated Depreciation | $ (1,203) | |
Medical office/outpatient [Member] | Austin, Texas [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 4 | |
Land | $ 12,756 | |
Buildings, Improvements,and Lease Intangibles | 85,961 | |
Personal Property | 105 | |
Total real estate properties | 98,822 | |
Accumulated Depreciation | $ (17,498) | |
Medical office/outpatient [Member] | Hawaii [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 3 | |
Land | $ 8,327 | |
Buildings, Improvements,and Lease Intangibles | 132,847 | |
Personal Property | 159 | |
Total real estate properties | 141,333 | |
Accumulated Depreciation | $ (30,066) | |
Medical office/outpatient [Member] | Illinois [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 3 | |
Land | $ 5,859 | |
Buildings, Improvements,and Lease Intangibles | 79,295 | |
Personal Property | 200 | |
Total real estate properties | 85,354 | |
Accumulated Depreciation | $ (15,476) | |
Medical office/outpatient [Member] | Dallas, Texas [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 24 | |
Land | $ 12,472 | |
Buildings, Improvements,and Lease Intangibles | 365,657 | |
Personal Property | 416 | |
Total real estate properties | 378,545 | |
Accumulated Depreciation | $ (128,557) | |
Medical office/outpatient [Member] | Indiana [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 3 | |
Land | $ 3,299 | |
Buildings, Improvements,and Lease Intangibles | 71,641 | |
Personal Property | 0 | |
Total real estate properties | 74,940 | |
Accumulated Depreciation | $ (18,742) | |
Medical office/outpatient [Member] | Memphis, Tennessee [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 7 | |
Land | $ 5,241 | |
Buildings, Improvements,and Lease Intangibles | 88,517 | |
Personal Property | 160 | |
Total real estate properties | 93,918 | |
Accumulated Depreciation | $ (31,675) | |
Medical office/outpatient [Member] | Nashville, Tennessee [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 5 | |
Land | $ 3,143 | |
Buildings, Improvements,and Lease Intangibles | 149,859 | |
Personal Property | 278 | |
Total real estate properties | 153,280 | |
Accumulated Depreciation | $ (43,000) | |
Medical office/outpatient [Member] | Iowa [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 6 | |
Land | $ 12,665 | |
Buildings, Improvements,and Lease Intangibles | 79,214 | |
Personal Property | 94 | |
Total real estate properties | 91,973 | |
Accumulated Depreciation | $ (18,263) | |
Medical office/outpatient [Member] | North Carolina [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 16 | |
Land | $ 4,200 | |
Buildings, Improvements,and Lease Intangibles | 163,603 | |
Personal Property | 95 | |
Total real estate properties | 167,898 | |
Accumulated Depreciation | $ (56,355) | |
Medical office/outpatient [Member] | Oklahoma [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 2 | |
Land | $ 7,673 | |
Buildings, Improvements,and Lease Intangibles | 101,432 | |
Personal Property | 6 | |
Total real estate properties | 109,111 | |
Accumulated Depreciation | $ (10,890) | |
Medical office/outpatient [Member] | Los Angeles, California [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 11 | |
Land | $ 27,709 | |
Buildings, Improvements,and Lease Intangibles | 141,681 | |
Personal Property | 277 | |
Total real estate properties | 169,667 | |
Accumulated Depreciation | $ (71,808) | |
Medical office/outpatient [Member] | Virginia [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 7 | |
Land | $ 0 | |
Buildings, Improvements,and Lease Intangibles | 146,176 | |
Personal Property | 98 | |
Total real estate properties | 146,274 | |
Accumulated Depreciation | $ (32,299) | |
Medical office/outpatient [Member] | San Antonio, Texas [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 7 | |
Land | $ 6,647 | |
Buildings, Improvements,and Lease Intangibles | 88,129 | |
Personal Property | 370 | |
Total real estate properties | 95,146 | |
Accumulated Depreciation | $ (34,514) | |
Medical office/outpatient [Member] | San Francisco, California [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 3 | |
Land | $ 14,054 | |
Buildings, Improvements,and Lease Intangibles | 103,938 | |
Personal Property | 43 | |
Total real estate properties | 118,035 | |
Accumulated Depreciation | $ (12,223) | |
Medical office/outpatient [Member] | Washington [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 17 | |
Land | $ 24,560 | |
Buildings, Improvements,and Lease Intangibles | 403,614 | |
Personal Property | 378 | |
Total real estate properties | 428,552 | |
Accumulated Depreciation | $ (52,457) | |
Medical office/outpatient [Member] | Other (22 MSAs) [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 52 | |
Land | $ 38,598 | |
Buildings, Improvements,and Lease Intangibles | 678,196 | |
Personal Property | 1,163 | |
Total real estate properties | 717,957 | |
Accumulated Depreciation | $ (206,844) | |
Inpatient [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 5 | |
Land | $ 7,054 | |
Buildings, Improvements,and Lease Intangibles | 247,125 | |
Personal Property | 0 | |
Total real estate properties | 254,179 | |
Accumulated Depreciation | $ (56,123) | |
Inpatient [Member] | Colorado [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 623 | |
Buildings, Improvements,and Lease Intangibles | 10,788 | |
Personal Property | 0 | |
Total real estate properties | 11,411 | |
Accumulated Depreciation | $ (1,781) | |
Inpatient [Member] | Dallas, Texas [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 4,442 | |
Buildings, Improvements,and Lease Intangibles | 92,990 | |
Personal Property | 0 | |
Total real estate properties | 97,432 | |
Accumulated Depreciation | $ (19,538) | |
Inpatient [Member] | Missouri [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 1,989 | |
Buildings, Improvements,and Lease Intangibles | 109,304 | |
Personal Property | 0 | |
Total real estate properties | 111,293 | |
Accumulated Depreciation | $ (12,046) | |
Inpatient [Member] | Los Angeles, California [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 0 | |
Buildings, Improvements,and Lease Intangibles | 12,688 | |
Personal Property | 0 | |
Total real estate properties | 12,688 | |
Accumulated Depreciation | $ (7,606) | |
Inpatient [Member] | Pennsylvania [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 0 | |
Buildings, Improvements,and Lease Intangibles | 21,355 | |
Personal Property | 0 | |
Total real estate properties | 21,355 | |
Accumulated Depreciation | $ (15,152) | |
Other [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 8 | |
Land | $ 1,925 | |
Buildings, Improvements,and Lease Intangibles | 64,274 | |
Personal Property | 598 | |
Total real estate properties | 66,797 | |
Accumulated Depreciation | $ (20,235) | |
Other [Member] | Austin, Texas [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 1,480 | |
Buildings, Improvements,and Lease Intangibles | 3,872 | |
Personal Property | 2 | |
Total real estate properties | 5,354 | |
Accumulated Depreciation | $ (164) | |
Other [Member] | Fenton, Michigan [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 40 | |
Buildings, Improvements,and Lease Intangibles | 3,468 | |
Personal Property | 32 | |
Total real estate properties | 3,540 | |
Accumulated Depreciation | $ (2,738) | |
Other [Member] | Ovid, Michigan [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 62 | |
Buildings, Improvements,and Lease Intangibles | 3,188 | |
Personal Property | 49 | |
Total real estate properties | 3,299 | |
Accumulated Depreciation | $ (2,096) | |
Other [Member] | Fremont, Michigan [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 7 | |
Buildings, Improvements,and Lease Intangibles | 3,242 | |
Personal Property | 35 | |
Total real estate properties | 3,284 | |
Accumulated Depreciation | $ (2,565) | |
Other [Member] | St. Louis, Michigan [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 31 | |
Buildings, Improvements,and Lease Intangibles | 1,735 | |
Personal Property | 33 | |
Total real estate properties | 1,799 | |
Accumulated Depreciation | $ 1,341 | |
Other [Member] | Iowa [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 0 | |
Buildings, Improvements,and Lease Intangibles | 40,354 | |
Personal Property | 5 | |
Total real estate properties | 40,359 | |
Accumulated Depreciation | $ (7,704) | |
Other [Member] | Johnson City, Tennessee [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 253 | |
Buildings, Improvements,and Lease Intangibles | 7,319 | |
Personal Property | 408 | |
Total real estate properties | 7,980 | |
Accumulated Depreciation | $ (2,798) | |
Other [Member] | Detroit, Michigan [Member] | ||
Summary of Company's investment | ||
Number of facilities | property | 1 | |
Land | $ 52 | |
Buildings, Improvements,and Lease Intangibles | 1,096 | |
Personal Property | 34 | |
Total real estate properties | 1,182 | |
Accumulated Depreciation | $ (829) |
Property Investments (Details T
Property Investments (Details Textual) $ in Billions | Dec. 31, 2017USD ($)property |
Real Estate Investment Property, Net [Abstract] | |
Investment in real estate properties and mortgage notes | $ | $ 3.8 |
Number of real estate investments | property | 201 |
Real Estate Leases (Details)
Real Estate Leases (Details) $ in Thousands | Dec. 31, 2017USD ($) |
Leases [Abstract] | |
2,018 | $ 330,526 |
2,019 | 282,910 |
2,020 | 236,454 |
2,021 | 196,346 |
2,022 | 168,183 |
2023 and thereafter | 544,677 |
Total | $ 1,759,096 |
Real Estate Leases - Narrative
Real Estate Leases - Narrative (Details) $ in Millions | 1 Months Ended | 12 Months Ended | ||
Oct. 31, 2017Purchase_options | Dec. 31, 2017USD ($)renewal_option | Dec. 31, 2016 | Dec. 31, 2015 | |
Concentration Risk [Line Items] | ||||
Approximate Investment in real estate properties subject to outstanding contractual option to purchase | $ 95.2 | |||
Number of exercisable purchase options | 1 | 4 | ||
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | ||||
Concentration Risk [Line Items] | ||||
Concentration risk (percent) | 9.70% | 9.80% | 9.80% |
Acquisitions, Dispositions an59
Acquisitions, Dispositions and Mortgage Repayments - Acquisitions (Details) $ in Millions | Dec. 21, 2017USD ($)ft² | Dec. 18, 2017USD ($)ft²Garage | Dec. 13, 2017USD ($)ft² | Nov. 01, 2017USD ($)ft² | Jul. 31, 2017USD ($)ft² | Jun. 13, 2017USD ($)ft² | Jun. 12, 2017USD ($)ft² | Mar. 06, 2017USD ($)ft² | Dec. 21, 2016USD ($)ft² | Oct. 17, 2016USD ($)ft² | Oct. 11, 2016USD ($)ft² | Sep. 26, 2016USD ($)ft² | Sep. 12, 2016USD ($)ft² | May 13, 2016USD ($)ft² | Apr. 29, 2016USD ($)ft² | Mar. 31, 2016USD ($)ft² | Dec. 31, 2017USD ($)ft² | Dec. 31, 2016USD ($)ft² |
Real estate acquisitions [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Purchase Price | $ 327.2 | $ 241.9 | ||||||||||||||||
Mortgage Notes Payable Assumed | (45.8) | (13.2) | ||||||||||||||||
Cash Consideration | 283.1 | 224.9 | ||||||||||||||||
Real Estate | 322.6 | 239.3 | ||||||||||||||||
Other | $ 6.3 | $ (1.2) | ||||||||||||||||
Square Footage | ft² | 877,873 | 583,011 | ||||||||||||||||
Fair value adjustments on mortgage notes payable assumed | $ 0.6 | $ (0.8) | ||||||||||||||||
Real estate acquisitions [Member] | Minnesota [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Mar. 6, 2017 | Dec. 21, 2016 | ||||||||||||||||
Purchase Price | $ 13.5 | $ 12.6 | ||||||||||||||||
Mortgage Notes Payable Assumed | 0 | 0 | ||||||||||||||||
Cash Consideration | 13.5 | 12.5 | ||||||||||||||||
Real Estate | 13.3 | 11.3 | ||||||||||||||||
Other | $ 0.2 | $ 1.2 | ||||||||||||||||
Square Footage | ft² | 34,608 | 48,281 | ||||||||||||||||
Real estate acquisitions [Member] | San Francisco, California [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Jun. 12, 2017 | |||||||||||||||||
Purchase Price | $ 26.8 | |||||||||||||||||
Mortgage Notes Payable Assumed | 0 | |||||||||||||||||
Cash Consideration | 26.8 | |||||||||||||||||
Real Estate | 26.8 | |||||||||||||||||
Other | $ 0 | |||||||||||||||||
Square Footage | ft² | 75,649 | |||||||||||||||||
Real estate acquisitions [Member] | DISTRICT OF COLUMBIA | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Jun. 13, 2017 | Sep. 26, 2016 | ||||||||||||||||
Purchase Price | $ 24 | $ 45.2 | ||||||||||||||||
Mortgage Notes Payable Assumed | (12.1) | 0 | ||||||||||||||||
Cash Consideration | 12.5 | 45.1 | ||||||||||||||||
Real Estate | 24.8 | 43.7 | ||||||||||||||||
Other | $ (0.2) | $ 1.4 | ||||||||||||||||
Square Footage | ft² | 62,379 | 103,783 | ||||||||||||||||
Real estate acquisitions [Member] | Maryland [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Oct. 11, 2016 | |||||||||||||||||
Purchase Price | $ 36.2 | |||||||||||||||||
Mortgage Notes Payable Assumed | 0 | |||||||||||||||||
Cash Consideration | 36.4 | |||||||||||||||||
Real Estate | 36.4 | |||||||||||||||||
Other | $ 0 | |||||||||||||||||
Square Footage | ft² | 113,631 | |||||||||||||||||
Real estate acquisitions [Member] | Los Angeles, California [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Jul. 31, 2017 | May 13, 2016 | ||||||||||||||||
Purchase Price | $ 16.3 | $ 20 | ||||||||||||||||
Mortgage Notes Payable Assumed | 0 | (13.2) | ||||||||||||||||
Cash Consideration | 16.7 | 6.5 | ||||||||||||||||
Real Estate | 16.9 | 20.4 | ||||||||||||||||
Other | $ (0.2) | $ (0.7) | ||||||||||||||||
Square Footage | ft² | 42,780 | 63,012 | ||||||||||||||||
Real estate acquisitions [Member] | Washington [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Dec. 18, 2017 | Nov. 1, 2017 | Dec. 21, 2016 | Oct. 17, 2016 | Sep. 12, 2016 | Apr. 29, 2016 | Mar. 31, 2016 | |||||||||||
Purchase Price | $ 8.8 | $ 12.7 | $ 5.1 | $ 9.8 | $ 53.1 | $ 21.6 | $ 38.3 | |||||||||||
Mortgage Notes Payable Assumed | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||
Cash Consideration | 8.8 | 12.6 | 5.1 | 9.8 | 53 | 18.8 | 37.7 | |||||||||||
Real Estate | 9 | 12.8 | 5.2 | 9.9 | 54.6 | 20.1 | 37.7 | |||||||||||
Other | $ (0.2) | $ (0.2) | $ (0.1) | $ (0.1) | $ (1.6) | $ (1.3) | $ 0 | |||||||||||
Square Footage | ft² | 32,828 | 26,345 | 20,740 | 29,753 | 87,462 | 46,637 | 69,712 | |||||||||||
Real estate acquisitions [Member] | Illinois [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Dec. 18, 2017 | |||||||||||||||||
Purchase Price | $ 28.7 | |||||||||||||||||
Mortgage Notes Payable Assumed | 0 | |||||||||||||||||
Cash Consideration | 27.7 | |||||||||||||||||
Real Estate | 28.5 | |||||||||||||||||
Other | $ (0.8) | |||||||||||||||||
Square Footage | ft² | 99,526 | |||||||||||||||||
Real estate acquisitions [Member] | Texas [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Dec. 21, 2017 | |||||||||||||||||
Purchase Price | $ 2.5 | |||||||||||||||||
Mortgage Notes Payable Assumed | 0 | |||||||||||||||||
Cash Consideration | 2.5 | |||||||||||||||||
Real Estate | 2.5 | |||||||||||||||||
Other | $ 0 | |||||||||||||||||
Square Footage | ft² | 7,972 | |||||||||||||||||
Property ownership percentage | 69.40% | |||||||||||||||||
Real Estate Acquisition One [Member] | Georgia [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Dec. 18, 2017 | Dec. 13, 2017 | Nov. 1, 2017 | |||||||||||||||
Purchase Price | $ 26.3 | $ 25.8 | $ 25.5 | |||||||||||||||
Mortgage Notes Payable Assumed | (11.8) | (10.5) | 0 | |||||||||||||||
Cash Consideration | 14.5 | 15.3 | 25.5 | |||||||||||||||
Real Estate | 24.6 | 22 | 26.3 | |||||||||||||||
Other | $ 1.7 | $ 3.8 | $ (0.8) | |||||||||||||||
Square Footage | ft² | 66,984 | 59,427 | 76,944 | |||||||||||||||
Number of parking garages | Garage | 2 | |||||||||||||||||
Real Estate Acquisition Two [Member] | Georgia [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Dec. 18, 2017 | Dec. 13, 2017 | Nov. 1, 2017 | |||||||||||||||
Purchase Price | $ 14.2 | $ 15.4 | $ 30.3 | |||||||||||||||
Mortgage Notes Payable Assumed | (6.7) | (4.7) | 0 | |||||||||||||||
Cash Consideration | 7.6 | 10.8 | 30.7 | |||||||||||||||
Real Estate | 14.5 | 15.7 | 30.7 | |||||||||||||||
Other | $ (0.2) | $ (0.2) | $ 0 | |||||||||||||||
Square Footage | ft² | 40,324 | 40,171 | 74,024 | |||||||||||||||
Real Estate Acquisition Three [Member] | Georgia [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Nov. 1, 2017 | |||||||||||||||||
Purchase Price | $ 49.7 | |||||||||||||||||
Mortgage Notes Payable Assumed | 0 | |||||||||||||||||
Cash Consideration | 50.9 | |||||||||||||||||
Real Estate | 47.5 | |||||||||||||||||
Other | $ 3.4 | |||||||||||||||||
Square Footage | ft² | 118,180 | |||||||||||||||||
Real Estate Acquisition Four [Member] | Georgia [Member] | ||||||||||||||||||
Real Estate Acquisitions and Mortgage Note Financing [Line Items] | ||||||||||||||||||
Date Acquired | Nov. 1, 2017 | |||||||||||||||||
Purchase Price | $ 6.7 | |||||||||||||||||
Mortgage Notes Payable Assumed | 0 | |||||||||||||||||
Cash Consideration | 6.7 | |||||||||||||||||
Real Estate | 6.7 | |||||||||||||||||
Other | $ 0 | |||||||||||||||||
Square Footage | ft² | 19,732 |
Acquisitions, Dispositions an60
Acquisitions, Dispositions and Mortgage Repayments - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Business Acquisition [Line Items] | ||
Building | $ 272.1 | $ 216.8 |
Land | 11.7 | 9.7 |
Land Improvements | 1.6 | |
Intangibles | 36.7 | 13.7 |
Mortgage notes payable assumed, including fair value adjustments | (46.4) | (14) |
Other assets acquired | 0.4 | 0.5 |
Equity investment in joint ventures | 8.7 | |
Accounts payable, accrued liabilities and other liabilities assumed | (1.7) | (1.8) |
Total cash paid | 283.1 | 224.9 |
At market lease Intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangibles | 37.2 | 12.8 |
Above-market lease intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangibles | 0.9 | |
Below-market ground lease intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangibles | $ 0.4 | $ 2 |
Minimum [Member] | At market lease Intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangible asset useful life | 2 years 1 month 6 days | 2 years 8 months 12 days |
Minimum [Member] | Above-market lease intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangible asset useful life | 8 months 12 days | |
Minimum [Member] | Below-market lease intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangible asset useful life | 8 years 6 months | 1 year 4 months 24 days |
Minimum [Member] | Below-market ground lease intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangible asset useful life | 36 years 9 months 18 days | 36 years 9 months 18 days |
Minimum [Member] | Building [Member] | ||
Business Acquisition [Line Items] | ||
Asset estimated useful life | 15 years | 20 years |
Minimum [Member] | Land Improvements [Member] | ||
Business Acquisition [Line Items] | ||
Asset estimated useful life | 5 years | |
Maximum [Member] | At market lease Intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangible asset useful life | 12 years 7 months 6 days | 10 years 3 months 18 days |
Maximum [Member] | Above-market lease intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangible asset useful life | 3 years 9 months 18 days | |
Maximum [Member] | Below-market lease intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangible asset useful life | 15 years | 9 years 4 months 24 days |
Maximum [Member] | Below-market ground lease intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangible asset useful life | 99 years | 99 years |
Maximum [Member] | Building [Member] | ||
Business Acquisition [Line Items] | ||
Asset estimated useful life | 37 years | 35 years |
Maximum [Member] | Land Improvements [Member] | ||
Business Acquisition [Line Items] | ||
Asset estimated useful life | 39 years | |
Above-market ground lease intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangible liabilities | $ (1.6) | |
Intangible asset useful life | 99 years | |
Below-market lease intangibles [Member] | ||
Business Acquisition [Line Items] | ||
Intangible liabilities | $ (0.9) | $ (0.4) |
2017 Acquisitions [Member] | Minimum [Member] | Land Improvements [Member] | ||
Business Acquisition [Line Items] | ||
Asset estimated useful life | 5 years | |
2017 Acquisitions [Member] | Maximum [Member] | Land Improvements [Member] | ||
Business Acquisition [Line Items] | ||
Asset estimated useful life | 12 years |
Acquisitions, Dispositions an61
Acquisitions, Dispositions and Mortgage Repayments - Dispositions (Details) $ in Thousands | Sep. 07, 2017USD ($)ft² | Jun. 29, 2017USD ($)ft² | Jun. 16, 2017USD ($)ft² | Mar. 31, 2017USD ($)ft² | Mar. 30, 2017USD ($)ft² | Mar. 07, 2017USD ($)ft² | Mar. 06, 2017USD ($)ft² | Dec. 22, 2016USD ($)ft² | Dec. 20, 2016USD ($)ft² | Oct. 28, 2016USD ($)ft² | Oct. 14, 2016USD ($)ft² | Mar. 31, 2017USD ($)ft² | Dec. 31, 2017USD ($)ft² | Dec. 31, 2016USD ($)ft² | Dec. 31, 2015USD ($) | Oct. 31, 2017USD ($) |
Real Estate Dispositions [Line Items] | ||||||||||||||||
Sales Price | $ 122,700 | $ 94,700 | $ 45,500 | |||||||||||||
Closing Adjustments | (3,300) | (1,400) | ||||||||||||||
Net Proceeds | 119,400 | 93,300 | ||||||||||||||
Net Real Estate Investment | 78,200 | 49,400 | ||||||||||||||
Other (including receivables) | 6,800 | 2,900 | ||||||||||||||
Gain/ (Impairment) | $ 34,400 | $ 41,000 | ||||||||||||||
Square Footage | ft² | 416,481 | 320,702 | ||||||||||||||
Impairment of real estate | $ 5,385 | $ 3,639 | ||||||||||||||
Indiana [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Mar. 6, 2017 | |||||||||||||||
Sales Price | $ 6,400 | |||||||||||||||
Closing Adjustments | 0 | |||||||||||||||
Net Proceeds | 6,400 | |||||||||||||||
Net Real Estate Investment | 1,100 | |||||||||||||||
Other (including receivables) | 0 | |||||||||||||||
Gain/ (Impairment) | $ 5,300 | |||||||||||||||
Square Footage | ft² | 29,500 | |||||||||||||||
Georgia [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Mar. 7, 2017 | Dec. 22, 2016 | ||||||||||||||
Sales Price | $ 600 | $ 2,800 | ||||||||||||||
Closing Adjustments | 0 | (200) | ||||||||||||||
Net Proceeds | 600 | 2,600 | ||||||||||||||
Net Real Estate Investment | 600 | 1,800 | ||||||||||||||
Other (including receivables) | 0 | 0 | ||||||||||||||
Gain/ (Impairment) | $ 0 | $ 800 | ||||||||||||||
Square Footage | ft² | 12,000 | 8,749 | ||||||||||||||
Nevada [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Mar. 30, 2017 | |||||||||||||||
Sales Price | $ 5,500 | |||||||||||||||
Closing Adjustments | (700) | |||||||||||||||
Net Proceeds | 4,800 | |||||||||||||||
Net Real Estate Investment | 2,200 | |||||||||||||||
Other (including receivables) | 300 | |||||||||||||||
Gain/ (Impairment) | $ 2,300 | |||||||||||||||
Square Footage | ft² | 18,147 | |||||||||||||||
Texas [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Mar. 31, 2017 | |||||||||||||||
Sales Price | $ 69,500 | $ 69,500 | ||||||||||||||
Closing Adjustments | (1,600) | (1,600) | ||||||||||||||
Net Proceeds | 67,900 | |||||||||||||||
Net Real Estate Investment | 46,900 | 46,900 | ||||||||||||||
Other (including receivables) | 5,200 | $ 5,200 | ||||||||||||||
Gain/ (Impairment) | $ 15,800 | |||||||||||||||
Square Footage | ft² | 169,722 | 169,722 | ||||||||||||||
Illinois [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Jun. 16, 2017 | |||||||||||||||
Sales Price | $ 500 | |||||||||||||||
Closing Adjustments | (100) | |||||||||||||||
Net Proceeds | 400 | |||||||||||||||
Net Real Estate Investment | 400 | |||||||||||||||
Other (including receivables) | 0 | |||||||||||||||
Gain/ (Impairment) | $ 0 | |||||||||||||||
Square Footage | ft² | 5,100 | |||||||||||||||
Impairment of real estate | $ 300 | |||||||||||||||
San Antonio, Texas [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Jun. 29, 2017 | |||||||||||||||
Sales Price | $ 14,500 | |||||||||||||||
Closing Adjustments | (200) | |||||||||||||||
Net Proceeds | 14,300 | |||||||||||||||
Net Real Estate Investment | 5,100 | |||||||||||||||
Other (including receivables) | 900 | |||||||||||||||
Gain/ (Impairment) | $ 8,300 | |||||||||||||||
Square Footage | ft² | 39,786 | |||||||||||||||
Oregon [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Jun. 29, 2017 | |||||||||||||||
Sales Price | $ 23,200 | |||||||||||||||
Closing Adjustments | (600) | |||||||||||||||
Net Proceeds | 22,600 | |||||||||||||||
Net Real Estate Investment | 14,500 | |||||||||||||||
Other (including receivables) | 300 | |||||||||||||||
Gain/ (Impairment) | $ 7,800 | |||||||||||||||
Square Footage | ft² | 62,246 | |||||||||||||||
Missouri [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Sep. 7, 2017 | |||||||||||||||
Sales Price | $ 2,500 | |||||||||||||||
Closing Adjustments | (100) | |||||||||||||||
Net Proceeds | 2,400 | |||||||||||||||
Net Real Estate Investment | 7,400 | |||||||||||||||
Other (including receivables) | 100 | |||||||||||||||
Gain/ (Impairment) | $ (5,100) | |||||||||||||||
Square Footage | ft² | 79,980 | |||||||||||||||
Kansas [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Oct. 14, 2016 | |||||||||||||||
Sales Price | $ 15,100 | |||||||||||||||
Closing Adjustments | 0 | |||||||||||||||
Net Proceeds | 15,100 | |||||||||||||||
Net Real Estate Investment | 7,200 | |||||||||||||||
Other (including receivables) | 300 | |||||||||||||||
Gain/ (Impairment) | $ 7,600 | |||||||||||||||
Square Footage | ft² | 70,908 | |||||||||||||||
Tennessee [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Oct. 28, 2016 | |||||||||||||||
Sales Price | $ 8,800 | |||||||||||||||
Closing Adjustments | (200) | |||||||||||||||
Net Proceeds | 8,600 | |||||||||||||||
Net Real Estate Investment | 6,300 | |||||||||||||||
Other (including receivables) | 200 | |||||||||||||||
Gain/ (Impairment) | $ 2,100 | |||||||||||||||
Square Footage | ft² | 45,274 | |||||||||||||||
Altoona, Pennsylvania [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Dec. 20, 2016 | |||||||||||||||
Sales Price | $ 21,500 | |||||||||||||||
Closing Adjustments | (400) | |||||||||||||||
Net Proceeds | 21,100 | |||||||||||||||
Net Real Estate Investment | 12,400 | |||||||||||||||
Other (including receivables) | 600 | |||||||||||||||
Gain/ (Impairment) | $ 8,100 | |||||||||||||||
Square Footage | ft² | 64,032 | |||||||||||||||
Harrisburg, Pennsylvania [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Dec. 20, 2016 | |||||||||||||||
Sales Price | $ 24,200 | |||||||||||||||
Closing Adjustments | (600) | |||||||||||||||
Net Proceeds | 23,600 | |||||||||||||||
Net Real Estate Investment | 8,200 | |||||||||||||||
Other (including receivables) | 400 | |||||||||||||||
Gain/ (Impairment) | $ 15,000 | |||||||||||||||
Square Footage | ft² | 79,836 | |||||||||||||||
Arizona [Member] | Real estate dispositions [Member] | ||||||||||||||||
Real Estate Dispositions [Line Items] | ||||||||||||||||
Date Disposed | Dec. 20, 2016 | |||||||||||||||
Sales Price | $ 22,300 | |||||||||||||||
Closing Adjustments | 0 | |||||||||||||||
Net Proceeds | 22,300 | |||||||||||||||
Net Real Estate Investment | 13,500 | |||||||||||||||
Other (including receivables) | 1,400 | |||||||||||||||
Gain/ (Impairment) | $ 7,400 | |||||||||||||||
Square Footage | ft² | 51,903 |
Acquisitions, Dispositions an62
Acquisitions, Dispositions and Mortgage Repayments - Additional information (Details) $ in Millions | 1 Months Ended | 12 Months Ended | |
Oct. 31, 2017USD ($)propertybuildingPurchase_options | Dec. 31, 2017USD ($)renewal_option | Dec. 31, 2016USD ($) | |
Acquisitions and Dispositions and Mortgage Repayments [Abstract] | |||
Number of properties exercising purchase option | property | 7 | ||
Number of single-tenant net leased buildings exercising purchase option | building | 5 | ||
Number of multi-tenant buildings exercisng purchase option | building | 2 | ||
Number of purchase options | 1 | 4 | |
Stated purchase price | $ | $ 45.5 | $ 122.7 | $ 94.7 |
Aggregate net book value of potential dispositions | $ | $ 23.9 |
Held for Sale and Discontinue63
Held for Sale and Discontinued Operations (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Balance Sheet data (as of the period ended): | ||
Land | $ 201,283 | $ 199,672 |
Buildings, improvements and lease intangibles | 3,601,460 | 3,386,480 |
Personal property | 10,314 | 10,291 |
Total real estate properties | 3,838,638 | 3,628,221 |
Less accumulated depreciation | (897,430) | (840,839) |
Total real estate properties, net | 2,941,208 | 2,787,382 |
Other assets, net (including receivables) | 213,015 | 195,666 |
Assets held for sale and discontinued operations, net | 33,147 | 3,092 |
Liabilities of assets held for sale and discontinued operations | 93 | 614 |
Discontinued Operations [Member] | ||
Balance Sheet data (as of the period ended): | ||
Land | 4,636 | 1,362 |
Buildings, improvements and lease intangibles | 63,654 | 4,410 |
Personal property | 82 | 0 |
Total real estate properties | 68,372 | 5,772 |
Less accumulated depreciation | (35,790) | (2,977) |
Total real estate properties, net | 32,582 | 2,795 |
Other assets, net (including receivables) | 565 | 297 |
Assets of discontinued operations, net | 565 | 297 |
Assets held for sale and discontinued operations, net | 33,147 | 3,092 |
Accounts payable and accrued liabilities | 38 | 22 |
Other liabilities | 55 | 592 |
Liabilities of assets held for sale and discontinued operations | $ 93 | $ 614 |
Held for Sale and Discontinue64
Held for Sale and Discontinued Operations (Details 1) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Revenues | |||||||||||
Rental income | $ 422,852 | $ 407,481 | $ 383,333 | ||||||||
Other operating | 1,647 | 4,149 | 5,047 | ||||||||
Expenses | |||||||||||
Property operating | 157,233 | 146,458 | 140,195 | ||||||||
Bad debt, net of recoveries | 169 | (21) | (193) | ||||||||
Other Income (Expense) | |||||||||||
Interest and other income, net | 896 | 375 | 389 | ||||||||
Income from discontinued operations | (9) | (71) | 715 | ||||||||
Impairments | (121) | (686) | |||||||||
Gain on sales of real estate properties | 5 | 7 | 10,571 | ||||||||
INCOME (LOSS) FROM DISCONTINUED OPERATIONS | $ 0 | $ 8 | $ 0 | $ (13) | $ (143) | $ (23) | $ (12) | $ (7) | $ (4) | $ (185) | $ 10,600 |
Income (Loss) from Discontinued Operations per Common Share - Basic (in dollars per share) | $ 0 | $ 0 | $ 0.11 | ||||||||
Income (Loss) from Discontinued Operations per Common Share - Diluted (in dollars per share) | $ 0 | $ 0 | $ 0.11 | ||||||||
Discontinued Operations [Member] | |||||||||||
Revenues | |||||||||||
Rental income | $ 0 | $ 0 | $ 752 | ||||||||
Other operating | 0 | 0 | 0 | ||||||||
Total Revenue | 0 | 0 | 752 | ||||||||
Expenses | |||||||||||
Property operating | 19 | 71 | 58 | ||||||||
Bad debt, net of recoveries | (10) | 0 | (1) | ||||||||
Total Expense | 9 | 71 | 57 | ||||||||
Other Income (Expense) | |||||||||||
Interest and other income, net | 0 | 0 | 20 | ||||||||
Total other income (expense) | 0 | 0 | 20 | ||||||||
Income from discontinued operations | (9) | (71) | 715 | ||||||||
Impairments | 0 | (121) | (686) | ||||||||
Gain on sales of real estate properties | 5 | 7 | 10,571 | ||||||||
INCOME (LOSS) FROM DISCONTINUED OPERATIONS | $ (4) | $ (185) | $ 10,600 | ||||||||
Income (Loss) from Discontinued Operations per Common Share - Basic (in dollars per share) | $ 0 | $ 0 | $ 0.11 | ||||||||
Income (Loss) from Discontinued Operations per Common Share - Diluted (in dollars per share) | $ 0 | $ 0 | $ 0.11 |
Held for Sale and Discontinue65
Held for Sale and Discontinued Operations (Details Textual) $ in Millions | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||
Oct. 31, 2017property | Dec. 31, 2017propertyProperty | Dec. 31, 2017property | Dec. 31, 2016USD ($)property | Dec. 31, 2015USD ($)property | |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||
Number of properties reclassified to held for sale | Property | 8 | ||||
Number of properties exercising purchase option | 7 | ||||
Number of properties held for sale | 8 | 8 | 2 | ||
Discontinued Operations [Member] | |||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||
Revenue related to properties sold | $ | $ 0.8 | ||||
Expenses related to sale of real estate | $ | $ 0.1 | 0.1 | |||
Impairments related to property held for sale | $ | $ 0.1 | $ 0.7 | |||
Number of impaired properties held for sale | 1 | ||||
Number of properties related to gain on sales | 1 | 1 | 1 |
Impairment Charges (Details Tex
Impairment Charges (Details Textual) $ in Thousands | 3 Months Ended | 12 Months Ended | ||||
Jun. 30, 2017property | Mar. 31, 2017property | Dec. 31, 2016property | Dec. 31, 2017USD ($)property | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($)property | |
Property, Plant and Equipment [Abstract] | ||||||
Impairments | $ 121 | $ 686 | ||||
Number of properties sold | property | 3 | 6 | 6 | 2 | 2 | |
Impairment of real estate | $ 5,385 | $ 3,639 |
Other Assets (Details)
Other Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | ||
Prepaid assets | $ 65,200 | $ 64,800 |
Equity investment in joint ventures | 8,700 | 0 |
Straight-line rent receivables | 67,000 | 64,600 |
Above-market intangible assets, net | 17,900 | 19,100 |
Additional long-lived assets, net | 24,900 | 14,500 |
Ground lease modification, net | 10,300 | 10,800 |
Accounts receivable | 7,400 | 8,100 |
Allowance for uncollectible accounts | (300) | (100) |
Credit facility deferred financing costs | 3,500 | 4,900 |
Goodwill | 3,487 | 3,487 |
Customer relationship intangible assets, net | 1,700 | 1,800 |
Other | 3,200 | 3,700 |
Other Assets | $ 213,015 | $ 195,666 |
Other Assets - Unconsolidated J
Other Assets - Unconsolidated Joint Ventures (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2017USD ($) | Dec. 31, 2017Garage | Dec. 31, 2017building | Dec. 31, 2017USD ($) | |
Equity Method Investments [Roll Forward] | ||||
Net LLC investment, beginning of period | $ 0 | |||
Equity income (loss) recognized during the period | 7 | |||
Net LLC investments, end of period | $ 8,700 | 8,700 | ||
Parking Garages [Member] | ||||
Property, Plant and Equipment [Line Items] | ||||
Number of parking garages | 2 | 2 | ||
Number of buildings acquired | building | 3 | |||
Equity Method Investments [Roll Forward] | ||||
Net LLC investment, beginning of period | 0 | |||
New investments during the period | 8,700 | 8,700 | ||
Equity income (loss) recognized during the period | 0 | |||
Net LLC investments, end of period | $ 8,700 | $ 8,700 |
Intangible Assets and Liabili69
Intangible Assets and Liabilities - Components of intangible assets and liabilities (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Schedule of finite lived intangible assets and liabilities | ||
Intangible assets and liabilities, gross | $ 144.2 | $ 120.7 |
Intangible assets and liabilities, accumulated amortization | $ 47.7 | 46.5 |
Assets and liabilities, weighted avg. life (years) | 15 years 2 months | |
Below-market lease intangibles [Member] | Other liabilities [Member] | ||
Schedule of finite lived intangible assets and liabilities | ||
Liabilities gross balance | $ (9.5) | (8.8) |
Liabilities accumulated amortization | $ (3.5) | (3.2) |
Liabilities, weighted avg. life (years) | 36 years 6 months | |
Deferred financing costs [Member] | Other liabilities [Member] | ||
Schedule of finite lived intangible assets and liabilities | ||
Liabilities gross balance | $ 9.3 | 9.4 |
Liabilities accumulated amortization | $ 1.8 | 4 |
Liabilities, weighted avg. life (years) | 4 years 6 months | |
Goodwill [Member] | Other assets [Member] | ||
Schedule of finite lived intangible assets and liabilities | ||
Assets gross balance | $ 3.5 | 3.5 |
Assets accumulated amortization | 0 | 0 |
Deferred financing costs [Member] | Other assets [Member] | ||
Schedule of finite lived intangible assets and liabilities | ||
Assets gross balance | 5.4 | 5.4 |
Assets accumulated amortization | $ 1.9 | 0.5 |
Assets, weighted avg. life (years) | 2 years 7 months 6 days | |
Above-market lease intangibles [Member] | Other assets [Member] | ||
Schedule of finite lived intangible assets and liabilities | ||
Assets gross balance | $ 22.9 | 24.5 |
Assets accumulated amortization | $ 5 | 5.4 |
Assets, weighted avg. life (years) | 57 years 9 months 18 days | |
Customer relationship intangibles [Member] | Other assets [Member] | ||
Schedule of finite lived intangible assets and liabilities | ||
Assets gross balance | $ 2.6 | 2.6 |
Assets accumulated amortization | $ 0.9 | 0.8 |
Assets, weighted avg. life (years) | 25 years 7 months 6 days | |
At market lease Intangibles [Member] | Real estate properties [Member] | ||
Schedule of finite lived intangible assets and liabilities | ||
Assets gross balance | $ 110 | 84.1 |
Assets accumulated amortization | $ 41.6 | $ 39 |
Assets, weighted avg. life (years) | 5 years 7 months 6 days |
Intangible Assets and Liabili70
Intangible Assets and Liabilities - Expected future amortization expense (Details) $ in Millions | Dec. 31, 2017USD ($) |
Future Amortization of Intangibles, Net [Abstract] | |
2,018 | $ 19.8 |
2,019 | 17.6 |
2,020 | 12 |
2,021 | 6.8 |
2,022 | $ 5.8 |
Notes and Bonds Payable (Detail
Notes and Bonds Payable (Details) | 3 Months Ended | 12 Months Ended | ||||
Dec. 31, 2017USD ($) | Dec. 31, 2017USD ($) | Dec. 11, 2017 | Dec. 31, 2016USD ($) | Apr. 24, 2015 | Mar. 26, 2013 | |
Debt Instrument [Line Items] | ||||||
Notes and bonds payable | $ 1,283,880,000 | $ 1,283,880,000 | $ 1,264,370,000 | |||
Line of Credit [Member] | Unsecured Credit Facility [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Notes and bonds payable | 189,000,000 | 189,000,000 | 107,000,000 | |||
Medium-term Notes [Member] | Unsecured Term Loan due 2022 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Notes and bonds payable | $ 148,994,000 | $ 148,994,000 | 149,491,000 | |||
Contractual interest rates, basis spread on variable rate | 1.10% | |||||
Senior Notes [Member] | Senior Notes due 2021 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Extinguishment of debt, number of transactions | 2 | |||||
Notes and bonds payable | $ 0 | $ 0 | 397,147,000 | |||
Contractual interest rates | 5.75% | 5.75% | ||||
Senior Notes [Member] | Senior Notes due 2023 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Notes and bonds payable | $ 247,703,000 | $ 247,703,000 | 247,296,000 | |||
Contractual interest rates | 3.75% | 3.75% | 3.75% | |||
Senior Notes [Member] | Senior Notes due 2025 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Notes and bonds payable | $ 248,044,000 | $ 248,044,000 | 247,819,000 | |||
Contractual interest rates | 3.88% | 3.88% | 3.875% | |||
Senior Notes [Member] | Senior Notes due 2028 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Notes and bonds payable | $ 294,757,000 | $ 294,757,000 | 0 | |||
Contractual interest rates | 3.63% | 3.63% | 3.625% | |||
Mortgage Notes [Member] | Mortgage notes payable [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Notes and bonds payable | $ 155,382,000 | $ 155,382,000 | $ 115,617,000 | |||
LIBOR [Member] | Line of Credit [Member] | Unsecured Credit Facility [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Contractual interest rates, basis spread on variable rate | 1.00% | |||||
LIBOR [Member] | Medium-term Notes [Member] | Unsecured Term Loan due 2022 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Contractual interest rates, basis spread on variable rate | 1.10% | |||||
Minimum [Member] | Medium-term Notes [Member] | Unsecured Term Loan due 2022 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Contractual interest rates, basis spread on variable rate | 0.90% | |||||
Minimum [Member] | Mortgage Notes [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Contractual interest rates | 3.30% | 3.30% | ||||
Minimum [Member] | Mortgage Notes [Member] | Mortgage notes payable [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Contractual interest rates | 3.31% | 3.31% | ||||
Maximum [Member] | Medium-term Notes [Member] | Unsecured Term Loan due 2022 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Contractual interest rates, basis spread on variable rate | 1.75% | |||||
Maximum [Member] | Mortgage Notes [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Contractual interest rates | 6.90% | 6.90% | ||||
Maximum [Member] | Mortgage Notes [Member] | Mortgage notes payable [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Contractual interest rates | 6.88% | 6.88% |
Notes and Bonds Payable - Narra
Notes and Bonds Payable - Narrative (Details) | Dec. 27, 2017USD ($) | Nov. 01, 2017USD ($) | Jul. 05, 2016USD ($) | Apr. 24, 2015USD ($)swap_agreement | Feb. 15, 2013extension_option | Dec. 31, 2017USD ($)swap_agreement | Dec. 31, 2017USD ($)swap_agreement | Dec. 31, 2017USD ($)swap_agreement | Dec. 31, 2016USD ($)swap_agreement | Dec. 31, 2015USD ($)swap_agreement | Jan. 30, 2018USD ($)swap_agreementderivative | Dec. 20, 2017USD ($)swap_agreement | Dec. 18, 2017Lender | Dec. 11, 2017USD ($) | Feb. 28, 2014USD ($)Lender | Mar. 26, 2013USD ($) | Oct. 14, 2011USD ($) |
Debt Instrument [Line Items] | |||||||||||||||||
Number of interest rate swaps | swap_agreement | 2 | 2 | 2 | ||||||||||||||
Unsecured term loan outstanding | $ 1,293,916,000 | $ 1,293,916,000 | $ 1,293,916,000 | ||||||||||||||
Interest paid | 64,395,000 | $ 55,878,000 | $ 69,773,000 | ||||||||||||||
Loss on extinguishment of debt | 45,000,000 | $ (44,985,000) | $ (27,998,000) | ||||||||||||||
Number of forward starting swaps | swap_agreement | 4 | 4 | 4 | ||||||||||||||
Subsequent Event [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Number of interest rate swaps | derivative | 2 | ||||||||||||||||
Line of Credit [Member] | Unsecured Credit Facility [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Unsecured credit facility | $ 700,000,000 | ||||||||||||||||
Number of extension options | extension_option | 2 | ||||||||||||||||
Period of extension option | 6 months | ||||||||||||||||
Extension fees as percentage of aggregate commitments | 0.075% | ||||||||||||||||
Facility fee on the aggregate amount of commitments | 0.20% | ||||||||||||||||
Amount outstanding under Unsecured Credit Facility | $ 189,000,000 | $ 189,000,000 | $ 189,000,000 | ||||||||||||||
Weighted average interest rate (LOC) | 2.56% | 2.56% | 2.56% | ||||||||||||||
Remaining borrowing capacity | $ 511,000,000 | $ 511,000,000 | $ 511,000,000 | ||||||||||||||
Line of Credit [Member] | Unsecured Credit Facility [Member] | Minimum [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Facility fee on the aggregate amount of commitments | 0.13% | ||||||||||||||||
Line of Credit [Member] | Unsecured Credit Facility [Member] | Maximum [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Facility fee on the aggregate amount of commitments | 0.30% | ||||||||||||||||
Line of Credit [Member] | Unsecured Credit Facility [Member] | LIBOR [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Percentage of interest in addition to LIBOR | 1.00% | ||||||||||||||||
Contractual interest rates, basis spread on variable rate | 1.00% | ||||||||||||||||
Line of Credit [Member] | Unsecured Credit Facility [Member] | LIBOR [Member] | Minimum [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Percentage of interest in addition to LIBOR | 0.83% | ||||||||||||||||
Line of Credit [Member] | Unsecured Credit Facility [Member] | LIBOR [Member] | Maximum [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Percentage of interest in addition to LIBOR | 1.55% | ||||||||||||||||
Medium-term Notes [Member] | Term Loan due 2022 [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Weighted average interest rate (LOC) | 2.77% | 2.77% | 2.77% | ||||||||||||||
Senior notes face value | $ 200,000,000 | ||||||||||||||||
Number of lenders, term loan | Lender | 9 | 9 | |||||||||||||||
Amount of debt repaid | $ 50,000,000 | ||||||||||||||||
Contractual interest rates, basis spread on variable rate | 1.10% | ||||||||||||||||
Number of interest rate swaps | swap_agreement | 2 | ||||||||||||||||
Unsecured term loan outstanding | $ 150,000,000 | $ 150,000,000 | $ 150,000,000 | ||||||||||||||
Medium-term Notes [Member] | Term Loan due 2022 [Member] | Subsequent Event [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Number of interest rate swaps | swap_agreement | 2 | ||||||||||||||||
Derivative notional amount | $ 50,000,000 | ||||||||||||||||
Derivative, fixed interest rate | 2.46% | ||||||||||||||||
Medium-term Notes [Member] | Term Loan due 2022 [Member] | Interest Rate Swap [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Derivative notional amount | $ 25,000,000 | ||||||||||||||||
Derivative, fixed interest rate | 2.18% | ||||||||||||||||
Medium-term Notes [Member] | Term Loan due 2022 [Member] | Minimum [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Contractual interest rates, basis spread on variable rate | 0.90% | ||||||||||||||||
Medium-term Notes [Member] | Term Loan due 2022 [Member] | Maximum [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Contractual interest rates, basis spread on variable rate | 1.75% | ||||||||||||||||
Medium-term Notes [Member] | Term Loan due 2022 [Member] | LIBOR [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Contractual interest rates, basis spread on variable rate | 1.10% | ||||||||||||||||
Senior Notes [Member] | Senior Notes due 2021 [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Senior notes face value | 0 | 0 | $ 0 | $ 400,000,000 | |||||||||||||
Amount of debt repaid | $ 300,000,000 | $ 100,000,000 | 400,000,000 | $ 400,000,000 | |||||||||||||
Extinguishment of debt, number of transactions | 2 | ||||||||||||||||
Aggregate redemption price of debt | 452,300,000 | ||||||||||||||||
Interest paid | 9,500,000 | ||||||||||||||||
Make-whole payment on early extinguishment of debt | 42,800,000 | ||||||||||||||||
Write off of unamortized deferred financing costs | 2,200,000 | ||||||||||||||||
Loss on extinguishment of debt | $ 45,000,000 | ||||||||||||||||
Interest rate on senior notes | 5.75% | 5.75% | 5.75% | ||||||||||||||
Unaccreted discount | $ 0 | $ 0 | $ 0 | 1,510,000 | |||||||||||||
Senior Notes [Member] | Senior Notes due 2023 [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Senior notes face value | $ 250,000,000 | $ 250,000,000 | $ 250,000,000 | 250,000,000 | $ 250,000,000 | ||||||||||||
Interest rate on senior notes | 3.75% | 3.75% | 3.75% | 3.75% | |||||||||||||
Unaccreted discount | $ 1,178,000 | $ 1,178,000 | $ 1,178,000 | 1,375,000 | $ 2,100,000 | ||||||||||||
Deferred finance costs, gross | $ 2,100,000 | ||||||||||||||||
Interest rate yielded per annum upon issuance | 3.95% | ||||||||||||||||
Amount of amortization included in interest expense on the Company's consolidated Statements of operations | 200,000 | 200,000 | $ 200,000 | ||||||||||||||
Amortization of debt issuance costs | 200,000 | 200,000 | 200,000 | ||||||||||||||
Senior Notes [Member] | Senior Notes due 2025 [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Senior notes face value | $ 250,000,000 | $ 250,000,000 | $ 250,000,000 | $ 250,000,000 | 250,000,000 | ||||||||||||
Interest rate on senior notes | 3.875% | 3.88% | 3.88% | 3.88% | |||||||||||||
Unaccreted discount | $ 200,000 | $ 160,000 | $ 160,000 | $ 160,000 | 178,000 | ||||||||||||
Deferred finance costs, gross | $ 2,300,000 | ||||||||||||||||
Interest rate yielded per annum upon issuance | 4.08% | ||||||||||||||||
Amortization of debt issuance costs | 200,000 | 200,000 | 100,000 | ||||||||||||||
Number of forward starting swaps | swap_agreement | 4 | ||||||||||||||||
Senior Notes [Member] | Senior Notes due 2025 [Member] | Interest Rate Swap [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Loss on forward starting interest rate swap agreements recognized in OCI | $ 1,700,000 | ||||||||||||||||
Senior Notes [Member] | Senior Notes due 2028 [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Senior notes face value | $ 300,000,000 | $ 300,000,000 | $ 300,000,000 | $ 300,000,000 | |||||||||||||
Interest rate on senior notes | 3.63% | 3.63% | 3.63% | 3.625% | |||||||||||||
Unaccreted discount | $ 2,529,000 | $ 2,529,000 | $ 2,529,000 | $ 2,500,000 | |||||||||||||
Deferred finance costs, gross | $ 2,700,000 | ||||||||||||||||
Interest rate yielded per annum upon issuance | 3.84% | ||||||||||||||||
Mortgage Notes [Member] | Minimum [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Interest rate on senior notes | 3.30% | 3.30% | 3.30% | ||||||||||||||
Mortgage Notes [Member] | Maximum [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Interest rate on senior notes | 6.90% | 6.90% | 6.90% | ||||||||||||||
Mortgage Notes [Member] | Mortgage notes payable [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Senior notes face value | $ 154,916,000 | $ 154,916,000 | $ 154,916,000 | 114,934,000 | |||||||||||||
Unaccreted discount | $ 1,332,000 | $ 1,332,000 | 1,332,000 | 1,450,000 | |||||||||||||
Amortization of debt issuance costs | 100,000 | 200,000 | 200,000 | ||||||||||||||
Amortization of debt discount | 300,000 | 300,000 | 800,000 | ||||||||||||||
Amortization of debt premium | $ 700,000 | $ 900,000 | $ 1,000,000 | ||||||||||||||
Mortgage Notes [Member] | Mortgage notes payable [Member] | Minimum [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Interest rate on senior notes | 3.31% | 3.31% | 3.31% | ||||||||||||||
Mortgage Notes [Member] | Mortgage notes payable [Member] | Maximum [Member] | |||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||
Interest rate on senior notes | 6.88% | 6.88% | 6.88% |
Notes and Bonds Payable - Senio
Notes and Bonds Payable - Senior Notes (Details) - USD ($) | Dec. 31, 2017 | Dec. 11, 2017 | Dec. 31, 2016 | Apr. 24, 2015 | Mar. 26, 2013 |
Debt Instrument [Line Items] | |||||
Issuance costs | $ (7,488,000) | ||||
Notes and bonds payable | 1,283,880,000 | $ 1,264,370,000 | |||
Senior Notes [Member] | Senior Notes due 2021 [Member] | |||||
Debt Instrument [Line Items] | |||||
Senior notes face value | 0 | 400,000,000 | |||
Unaccreted discount | 0 | (1,510,000) | |||
Issuance costs | 0 | (1,343,000) | |||
Notes and bonds payable | 0 | 397,147,000 | |||
Senior Notes [Member] | Senior Notes due 2023 [Member] | |||||
Debt Instrument [Line Items] | |||||
Senior notes face value | 250,000,000 | 250,000,000 | $ 250,000,000 | ||
Unaccreted discount | (1,178,000) | (1,375,000) | $ (2,100,000) | ||
Issuance costs | (1,119,000) | (1,329,000) | |||
Notes and bonds payable | 247,703,000 | 247,296,000 | |||
Senior Notes [Member] | Senior Notes due 2025 [Member] | |||||
Debt Instrument [Line Items] | |||||
Senior notes face value | 250,000,000 | 250,000,000 | $ 250,000,000 | ||
Unaccreted discount | (160,000) | (178,000) | $ (200,000) | ||
Issuance costs | (1,796,000) | (2,003,000) | |||
Notes and bonds payable | 248,044,000 | 247,819,000 | |||
Senior Notes [Member] | Senior Notes due 2028 [Member] | |||||
Debt Instrument [Line Items] | |||||
Senior notes face value | 300,000,000 | $ 300,000,000 | |||
Unaccreted discount | (2,529,000) | $ (2,500,000) | |||
Issuance costs | (2,714,000) | ||||
Notes and bonds payable | $ 294,757,000 | $ 0 |
Notes and Bonds Payable - Mortg
Notes and Bonds Payable - Mortgage Notes (Details) $ in Thousands | Dec. 31, 2017USD ($)mortgage_note_payable | Dec. 31, 2016USD ($) |
Debt Instrument [Line Items] | ||
Issuance costs | $ (7,488) | |
Notes and bonds payable | $ 1,283,880 | $ 1,264,370 |
Number of Outstanding Mortgage Notes | mortgage_note_payable | 18 | |
Mortgage Notes [Member] | ||
Debt Instrument [Line Items] | ||
Issuance costs | $ (900) | |
Number of Outstanding Mortgage Notes | mortgage_note_payable | 19 | |
Mortgage notes payable [Member] | Mortgage Notes [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 154,916 | 114,934 |
Unamortized premium | 2,651 | 2,569 |
Unaccreted discount | (1,332) | (1,450) |
Issuance costs | (853) | (436) |
Notes and bonds payable | 155,382 | $ 115,617 |
Municipal Government [Member] | Mortgage Notes 4.79% [Member] | Mortgage Notes [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | 11,000 | |
Unamortized premium | $ 1,000 | |
Number of Outstanding Mortgage Notes | mortgage_note_payable | 3 |
Notes and Bonds Payable - Detai
Notes and Bonds Payable - Details of Mortgage Notes (Details) $ in Millions | 12 Months Ended | |
Dec. 31, 2017USD ($)mortgage_note_payable | Dec. 31, 2016USD ($) | |
Debt Instrument [Line Items] | ||
Number of outstanding mortgage notes | mortgage_note_payable | 18 | |
Mortgage Notes [Member] | ||
Debt Instrument [Line Items] | ||
Investment in Collateral | $ 400.9 | |
Mortgage notes payable carrying amount | $ 155.4 | $ 115.6 |
Number of outstanding mortgage notes | mortgage_note_payable | 19 | |
Mortgage Notes [Member] | Maximum [Member] | ||
Debt Instrument [Line Items] | ||
Contractual interest rates | 6.90% | |
Mortgage Notes [Member] | Minimum [Member] | ||
Debt Instrument [Line Items] | ||
Contractual interest rates | 3.30% | |
Mortgage Notes [Member] | Mortgage Notes 5.53% [Member] | Life Insurance Co. [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 7 | |
Effective Interest rate | 5.53% | |
Maturity Date | 2018-01 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/15-yr amort. | |
Principal and interest amortization period | 15 years | |
Investment in Collateral | $ 0 | |
Mortgage notes payable carrying amount | 0 | 0.7 |
Unemcumbered gross investment | 14.3 | |
Mortgage Notes [Member] | Mortgage Notes 5.55% [Member] | Commercial Bank [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 1.8 | |
Effective Interest rate | 5.55% | |
Maturity Date | 2030-10 | |
Collateral | OTH | |
Principal and Interest Payments | Monthly/27-yr amort. | |
Principal and interest amortization period | 27 years | |
Investment in Collateral | $ 0 | |
Mortgage notes payable carrying amount | 0 | 1.3 |
Unemcumbered gross investment | 8 | |
Mortgage Notes [Member] | Mortgage Notes 5.54% [Member] | Insurance Co. [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 7.3 | |
Effective Interest rate | 5.54% | |
Maturity Date | 2018-12 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/25-yr amort. | |
Principal and interest amortization period | 25 years | |
Investment in Collateral | $ 14.3 | |
Mortgage notes payable carrying amount | 6 | 6.2 |
Unamortized premium | 0.6 | |
Mortgage Notes [Member] | Mortgage Notes 5.07% [Member] | Commercial Bank [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 9.5 | |
Effective Interest rate | 5.07% | |
Maturity Date | 2019-03 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/5-yr amort. | |
Principal and interest amortization period | 5 years | |
Investment in Collateral | $ 13.9 | |
Mortgage notes payable carrying amount | 9.3 | 9.5 |
Unamortized premium | 0.2 | |
Mortgage Notes [Member] | Mortgage Notes 4.55% [Member] | Commercial Bank [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 9.4 | |
Effective Interest rate | 4.55% | |
Maturity Date | 2019-07 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/8-yr amort | |
Principal and interest amortization period | 8 years | |
Investment in Collateral | $ 27.8 | |
Mortgage notes payable carrying amount | 9.2 | 9.3 |
Unamortized premium | 0.3 | |
Mortgage Notes [Member] | Mortgage Notes 7.65% [Member] | Commercial Bank [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 15.2 | |
Effective Interest rate | 7.65% | |
Maturity Date | 2020-07 | |
Collateral | MOB | |
Principal and Interest Payments | (21) | |
Principal and interest amortization period | 11 years | |
Investment in Collateral | $ 20.2 | |
Mortgage notes payable carrying amount | 12.7 | 12.7 |
Unaccreted discount | $ 2.4 | |
Period for monthly installments of interest | 24 months | |
Mortgage Notes [Member] | Mortgage Notes 4.00% [Member] | Life Insurance Co. [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 7.9 | |
Effective Interest rate | 4.00% | |
Maturity Date | 2020-08 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/15-yr amort. | |
Principal and interest amortization period | 15 years | |
Investment in Collateral | $ 20.7 | |
Mortgage notes payable carrying amount | 2 | 2.7 |
Unamortized premium | 0.3 | |
Mortgage Notes [Member] | Mortgage Notes 5.25% [Member] | Life Insurance Co. [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 7.3 | |
Effective Interest rate | 5.25% | |
Maturity Date | 2020-08 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/27-yr amort. | |
Principal and interest amortization period | 27 years | |
Investment in Collateral | $ 17.9 | |
Mortgage notes payable carrying amount | 6.5 | 6.7 |
Unamortized premium | 0.4 | |
Mortgage Notes [Member] | Mortgage Notes 4.27% [Member] | Life Insurance Co. [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 5.6 | |
Effective Interest rate | 4.27% | |
Maturity Date | 2021-01 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/10-yr amort. | |
Principal and interest amortization period | 10 years | |
Investment in Collateral | $ 15.7 | |
Mortgage notes payable carrying amount | 4.8 | 0 |
Unamortized premium | 0.2 | |
Mortgage Notes [Member] | Mortgage Notes 6.43% [Member] | Commercial Bank [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 12.9 | |
Effective Interest rate | 6.43% | |
Maturity Date | 2021-02 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/12-yr amort. | |
Principal and interest amortization period | 12 years | |
Investment in Collateral | $ 54.9 | |
Mortgage notes payable carrying amount | 10.5 | 10.7 |
Unaccreted discount | 1 | |
Mortgage Notes [Member] | Mortgage Notes 3.85% [Member] | Life Insurance Co. [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 11 | |
Effective Interest rate | 3.85% | |
Maturity Date | 2022-11 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/7-yr amort. | |
Principal and interest amortization period | 7 years | |
Investment in Collateral | $ 22 | |
Mortgage notes payable carrying amount | 10.4 | 0 |
Unaccreted discount | 0.1 | |
Mortgage Notes [Member] | Mortgage Notes 3.85% [Member] | Life Insurance Co. [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 12.3 | |
Effective Interest rate | 3.85% | |
Maturity Date | 2023-08 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/7-yr amort. | |
Principal and interest amortization period | 7 years | |
Investment in Collateral | $ 24.6 | |
Mortgage notes payable carrying amount | 11.5 | 0 |
Unaccreted discount | 0.2 | |
Mortgage Notes [Member] | Mortgage Notes 4.27% [Member] | Financial Services [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 12.4 | |
Effective Interest rate | 4.27% | |
Maturity Date | 2023-10 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/10-yr amort. | |
Principal and interest amortization period | 10 years | |
Investment in Collateral | $ 24.7 | |
Mortgage notes payable carrying amount | 12.2 | 0 |
Unamortized premium | 0.4 | |
Mortgage Notes [Member] | Mortgage Notes 4.13% [Member] | Life Insurance Co. [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 13.3 | |
Effective Interest rate | 4.13% | |
Maturity Date | 2024-01 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/10-yr amort. | |
Principal and interest amortization period | 10 years | |
Investment in Collateral | $ 21.1 | |
Mortgage notes payable carrying amount | 13.3 | 13.6 |
Unamortized premium | 0.8 | |
Mortgage Notes [Member] | Mortgage Notes 3.94% [Member] | Life Insurance Co. [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 6.8 | |
Effective Interest rate | 3.94% | |
Maturity Date | 2024-02 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/7-yr amort. | |
Principal and interest amortization period | 7 years | |
Investment in Collateral | $ 14.5 | |
Mortgage notes payable carrying amount | 6.7 | 0 |
Unamortized premium | 0.2 | |
Mortgage Notes [Member] | Mortgage Notes 4.32% [Member] | Financial Services [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 9.7 | |
Effective Interest rate | 4.32% | |
Maturity Date | 2024-09 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/10-yr amort. | |
Principal and interest amortization period | 10 years | |
Investment in Collateral | $ 16.4 | |
Mortgage notes payable carrying amount | 8.8 | 9.1 |
Unamortized premium | 0.1 | |
Mortgage Notes [Member] | Mortgage Notes 3.71% [Member] | Commercial Bank [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 11.5 | |
Effective Interest rate | 3.71% | |
Maturity Date | 2026-01 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/10-yr amort. | |
Principal and interest amortization period | 10 years | |
Investment in Collateral | $ 37.9 | |
Mortgage notes payable carrying amount | 10.5 | 11 |
Mortgage Notes [Member] | Mortgage Notes 5.25% 20 Year [Member] | Commercial Bank [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 15 | |
Effective Interest rate | 5.25% | |
Maturity Date | 2027-04 | |
Collateral | MOB | |
Principal and Interest Payments | Monthly/20-yr amort. | |
Principal and interest amortization period | 20 years | |
Investment in Collateral | $ 33.4 | |
Mortgage notes payable carrying amount | 9.6 | 10.4 |
Unamortized premium | 0.7 | |
Mortgage Notes [Member] | Mortgage Notes 4.79% [Member] | Municipal Government [Member] | ||
Debt Instrument [Line Items] | ||
Mortgage notes | $ 11 | |
Effective Interest rate | 4.79% | |
Collateral | MOB | |
Principal and Interest Payments | Semi-Annual (20) | |
Investment in Collateral | $ 20.9 | |
Mortgage notes payable carrying amount | 11.4 | $ 11.7 |
Unamortized premium | $ 1 | |
Number of outstanding mortgage notes | mortgage_note_payable | 3 |
Notes and Bonds Payable - Futur
Notes and Bonds Payable - Future Maturities (Details) $ in Thousands | Dec. 31, 2017USD ($)mortgage_note_payable | Dec. 31, 2016USD ($) |
Long Term Debt Maturities [Line Items] | ||
Number of outstanding mortgage notes | mortgage_note_payable | 18 | |
Excluded debt issuance costs | $ 3,500 | |
Future contractual maturities of the Company's notes and bonds payable | ||
Principal Maturities | 1,293,916 | |
Net Accretion/Amortization | (2,548) | |
Debt Issuance Costs (2) | (7,488) | |
Notes and bonds payable | $ 1,283,880 | $ 1,264,370 |
% | 100.00% | |
2018 [Member] | ||
Future contractual maturities of the Company's notes and bonds payable | ||
Principal Maturities | $ 10,605 | |
Net Accretion/Amortization | (18) | |
Debt Issuance Costs (2) | (1,051) | |
Notes and bonds payable | $ 9,536 | |
% | 0.70% | |
2019 [Member] | ||
Future contractual maturities of the Company's notes and bonds payable | ||
Principal Maturities | $ 22,711 | |
Net Accretion/Amortization | (224) | |
Debt Issuance Costs (2) | (1,044) | |
Notes and bonds payable | $ 21,443 | |
% | 1.70% | |
2020 [Member] | ||
Future contractual maturities of the Company's notes and bonds payable | ||
Principal Maturities | $ 211,803 | |
Net Accretion/Amortization | (382) | |
Debt Issuance Costs (2) | (1,039) | |
Notes and bonds payable | $ 210,382 | |
% | 16.40% | |
2021 [Member] | ||
Future contractual maturities of the Company's notes and bonds payable | ||
Principal Maturities | $ 17,321 | |
Net Accretion/Amortization | (312) | |
Debt Issuance Costs (2) | (1,025) | |
Notes and bonds payable | $ 15,984 | |
% | 1.20% | |
2022 [Member] | ||
Future contractual maturities of the Company's notes and bonds payable | ||
Principal Maturities | $ 162,692 | |
Net Accretion/Amortization | (328) | |
Debt Issuance Costs (2) | (1,037) | |
Notes and bonds payable | $ 161,327 | |
% | 12.60% | |
2023 and thereafter [Member] | ||
Future contractual maturities of the Company's notes and bonds payable | ||
Principal Maturities | $ 868,784 | |
Net Accretion/Amortization | (1,284) | |
Debt Issuance Costs (2) | (2,292) | |
Notes and bonds payable | $ 865,208 | |
% | 67.40% |
Derivative Financial Instrume77
Derivative Financial Instruments (Details) | 12 Months Ended | |||
Dec. 31, 2017USD ($)swap_agreement | Dec. 31, 2016swap_agreement | Dec. 31, 2015USD ($)swap_agreement | Jan. 30, 2018USD ($)derivative | |
Derivative [Line Items] | ||||
Number of forward starting swaps | swap_agreement | 4 | 4 | 4 | |
Derivatives in a net liability position | $ 100,000 | |||
Derivative termination value | 100,000 | |||
Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months | $ (300,000) | |||
Number of interest rate derivatives | swap_agreement | 2 | |||
Cash Flow Hedging [Member] | Forward Starting Interest Rate Swap [Member] | ||||
Derivative [Line Items] | ||||
Notional value | $ 225,000,000 | |||
Subsequent Event [Member] | ||||
Derivative [Line Items] | ||||
Number of interest rate derivatives | derivative | 2 | |||
Subsequent Event [Member] | Cash Flow Hedging [Member] | Interest Rate Contract [Member] | ||||
Derivative [Line Items] | ||||
Notional value | $ 50,000,000 |
Derivative Financial Instrume78
Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details) $ in Millions | Dec. 31, 2017USD ($)swap_agreement |
Derivative [Line Items] | |
Number of interest rate swaps | 2 |
Cash Flow Hedging [Member] | Designated as Hedging Instrument [Member] | Interest Rate Swap [Member] | |
Derivative [Line Items] | |
Number of interest rate swaps | 2 |
Derivative notional amount | $ | $ 25 |
Derivative Financial Instrume79
Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details) - Interest Rate Swap [Member] - Designated as Hedging Instrument [Member] $ in Thousands | Dec. 31, 2017USD ($) |
Derivatives, Fair Value [Line Items] | |
Liability Derivatives, Fair Value | $ 67 |
Other Liabilities [Member] | |
Derivatives, Fair Value [Line Items] | |
Liability Derivatives, Fair Value | $ 67 |
Derivative Financial Instrume80
Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details) - Cash Flow Hedging [Member] - Designated as Hedging Instrument [Member] - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Derivative [Line Items] | ||
Amount of Loss Recognized in OCI on Derivative | $ 74 | |
Interest Rate Contract [Member] | ||
Derivative [Line Items] | ||
Amount of Loss Recognized in OCI on Derivative | 74 | |
Interest Rate Swap [Member] | ||
Derivative [Line Items] | ||
Amount of Loss Recognized in OCI on Derivative | 0 | |
Interest Expense [Member] | ||
Derivative [Line Items] | ||
Amount of Loss Reclassified from OCI into Income | 176 | $ 168 |
Interest Expense [Member] | Interest Rate Contract [Member] | ||
Derivative [Line Items] | ||
Amount of Loss Reclassified from OCI into Income | 7 | 0 |
Interest Expense [Member] | Interest Rate Swap [Member] | ||
Derivative [Line Items] | ||
Amount of Loss Reclassified from OCI into Income | $ 169 | $ 168 |
Stockholders' Equity - Common s
Stockholders' Equity - Common shares (Details) - shares | Aug. 14, 2017 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 |
Reconciliation of the beginning and ending common stock outstanding | ||||
Balance, beginning of year (shares) | 116,417,000 | |||
Balance, end of year (shares) | 125,132,000 | 116,417,000 | ||
Common Stock [Member] | ||||
Reconciliation of the beginning and ending common stock outstanding | ||||
Balance, beginning of year (shares) | 116,416,900 | 101,517,009 | 98,828,098 | |
Issuance of common stock (shares) | 8,337,500 | 8,395,607 | 14,063,100 | 2,493,171 |
Non-vested stock-based awards, net of withheld shares and forfeitures (shares) | 319,086 | 836,791 | 195,740 | |
Balance, end of year (shares) | 125,131,593 | 116,416,900 | 101,517,009 |
Stockholders' Equity - Narrativ
Stockholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions | Feb. 13, 2018 | Aug. 14, 2017 | Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | May 02, 2017 | May 01, 2017 |
Class of Stock [Line Items] | |||||||||||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | |||||||
Dividend per share to common stockholders, paid (in dollars per share) | $ 0.3 | $ 0.3 | $ 0.3 | 1.20 | $ 1.20 | $ 1.20 | |||||
Dividends per share to common stockholders, declared (in dollars per share) | $ 0.30 | $ 1.20 | |||||||||
Common stock, authorized shares | 300,000,000 | 300,000,000 | 150,000,000 | 300,000,000 | 150,000,000 | ||||||
Number of common shares authorized to be repurchased (shares) | 3,000,000 | 3,000,000 | |||||||||
Dividend Declared [Member] | Subsequent Event [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Dividends per share to common stockholders, declared (in dollars per share) | $ 0.30 | ||||||||||
Common Stock [Member] | |||||||||||
Class of Stock [Line Items] | |||||||||||
Issuance of common stock (shares) | 8,337,500 | 8,395,607 | 14,063,100 | 2,493,171 | |||||||
Price per share (dollars per share) | $ 30.90 | ||||||||||
Proceeds from Issuance or Sale of Equity | $ 247.1 |
Stockholders' Equity - At the M
Stockholders' Equity - At the Market Equity Offering Program (Details) $ / shares in Units, $ in Thousands | 12 Months Ended | |||||
Dec. 31, 2017USD ($)$ / sharesshares | Dec. 31, 2016USD ($)$ / sharesshares | Dec. 31, 2015USD ($)$ / sharesshares | Feb. 14, 2018shares | Feb. 19, 2016investment_bankshares | Feb. 17, 2016investment_bank | |
Class of Stock [Line Items] | ||||||
Proceeds from Issuance of Common Stock | $ | $ 248,554 | $ 450,503 | $ 66,942 | |||
At The Market Equity Offering Program [Member] | ||||||
Class of Stock [Line Items] | ||||||
Equity offering program, number of investment banks in sales agreements | investment_bank | 5 | |||||
Equity offering program, shares authorized to be sold | 10,000,000 | |||||
Issuance of common stock (shares) | 0 | 4,795,601 | 2,434,239 | |||
Proceeds from Issuance of Common Stock | $ | $ 0 | $ 144,600 | $ 65,800 | |||
Previous At the Market Equity Offering Program [Member] | ||||||
Class of Stock [Line Items] | ||||||
Equity offering program, number of investment banks in sales agreements | investment_bank | 1 | |||||
Minimum [Member] | At The Market Equity Offering Program [Member] | ||||||
Class of Stock [Line Items] | ||||||
Shares issued during period (USD per share) | $ / shares | $ 0 | $ 28.31 | $ 25 | |||
Maximum [Member] | At The Market Equity Offering Program [Member] | ||||||
Class of Stock [Line Items] | ||||||
Shares issued during period (USD per share) | $ / shares | $ 0 | $ 33.66 | $ 29.15 | |||
Subsequent Event [Member] | At The Market Equity Offering Program [Member] | ||||||
Class of Stock [Line Items] | ||||||
Number of authorized shares remaining under offering program (shares) | 5,868,697 |
Stockholders' Equity - Accumula
Stockholders' Equity - Accumulated Other Comprehensive Income (Details) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017USD ($)swap_agreement | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Number of interest rate swaps | swap_agreement | 2 | ||
Increase to accumulated other comprehensive loss | $ (74) | $ (1,684) | |
Period of impact on net income | 10 years | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Other comprehensive income | $ 102 | $ 168 | $ 950 |
Forward Starting Swaps [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | |||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Balance, beginning of period | (1,401) | ||
Other comprehensive loss before reclassifications | 176 | ||
Amounts reclassified from accumulated other comprehensive income (loss) | (74) | ||
Other comprehensive income | 102 | ||
Balance, end of period | (1,299) | (1,401) | |
Interest Rate Swap [Member] | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Increase to accumulated other comprehensive loss | 100 | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Balance, beginning of period | 1,400 | ||
Balance, end of period | $ 1,300 | $ 1,400 |
Stockholders' Equity - Reclassi
Stockholders' Equity - Reclassifications out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Interest Expense | $ 56,402 | $ 57,351 | $ 65,534 |
Reclassification out of Accumulated Other Comprehensive Income [Member] | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Amounts reclassified from accumulated other comprehensive income (loss) | 176 | ||
Amounts reclassified from accumulated other comprehensive income (loss) related to settled interest rate swaps [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Interest Expense | 169 | ||
Amounts reclassified from accumulated other comprehensive income (loss) related to current interest rate swaps [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | |||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||
Interest Expense | $ 7 |
Benefit Plans (Details Textual)
Benefit Plans (Details Textual) | May 05, 2015USD ($)plan_participant | May 31, 2016USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | May 06, 2016USD ($) |
Defined Benefit Plan Disclosure [Line Items] | |||||
Current period charge | $ 5,300,000 | ||||
Total benefit obligation | $ 19,600,000 | $ 0 | $ 0 | $ 19,600,000 | |
Number of plan participants who have not reached age 65 | plan_participant | 2 | ||||
Chief Executive Officer [Member] | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Lump sum obligation at termination of plan | $ 14,400,000 | ||||
Accumulated Other Comprehensive Income (Loss) [Member] | |||||
Defined Benefit Plan Disclosure [Line Items] | |||||
Current period charge | $ 2,500,000 |
Benefit Plans (Details)
Benefit Plans (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Net periodic benefit cost for both the Executive Retirement Plan and the Outside Director Plan | |||
Service cost | $ 29 | ||
Interest cost | 225 | ||
Amortization of prior service cost (benefit) | (198) | ||
Amortization of net gain | 343 | ||
Total | 399 | ||
Net loss recognized in Accumulated other comprehensive income (loss) | $ 0 | $ 0 | 0 |
Total recognized in net periodic benefit gain and Accumulated other comprehensive income (1) | $ 399 |
Stock and Other Incentive Pla88
Stock and Other Incentive Plans - Amortization of Compensation for Nonvested Shares (Details) $ in Millions | Dec. 31, 2017USD ($) |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
2,018 | $ 9.4 |
2,019 | 7 |
2,020 | 6.7 |
2,021 | 5.7 |
2,022 | 3.2 |
2023 and thereafter | 3.6 |
Total | $ 35.6 |
Stock and Other Incentive Pla89
Stock and Other Incentive Plans (Details) - Stock Incentive Plan [Member] - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Summary of the activity under the incentive plans | |||
Stock-based awards, beginning of year (shares) | 1,786,497 | 1,092,262 | 1,057,732 |
Granted (shares) | 413,489 | 885,219 | 251,789 |
Vested (shares) | (292,341) | (190,984) | (210,955) |
Forfeited (shares) | 0 | 0 | (6,304) |
Stock-based awards, end of year (shares) | 1,907,645 | 1,786,497 | 1,092,262 |
Weighted-average grant date fair value of: | |||
Stock-based awards, beginning of year (in USD per share) | $ 27.18 | $ 24.72 | $ 24.01 |
Stock-based awards granted during the year (in USD per share) | 32.05 | 29.60 | 27.70 |
Stock-based awards vested during the year (in USD per share) | 25.88 | 24.34 | 25.05 |
Stock-based awards forfeited during the year (in USD per share) | 0 | 0 | 24.80 |
Stock-based awards, end of year (in USD per share) | $ 28.44 | $ 27.18 | $ 24.72 |
Grant date fair value of shares granted during the year | $ 13,254 | $ 26,204 | $ 6,975 |
Stock and Other Incentive Pla90
Stock and Other Incentive Plans (Details 1) - Employee Stock Purchase Plan [Member] - USD ($) | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Stock Options Outstanding: | |||
Options outstanding, beginning of year (shares) | 316,321 | 340,958 | 393,902 |
Granted (shares) | 206,824 | 198,450 | 197,640 |
Exercised (shares) | (32,076) | (57,924) | (44,462) |
Forfeited (shares) | (40,659) | (22,081) | (47,176) |
Expired (shares) | (132,310) | (143,082) | (158,946) |
Outstanding, end of period (shares) | 318,100 | 316,321 | 340,958 |
Exercisable, end of period (shares) | 318,100 | 316,321 | 340,958 |
Weighted-average exercise price: | |||
Options outstanding, beginning of year (in USD per share) | $ 23.69 | $ 20.70 | $ 19.17 |
Options granted during the year (in USD per share) | 25.77 | 24.07 | 23.22 |
Options exercised during the year (in USD per share) | 24.31 | 21.40 | 19.41 |
Options forfeited during the year (in USD per share) | 25.01 | 23.16 | 19.90 |
Options expired during the year (in USD per share) | 23.22 | 18.11 | 20.41 |
Options outstanding, end of year (in USD per share) | 25 | 23.69 | 20.70 |
Weighted-average fair value of options granted during the year (calculated as of the grant date) (in USD per share) | $ 6.31 | $ 5.37 | $ 5.39 |
Intrinsic value of options exercised during the year | $ 271,000 | $ 634,000 | $ 381,000 |
Intrinsic value of options outstanding (calculated as of December 31) | 2,683,000 | 2,098,000 | 2,597,000 |
Intrinsic value of options exercisable (calculated as of December 31) | $ 2,682,519 | $ 2,097,898 | $ 2,597,238 |
Exercise prices of options outstanding (calculated as of December 31) (in USD per share) | $ 25 | $ 23.69 | $ 20.70 |
Weighted-average contractual life of outstanding options (calculated as of December 31, in years) | 9 months 18 days | 9 months 18 days | 9 months 18 days |
Stock and Other Incentive Pla91
Stock and Other Incentive Plans (Details 2) | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Fair value of options issued based on weighted-average assumptions | |||
Risk-free interest rates | 1.20% | 1.06% | 0.67% |
Expected dividend yields | 3.70% | 4.64% | 4.79% |
Expected life (in years) | 1 year 5 months 12 days | 1 year 5 months 1 day | 1 year 4 months 17 days |
Expected volatility | 20.40% | 17.60% | 21.00% |
Expected forfeiture rates | 85.00% | 85.00% | 80.00% |
Stock and Other Incentive Pla92
Stock and Other Incentive Plans (Details Textual) | Dec. 11, 2017USD ($)executive_officershares | Dec. 30, 2016USD ($)shares | Dec. 16, 2016USD ($)executive_officershares | Mar. 01, 2016USD ($)shares | Feb. 16, 2016USD ($)executive_officershares | Dec. 18, 2015USD ($)executive_officershares | Jul. 31, 2012 | Mar. 31, 2017USD ($)executive_officershares | Mar. 31, 2016USD ($)executive_officershares | Dec. 31, 2022USD ($) | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Dec. 31, 2018USD ($) | Dec. 31, 2017USD ($)shares | Dec. 31, 2016USD ($)Awardsshares | Dec. 31, 2015USD ($)shares | Dec. 31, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Executive Incentive Plan, Cash-based Award | $ 1,100,000 | |||||||||||||||||
401(k) Plan [Abstract] | ||||||||||||||||||
Percentage of matching contribution | 3.00% | |||||||||||||||||
Value of matching contribution | $ 400,000 | $ 400,000 | $ 400,000 | |||||||||||||||
Discount on market price on the date of grant | 85.00% | |||||||||||||||||
Discount on market price on the date of exercise | 85.00% | |||||||||||||||||
Employee Stock Purchase Plan [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of shares authorized | shares | 25,535 | 63,690 | 96,977 | |||||||||||||||
401(k) Plan [Abstract] | ||||||||||||||||||
Value of shares available for grant each year | $ 25,000 | |||||||||||||||||
Discount on market price on the date of grant | 85.00% | |||||||||||||||||
Discount on market price on the date of exercise | 85.00% | |||||||||||||||||
Option expiration period | 27 months | |||||||||||||||||
Cash received from employees upon exercising options | $ 800,000 | $ 1,200,000 | $ 900,000 | |||||||||||||||
2015 Incentive Plan [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Authorization of common shares to issue | shares | 3,500,000 | |||||||||||||||||
Common shares issued, net of forfeitures | shares | 1,438,228 | 1,024,739 | ||||||||||||||||
Number of shares authorized | shares | 2,061,772 | 2,475,261 | ||||||||||||||||
2015 Incentive Plan [Member] | Restricted Stock [Member] | Minimum [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 3 years | |||||||||||||||||
2015 Incentive Plan [Member] | Restricted Stock [Member] | Maximum [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 8 years | |||||||||||||||||
Stock Incentive Plan [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Common shares issued, net of forfeitures | shares | 1,878,637 | |||||||||||||||||
Granted in period (in shares) | shares | 413,489 | 885,219 | 251,789 | |||||||||||||||
Stock Incentive Plan [Member] | Executive Officer [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Share-based compensation expense | $ 1,700,000 | $ 100,000 | ||||||||||||||||
Number of one-time non-vested share grants | Awards | 3 | |||||||||||||||||
Stock Incentive Plan [Member] | Director [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 1 year | 3 years | ||||||||||||||||
Share-based compensation expense | $ 800,000 | $ 1,000,000 | $ 1,000,000 | |||||||||||||||
Shares issued under the plan | shares | 23,231 | 21,374 | 23,201 | |||||||||||||||
Stock Incentive Plan [Member] | Chief Financial Officer [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 10 years | |||||||||||||||||
Share-based compensation expense | $ 200,000 | |||||||||||||||||
Granted in period (in shares) | shares | 50,000 | |||||||||||||||||
Stock Incentive Plan [Member] | President and Chief Executive Officer [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 10 years | |||||||||||||||||
Share-based compensation expense | $ 600,000 | |||||||||||||||||
Granted in period (in shares) | shares | 200,000 | |||||||||||||||||
Stock Incentive Plan [Member] | Executive Chairman [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 5 years | |||||||||||||||||
Share-based compensation expense | $ 900,000 | |||||||||||||||||
Granted in period (in shares) | shares | 150,000 | |||||||||||||||||
Stock Incentive Plan [Member] | Restricted Stock [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Share-based compensation expense | $ 9,800,000 | $ 7,400,000 | $ 5,900,000 | |||||||||||||||
Withheld of common stock | shares | 94,403 | 48,248 | 49,225 | |||||||||||||||
Stock Incentive Plan [Member] | Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Value of performance based awards released | $ 1,300,000 | $ 1,300,000 | ||||||||||||||||
Shares issued under the plan | shares | 41,368 | 44,162 | ||||||||||||||||
Stock Incentive Plan [Member] | Performance Shares [Member] | Executive Officer [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of executive officers granted awards | executive_officer | 5 | 5 | ||||||||||||||||
Stock Incentive Plan [Member] | Performance Shares [Member] | Senior Vice President [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of executive officers granted awards | executive_officer | 4 | 4 | ||||||||||||||||
Stock Incentive Plan [Member] | Performance Shares [Member] | Officer [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Share-based compensation expense | $ 1,100,000 | $ 0 | $ 1,100,000 | |||||||||||||||
Stock Incentive Plan [Member] | Performance Shares [Member] | Minimum [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 3 years | |||||||||||||||||
Stock Incentive Plan [Member] | Performance Shares [Member] | Maximum [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 8 years | |||||||||||||||||
Stock Incentive Plan [Member] | Performance Shares [Member] | Weighted Average [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 6 years | |||||||||||||||||
Stock Incentive Plan [Member] | Restricted Stock and Performance Based Awards [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Weighted average amortization period remaining | 5 years 1 month 6 days | |||||||||||||||||
Stock Incentive Plan [Member] | Restricted Stock and Performance Based Awards [Member] | Minimum [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 1 year | |||||||||||||||||
Stock Incentive Plan [Member] | Restricted Stock and Performance Based Awards [Member] | Maximum [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 8 years | |||||||||||||||||
Executive Incentive Plan [Member] | Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Share-based compensation expense | $ 5,000,000 | 4,000,000 | 2,700,000 | |||||||||||||||
Executive Incentive Plan [Member] | Performance Shares [Member] | Minimum [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Shareholder return performance period used to measure award | 1 year | |||||||||||||||||
Executive Incentive Plan [Member] | Performance Shares [Member] | Maximum [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Shareholder return performance period used to measure award | 3 years | |||||||||||||||||
Executive Incentive Plan [Member] | 2017 Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 5 years | |||||||||||||||||
Granted in period | $ 10,100,000 | |||||||||||||||||
Granted in period (in shares) | shares | 309,874 | |||||||||||||||||
Executive Incentive Plan [Member] | 2017 Performance Shares [Member] | Executive Officer [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of executive officers granted awards | executive_officer | 5 | |||||||||||||||||
Executive Incentive Plan [Member] | 2017 Performance Shares [Member] | Senior Vice President [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of executive officers granted awards | executive_officer | 4 | |||||||||||||||||
Executive Incentive Plan [Member] | February 2016 Cash Incentive and Performance-based Awards [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Granted in period | $ 5,800,000 | |||||||||||||||||
Executive Incentive Plan [Member] | February 2016 Cash Incentive and Performance-based Awards [Member] | Executive Officer [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of executive officers granted awards | executive_officer | 5 | |||||||||||||||||
Executive Incentive Plan [Member] | February 2016 Cash Incentive and Performance-based Awards [Member] | Senior Vice President [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of executive officers granted awards | executive_officer | 5 | |||||||||||||||||
Executive Incentive Plan [Member] | February 2016 Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Granted in period | $ 4,700,000 | |||||||||||||||||
Granted in period (in shares) | shares | 163,788 | |||||||||||||||||
Executive Incentive Plan [Member] | 2015 Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 3 years | |||||||||||||||||
Granted in period | $ 3,900,000 | |||||||||||||||||
Granted in period (in shares) | shares | 139,000 | |||||||||||||||||
Executive Incentive Plan [Member] | 2015 Performance Shares [Member] | Executive Officer [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of executive officers granted awards | executive_officer | 5 | |||||||||||||||||
Executive Incentive Plan [Member] | 2015 Performance Shares [Member] | Senior Vice President [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of executive officers granted awards | executive_officer | 5 | |||||||||||||||||
Executive Incentive Plan [Member] | 2016 Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 5 years | |||||||||||||||||
Granted in period | $ 6,300,000 | |||||||||||||||||
Granted in period (in shares) | shares | 213,639 | |||||||||||||||||
Executive Incentive Plan [Member] | 2016 Performance Shares [Member] | Executive Officer [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of executive officers granted awards | executive_officer | 5 | |||||||||||||||||
Executive Incentive Plan [Member] | 2016 Performance Shares [Member] | Senior Vice President [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Number of executive officers granted awards | executive_officer | 5 | |||||||||||||||||
Salary Deferral Plan [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Share-based compensation expense | $ 1,200,000 | $ 1,200,000 | $ 1,100,000 | |||||||||||||||
Shares issued under the plan | shares | 39,016 | 42,256 | 55,923 | |||||||||||||||
Maximum salary deferral for officers under the plan, percent | 50.00% | |||||||||||||||||
Dividend Reinvestment Plan [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Authorization of common shares to issue | shares | 1,000,000 | |||||||||||||||||
401(k) Plan [Abstract] | ||||||||||||||||||
Total DRIP shares issued under the Plan | shares | 581,627 | |||||||||||||||||
Total shares issued under the Dividend Reinvestment Plan | shares | 26,031 | 9,575 | 13,950 | |||||||||||||||
3-year Vesting [Member] | Executive Incentive Plan [Member] | February 2016 Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 3 years | |||||||||||||||||
5-year Vesting [Member] | Executive Incentive Plan [Member] | February 2016 Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 5 years | |||||||||||||||||
Deferral Option One [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Salary Deferral Plan employer matching contribution, percent | 30.00% | |||||||||||||||||
Deferral Option One [Member] | Salary Deferral Plan [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 3 years | |||||||||||||||||
Deferral Option Two [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Salary Deferral Plan employer matching contribution, percent | 50.00% | |||||||||||||||||
Deferral Option Two [Member] | Salary Deferral Plan [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 5 years | |||||||||||||||||
Deferral Option Three [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Salary Deferral Plan employer matching contribution, percent | 100.00% | |||||||||||||||||
Deferral Option Three [Member] | Salary Deferral Plan [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Award vesting period | 8 years | |||||||||||||||||
Scenario, Forecast [Member] | Executive Incentive Plan [Member] | 2017 Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Share-based compensation expense | $ 1,900,000 | $ 2,000,000 | $ 2,000,000 | $ 2,000,000 | $ 2,000,000 | |||||||||||||
Scenario, Forecast [Member] | Executive Incentive Plan [Member] | February 2016 Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Share-based compensation expense | 700,000 | 700,000 | 1,100,000 | |||||||||||||||
Scenario, Forecast [Member] | Executive Incentive Plan [Member] | 2015 Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Share-based compensation expense | 1,300,000 | |||||||||||||||||
Scenario, Forecast [Member] | Executive Incentive Plan [Member] | 2016 Performance Shares [Member] | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||
Share-based compensation expense | $ 1,200,000 | $ 1,300,000 | $ 1,300,000 | $ 1,300,000 |
Earnings Per Share (Details)
Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Weighted Average Common Shares | |||||||||||
Weighted average Common Shares outstanding | 119,739,216 | 109,861,580 | 100,280,059 | ||||||||
Non-vested shares | (1,813,058) | (1,289,478) | (1,108,707) | ||||||||
Weighted average Common Shares - Basic | 117,926,158 | 108,572,102 | 99,171,352 | ||||||||
Dilutive effect of non-vested shares | 0 | 709,559 | 623,212 | ||||||||
Dilutive effect of employee stock purchase plan | 91,007 | 105,336 | 85,738 | ||||||||
Weighted average Common Shares - Diluted | 118,017,165 | 109,386,997 | 99,880,302 | ||||||||
Net Income | |||||||||||
Income (loss) from continuing operations | $ (37,151) | $ 3,165 | $ 25,224 | $ 31,858 | $ 52,580 | $ 11,857 | $ 12,157 | $ 9,163 | $ 23,096 | $ 85,756 | $ 58,836 |
Dividends paid on nonvested share-based awards | (2,149) | 0 | 0 | ||||||||
Income from continuing operations applicable to common stockholders | 20,947 | 85,756 | 58,836 | ||||||||
Discontinued operations | 0 | 8 | 0 | (13) | (143) | (23) | (12) | (7) | (4) | (185) | 10,600 |
NET INCOME | $ (37,151) | $ 3,173 | $ 25,224 | $ 31,845 | $ 52,437 | $ 11,834 | $ 12,145 | $ 9,156 | $ 20,943 | $ 85,571 | $ 69,436 |
Basic Earnings (loss) Per Common Share | |||||||||||
Income from continuing operations (in dollars per share) | $ 0.18 | $ 0.79 | $ 0.59 | ||||||||
Income from discontinued operations (in dollars per share) | 0 | 0 | 0.11 | ||||||||
Net income (in dollars per share) | $ (0.31) | $ 0.02 | $ 0.22 | $ 0.28 | $ 0.46 | $ 0.10 | $ 0.12 | $ 0.09 | 0.18 | 0.79 | 0.70 |
Diluted Earnings (loss) Per Common Share | |||||||||||
Income from continuing operations (in dollars per share) | 0.18 | 0.78 | 0.59 | ||||||||
Income from discontinued operations (in dollars per share) | 0 | 0 | 0.11 | ||||||||
Net income (in dollars per share) | $ (0.31) | $ 0.02 | $ 0.22 | $ 0.28 | $ 0.45 | $ 0.10 | $ 0.12 | $ 0.09 | $ 0.18 | $ 0.78 | $ 0.70 |
Commitments and Contingencies -
Commitments and Contingencies - Narrative (Details) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017USD ($)ft²land_parcelpropertyrenewal_optionLease | Dec. 31, 2016USD ($)land_parcel | Dec. 31, 2015USD ($) | |
Property, Plant and Equipment [Line Items] | |||
Approximate square feet | ft² | 14,600,000 | ||
Number of land parcels held for development | land_parcel | 6 | 6 | |
Investment in land held for development | $ 20,100 | $ 20,100 | |
Number of ground leases | property | 109 | ||
Square feet subject to ground leases | ft² | 8,900,000 | ||
Ground leases, weighted average remaining term | 68 years 8 months 12 days | ||
Approximately corporate office lease covers of rented space | ft² | 36,653 | ||
Rental expense relating to the operating leases | $ 6,300 | 5,700 | $ 5,100 |
Number of ground leases prepaid | Lease | 48 | ||
Prepaid ground leases which represented rental expense | $ 500 | $ 500 | $ 500 |
Number of ground leases, excluding prepaid leases | Lease | 61 | ||
First and Second Generation Leases [Member] | Tenant Improvement Allowances [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Anticipated amount of investment | $ 27,800 | ||
Tennessee [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Number of redevelopment properties under expansion | property | 1 | ||
Total amount funded | $ 12,600 | ||
Tennessee [Member] | Tenant Improvement Allowances [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Total amount funded | $ 3,200 | ||
Medical Office Building Expansion [Member] | North Carolina [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Approximate square feet | ft² | 38,000 | ||
Medical Office Building [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Total amount funded | $ 5,759 | ||
Estimated total investment | 76,120 | ||
Estimated remaining fundings (unaudited) | $ 70,361 | ||
Approximate square feet | ft² | 355,000 | ||
Total Funded During the Year | $ 5,073 | ||
Medical Office Building [Member] | North Carolina [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Total amount funded | 3,487 | ||
Estimated total investment | 12,000 | ||
Estimated remaining fundings (unaudited) | $ 8,513 | ||
Approximate square feet | ft² | 204,000 | ||
Total Funded During the Year | $ 3,264 | ||
Medical Office Building [Member] | Washington [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Total amount funded | 2,272 | ||
Estimated total investment | 64,120 | ||
Estimated remaining fundings (unaudited) | $ 61,848 | ||
Approximate square feet | ft² | 151,000 | ||
Total Funded During the Year | $ 1,809 | ||
Medical Office Building [Member] | Colorado [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Total amount funded | $ 14,600 | ||
Approximate square feet | ft² | 99,957 | ||
Medical Office Building [Member] | Colorado [Member] | Tenant Improvement Allowances [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Total amount funded | $ 2,800 | ||
Minimum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Ground leases, initial term | 50 years | ||
Ground leases, number of renewal options | renewal_option | 1 | ||
Ground leases, renewal term | 75 years | ||
Maximum [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Ground leases, initial term | 75 years | ||
Ground leases, number of renewal options | renewal_option | 2 | ||
Ground leases, renewal term | 100 years |
Commitments and Contingencies95
Commitments and Contingencies - Construction Activity (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2017USD ($)ft²property | |
Other Commitments [Line Items] | |
Number of Properties | property | 201 |
Approximate Square Feet | ft² | 14,600,000 |
Medical Office Building [Member] | |
Other Commitments [Line Items] | |
Construction in Progress Balance | $ 5,458 |
Total Funded During the Year | 5,073 |
Total Amount Funded | 5,759 |
Estimated Remaining Fundings (unaudited) | 70,361 |
Estimated Total Investment (unaudited) | $ 76,120 |
Approximate Square Feet | ft² | 355,000 |
North Carolina [Member] | Medical Office Building [Member] | |
Other Commitments [Line Items] | |
Number of Properties | property | 1 |
Construction in Progress Balance | $ 3,487 |
Total Funded During the Year | 3,264 |
Total Amount Funded | 3,487 |
Estimated Remaining Fundings (unaudited) | 8,513 |
Estimated Total Investment (unaudited) | $ 12,000 |
Approximate Square Feet | ft² | 204,000 |
Washington [Member] | Medical Office Building [Member] | |
Other Commitments [Line Items] | |
Number of Properties | property | 1 |
Construction in Progress Balance | $ 1,971 |
Total Funded During the Year | 1,809 |
Total Amount Funded | 2,272 |
Estimated Remaining Fundings (unaudited) | 61,848 |
Estimated Total Investment (unaudited) | $ 64,120 |
Approximate Square Feet | ft² | 151,000 |
Commitments and Contingencies96
Commitments and Contingencies - Minimum lease payments (Details) $ in Thousands | Dec. 31, 2017USD ($) |
Future minimum lease payments due to the Company under property operating agreements | |
2,018 | $ 5,341 |
2,019 | 5,420 |
2,020 | 5,459 |
2,021 | 5,488 |
2,022 | 5,516 |
2023 and thereafter | 283,056 |
Total | $ 310,280 |
Other Data (Details)
Other Data (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Income Tax Disclosure [Abstract] | |||
Net income | $ 23,092 | $ 85,571 | $ 69,436 |
Reconciling items to taxable income: | |||
Depreciation and amortization | 46,426 | 38,260 | 30,457 |
Gain or loss on disposition of depreciable assets | 1,570 | (32,103) | 1,659 |
Impairments | 0 | 121 | 687 |
Straight-line rent | (4,551) | (7,101) | (8,833) |
Receivable allowances | 1,680 | 2,067 | 571 |
Stock-based compensation | 1,855 | 1,301 | 7,518 |
Other | 6,552 | 2,236 | 4,304 |
Reconciling items to taxable income, total | 53,532 | 4,781 | 36,363 |
Taxable income | 76,624 | 90,352 | 105,799 |
Dividends paid | $ 142,327 | $ 131,759 | $ 120,266 |
Other Data (Details 1)
Other Data (Details 1) - $ / shares | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Characterization of distributions on common stock | |||
Ordinary income per share | $ 0.42 | $ 0.78 | $ 0.61 |
Return of capital per share | 0.50 | 0.35 | 0.08 |
Unrecaptured section 1250 gain per share | 0.28 | 0.07 | 0.51 |
Common stock distributions per share | $ 1.2 | $ 1.2 | $ 1.2 |
Ordinary income in percent of common stock distribution | 34.50% | 65.00% | 51.00% |
Return of capital in percent of common stock distribution | 42.00% | 29.50% | 6.70% |
Unrecaptured section 1250 gain in percent of common stock distribution | 23.50% | 5.50% | 42.30% |
Common stock distribution in percentage | 100.00% | 100.00% | 100.00% |
Other Data (Details 2)
Other Data (Details 2) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
State income tax expense: | |||
Texas gross margins tax | $ 608 | $ 562 | $ 528 |
Other | 0 | 2 | 37 |
Total state income tax expense | 608 | 564 | 565 |
State income tax payments, net of refunds and collections | $ 555 | $ 544 | 758 |
Income tax expense in discontinued operations | $ 50 |
Other Data (Details Textual)
Other Data (Details Textual) - USD ($) | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Other Data (Textual) [Abstract] | |||
Condition to qualify as a REIT as defined under the Internal Revenue Code | Company must meet a number of organizational and operational requirements, including a requirement that it currently distribute at least 90% of its taxable income to its stockholders. | ||
Estimated aggregate total cost of total assets for federal income tax purposes | $ 4,000,000,000 | $ 3,700,000,000 | $ 3,400,000,000 |
Number of preferred shares outstanding | 0 | 0 | 0 |
Dividends distributed to preferred shares | $ 0 |
Fair Value of Financial Inst101
Fair Value of Financial Instruments (Details) - USD ($) $ in Millions | Dec. 31, 2017 | Dec. 31, 2016 |
Carrying Value [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Notes and bonds payable | $ 1,283.9 | $ 1,264.4 |
Fair Value [Member] | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Notes and bonds payable | $ 1,269.7 | $ 1,265.1 |
Selected Quarterly Financial102
Selected Quarterly Financial Data (unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Summary of quarterly financial information | |||||||||||
Revenues from continuing operations | $ 107,731 | $ 106,953 | $ 105,245 | $ 104,569 | $ 105,309 | $ 103,659 | $ 102,642 | $ 100,021 | $ 424,499 | $ 411,630 | $ 388,471 |
Income (loss) from continuing operations | (37,151) | 3,165 | 25,224 | 31,858 | 52,580 | 11,857 | 12,157 | 9,163 | 23,096 | 85,756 | 58,836 |
Income (loss) from discontinued operations | 0 | 8 | 0 | (13) | (143) | (23) | (12) | (7) | (4) | (185) | 10,600 |
NET INCOME | $ (37,151) | $ 3,173 | $ 25,224 | $ 31,845 | $ 52,437 | $ 11,834 | $ 12,145 | $ 9,156 | $ 20,943 | $ 85,571 | $ 69,436 |
Net income attributable to common stockholders per share: | |||||||||||
Basic earnings per common share (dollars per share) | $ (0.31) | $ 0.02 | $ 0.22 | $ 0.28 | $ 0.46 | $ 0.10 | $ 0.12 | $ 0.09 | $ 0.18 | $ 0.79 | $ 0.70 |
Diluted earnings per common share (dollars per share) | $ (0.31) | $ 0.02 | $ 0.22 | $ 0.28 | $ 0.45 | $ 0.10 | $ 0.12 | $ 0.09 | $ 0.18 | $ 0.78 | $ 0.70 |
Selected Quarterly Financial103
Selected Quarterly Financial Data (unaudited) - Additional information (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | ||||||
Dec. 31, 2017USD ($) | Sep. 30, 2017USD ($) | Jun. 30, 2017USD ($)property | Mar. 31, 2017USD ($)property | Dec. 31, 2016USD ($)property | Dec. 31, 2017USD ($)property | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($)property | |
Quarterly Financial Information Disclosure [Abstract] | ||||||||
Gain on sales of real estate assets | $ 16,100 | $ 23,400 | $ 41,000 | $ 39,519 | $ 41,038 | $ 56,602 | ||
Number of properties sold | property | 3 | 6 | 6 | 2 | 2 | |||
Impairment charges | $ 5,100 | |||||||
Loss on extinguishment of debt | $ (45,000) | $ 44,985 | $ 27,998 |
Schedule II - Valuation and 104
Schedule II - Valuation and Qualifying Accounts (Details) - Accounts receivable allowance [Member] - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Balance at Beginning of Period | $ 148 | $ 179 | $ 465 |
Charged/(Credited) to Costs and Expenses, Additions and Deductions | 159 | (21) | (194) |
Charged to Other Accounts, Additions and Deductions | 0 | 0 | 0 |
Uncollectible Accounts Written-off | 51 | 10 | 92 |
Balance at End of Period | $ 256 | $ 148 | $ 179 |
Schedule III - Real Estate a105
Schedule III - Real Estate and Accumulated Depreciation (Details) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2017USD ($)propertyProperty | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | Dec. 31, 2014USD ($) | |
Summary of real estate properties | ||||
Number of Properties | property | 201 | |||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Gross real estate asset, Total | $ 3,907,010 | $ 3,633,993 | $ 3,382,680 | $ 3,271,536 |
Accumulated depreciation | $ 933,220 | $ 843,816 | $ 762,996 | $ 705,135 |
Medical office/outpatient [Member] | ||||
Summary of real estate properties | ||||
Number of Properties | Property | 193 | |||
State | AL, AZ, CA, CO, DC, FL, GA, HI, IA, IL, IN, LA, MD, MI, MN, MO, MS, NC, OH, OK, SC, SD, TN, TX, VA, WA | |||
Land (1) | ||||
Initial Investment | $ 190,813 | |||
Cost Capitalized Subsequent to Acquisition | 3,862 | |||
Total | 194,675 | |||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Initial Investment | 2,823,611 | |||
Cost Capitalized Subsequent to Acquisition | 502,564 | |||
Total | 3,326,175 | |||
Personal Property | 4,193 | |||
Gross real estate asset, Total | 3,525,043 | |||
Accumulated depreciation | 835,768 | |||
Encumbrances | $ 154,916 | |||
Medical office/outpatient [Member] | Minimum [Member] | ||||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Date Acquired | Jan. 1, 1993 | |||
Date Constructed | Jan. 1, 1906 | |||
Medical office/outpatient [Member] | Maximum [Member] | ||||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Date Acquired | Dec. 31, 2017 | |||
Date Constructed | Dec. 31, 2015 | |||
Inpatient [Member] | ||||
Summary of real estate properties | ||||
Number of Properties | Property | 6 | |||
State | CA, CO, MO, PA, TX | |||
Land (1) | ||||
Initial Investment | $ 8,179 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Total | 8,179 | |||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Initial Investment | 255,495 | |||
Cost Capitalized Subsequent to Acquisition | 9,861 | |||
Total | 265,356 | |||
Personal Property | 0 | |||
Gross real estate asset, Total | 273,535 | |||
Accumulated depreciation | 66,780 | |||
Encumbrances | $ 0 | |||
Inpatient [Member] | Minimum [Member] | ||||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Date Acquired | Jan. 1, 1994 | |||
Date Constructed | Jan. 1, 1986 | |||
Inpatient [Member] | Maximum [Member] | ||||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Date Acquired | Dec. 31, 2013 | |||
Date Constructed | Dec. 31, 2013 | |||
Other [Member] | ||||
Summary of real estate properties | ||||
Number of Properties | Property | 10 | |||
State | IA, MI, TN, TX, VA | |||
Land (1) | ||||
Initial Investment | $ 2,992 | |||
Cost Capitalized Subsequent to Acquisition | 73 | |||
Total | 3,065 | |||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Initial Investment | 66,440 | |||
Cost Capitalized Subsequent to Acquisition | 7,143 | |||
Total | 73,583 | |||
Personal Property | 600 | |||
Gross real estate asset, Total | 77,248 | |||
Accumulated depreciation | 26,032 | |||
Encumbrances | $ 0 | |||
Other [Member] | Minimum [Member] | ||||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Date Acquired | Jan. 1, 1993 | |||
Date Constructed | Jan. 1, 1964 | |||
Other [Member] | Maximum [Member] | ||||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Date Acquired | Dec. 31, 2015 | |||
Date Constructed | Dec. 31, 2015 | |||
Real Estate [Member] | ||||
Summary of real estate properties | ||||
Number of Properties | Property | 209 | |||
Land (1) | ||||
Initial Investment | $ 201,984 | |||
Cost Capitalized Subsequent to Acquisition | 3,935 | |||
Total | 205,919 | |||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Initial Investment | 3,145,546 | |||
Cost Capitalized Subsequent to Acquisition | 519,568 | |||
Total | 3,665,114 | |||
Personal Property | 4,793 | |||
Gross real estate asset, Total | 3,875,826 | |||
Accumulated depreciation | 928,580 | |||
Encumbrances | $ 154,916 | |||
Land Held for Development [Member] | ||||
Summary of real estate properties | ||||
Number of Properties | Property | 0 | |||
Land (1) | ||||
Initial Investment | $ 20,123 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Total | 20,123 | |||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Initial Investment | 0 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Total | 0 | |||
Personal Property | 0 | |||
Gross real estate asset, Total | 20,123 | |||
Accumulated depreciation | 239 | |||
Encumbrances | 0 | |||
Construction in Progress [Member] | ||||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Total | 5,458 | |||
Gross real estate asset, Total | $ 5,458 | |||
Corporate Property [Member] | ||||
Summary of real estate properties | ||||
Number of Properties | Property | 0 | |||
Land (1) | ||||
Initial Investment | $ 0 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Total | 0 | |||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Initial Investment | 0 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Total | 0 | |||
Personal Property | 5,603 | |||
Gross real estate asset, Total | 5,603 | |||
Accumulated depreciation | 4,401 | |||
Encumbrances | $ 0 | |||
Owned Property [Member] | ||||
Summary of real estate properties | ||||
Number of Properties | Property | 209 | |||
Land (1) | ||||
Initial Investment | $ 222,107 | |||
Cost Capitalized Subsequent to Acquisition | 3,935 | |||
Total | 226,042 | |||
Buildings, Improvements, Lease Intangibles and CIP (1) | ||||
Initial Investment | 3,145,546 | |||
Cost Capitalized Subsequent to Acquisition | 519,568 | |||
Total | 3,670,572 | |||
Personal Property | 10,396 | |||
Gross real estate asset, Total | 3,907,010 | |||
Accumulated depreciation | 933,220 | |||
Encumbrances | $ 154,916 |
Schedule III - Real Estate a106
Schedule III - Real Estate and Accumulated Depreciation (Details 1) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Reconciliation of Carrying Amount of Real Estate Investments [Roll Forward] | |||
Beginning Balance, Total Property | $ 3,633,993 | $ 3,382,680 | $ 3,271,536 |
Retirement/dispositions: | |||
Ending Balance, Total Property | 3,907,010 | 3,633,993 | 3,382,680 |
Reconciliation of Real Estate Accumulated Depreciation [Roll Forward] | |||
Beginning Balance, Accumulated Depreciation | 843,816 | 762,996 | 705,135 |
Retirement/dispositions: | |||
Ending Balance, Accumulated Depreciation | 933,220 | 843,816 | 762,996 |
Real Estate [Member] | |||
Additions during the period: | |||
Total Property | 322,616 | 239,265 | 183,478 |
Retirement/dispositions: | |||
Total Property | (123,639) | (94,143) | (139,741) |
Ending Balance, Total Property | 3,875,826 | ||
Additions during the period: | |||
Accumulated Depreciation | 4,206 | 3,898 | 3,048 |
Retirement/dispositions: | |||
Accumulated Depreciation | (50,683) | (44,696) | (56,838) |
Ending Balance, Accumulated Depreciation | 928,580 | ||
Other improvements [Member] | |||
Additions during the period: | |||
Total Property | 59,442 | 70,595 | 47,985 |
Additions during the period: | |||
Accumulated Depreciation | 135,807 | 121,592 | 111,625 |
Land held for development [Member] | |||
Additions during the period: | |||
Total Property | 0 | 0 | 500 |
Retirement/dispositions: | |||
Total Property | 0 | 0 | (102) |
Additions during the period: | |||
Accumulated Depreciation | 74 | 26 | 26 |
Retirement/dispositions: | |||
Accumulated Depreciation | 0 | 0 | 0 |
Construction in Progress [Member] | |||
Additions during the period: | |||
Total Property | 14,598 | 35,596 | 19,024 |
Retirement/dispositions: | |||
Ending Balance, Total Property | 5,458 | ||
Additions during the period: | |||
Accumulated Depreciation | $ 0 | $ 0 | $ 0 |
Schedule III - Real Estate a107
Schedule III - Real Estate and Accumulated Depreciation (Details Textual) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017USD ($)property | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | |
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Number of real estate assets held for sale | property | 8 | ||
Gross value of assets held for sale | $ 68,400 | ||
Accumulated depreciation on real estate assets held for sale | 35,800 | ||
Issuance costs | 7,488 | ||
Estimated aggregate total cost of total assets for federal income tax purposes | $ 4,000,000 | $ 3,700,000 | $ 3,400,000 |
Minimum [Member] | Building and improvements [Member] | |||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Asset estimated useful life | 3 years 3 months 18 days | ||
Minimum [Member] | Lease intangibles [Member] | |||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Asset estimated useful life | 2 years 1 month 6 days | ||
Minimum [Member] | Personal Property [Member] | |||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Asset estimated useful life | 2 years 9 months 18 days | ||
Minimum [Member] | Land improvements [Member] | |||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Asset estimated useful life | 5 years | ||
Maximum [Member] | Building and improvements [Member] | |||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Asset estimated useful life | 39 years | ||
Maximum [Member] | Lease intangibles [Member] | |||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Asset estimated useful life | 99 years 6 days | ||
Maximum [Member] | Personal Property [Member] | |||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Asset estimated useful life | 20 years | ||
Maximum [Member] | Land improvements [Member] | |||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Asset estimated useful life | 39 years | ||
Mortgage Notes [Member] | |||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Issuance costs | $ 900 | ||
Mortgage notes payable [Member] | Mortgage Notes [Member] | |||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||
Unamortized premium | 2,651 | 2,569 | |
Unaccreted discount | 1,332 | 1,450 | |
Issuance costs | $ 853 | $ 436 |
Schedule IV - Mortgage Loans108
Schedule IV - Mortgage Loans on Real Estate (Details 1) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Rollforward of Mortgage loans on real estate | |||
Balance at beginning of period | $ 0 | $ 0 | $ 1,900 |
Deductions during period: | |||
Principal repayments and reductions | 0 | 0 | (1,900) |
Deductions during period, total | 0 | 0 | (1,900) |
Balance at end of period | $ 0 | $ 0 | $ 0 |